Page last updated: 2024-12-10

rutin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hydroxyethylrutoside: Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

quercetin-3-O-rutinoside: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
ViolagenusA plant genus of the family VIOLACEAE. Some species in this genus are called bouncing bet which is a common name more often used with SAPONARIA OFFICINALIS. Members contain macrocyclic peptides.[MeSH]ViolaceaeA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.[MeSH]
ViolagenusA plant genus of the family VIOLACEAE. Some species in this genus are called bouncing bet which is a common name more often used with SAPONARIA OFFICINALIS. Members contain macrocyclic peptides.[MeSH]ViolaceaeA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID5280805
CHEMBL ID226335
CHEBI ID28527
SCHEMBL ID23243
MeSH IDM0019316
PubMed CID5293655
CHEMBL ID32579
CHEBI ID91643
SCHEMBL ID3764184
SCHEMBL ID23244
SCHEMBL ID21424757
MeSH IDM0019316

Synonyms (231)

Synonym
BIDD:ER0377
BIDD:PXR0020
KBIO1_000644
DIVK1C_000644
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-mannopyranoside
3-rhamnoglucoside of 3,3',4',5,7-pentahydroxyflavone
rutinum
ccris 7564
3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
3,3',4',5,7-pentahydroxyflavone-3-rutinoside
quercetin, 3-(6-o-alpha-l-rhamnopyranosyl-beta-d-glucopyranoside)
quercetin, 3-(6-0-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
rutinoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-3-yl
ai3-19098
quercetin-3beta-rutinoside
bioflavonoid
rutosido [inn-spanish]
rutosidum
quercetin rhamnoglucosine
rutosidum [inn-latin]
einecs 205-814-1
nsc 9220
rutosido
rutine
rutinoside, quercetin-3, beta-
glucopyranoside, quercetin-3 6-o-alpha-l-rhamnopyranosyl-, beta-d
3,3',4',5,5',7-hexahydroxyflavone (6-o-alpha-l-rhamnosyl-beta-d-glucoside)
brn 0075455
quercetin 3-o-beta-d-rutinoside
glucopyranoside, quercetin-3 6-o-(6-deoxy-alpha-l-mannopyranosyl)-, beta-d-
4h-1-benzopyran-4-one, 3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
usaf cf-5
flavone, 3,3',4',5,7-pentahydroxy-, 3-(o-rhamnosylglucoside)
quercetin-3-rutinoside
CHEBI:28527 ,
rutinic acid
3-rutinosyl quercetin
birutin
quercetin 3-rhamnoglucoside
3-rhamnoglucosylquercetin
tanrutin
rutabion
ilixanthin
paliuroside
globularicitrin
oxyritin
quercetol 3-rhamnoglucoside
c.i. 75730
melin
globulariacitrin
osyritrin
violaquercitrin
myrticolorin
venoruton
rutozyd
quercitin 3-rutinoside
eldrin
rutinion acid
birutan forte
nsc-9220
birutan
quercetin 3-o-rutinoside
IDI1_000644
RUT ,
MEGXP0_000068
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
4h-1-benzopyran-4-one, 3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]-oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
3'4'5,7-tetoh-flavone-3-rut
MLS001424098
C05625
phytomelin
quercetin 3-rutinoside
RUTIN ,
rutoside
153-18-4
3-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
smr000112560
MLS000759398
DB01698
NCGC00160628-01
ACON1_000075
NINDS_000644
hydroxyethylrutoside
quercetin 3-o-[alpha-l-rhamnosyl-(1->6)-beta-d-glucoside]
A8241DA0-6EC6-48BA-BD10-3F7BD61D42CE
HMS2051B06
novarrutina
violaquercetrin
CHEMBL226335 ,
yunxianggan
BRD-K20482099-001-01-1
rutoside (inn)
venoruton (tn)
D08499
HMS502A06
cid_5280805
bdbm50217942
R0035
3,3',4',5,7-pentahydroxyflavone 3-rutinoside
A809400
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one;rutin
NCGC00160628-02
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
rutin [jan:nf]
rutoside [inn:jan:nf]
5-18-05-00519 (beilstein handbook reference)
5g06tvy3r7 ,
unii-5g06tvy3r7
dtxsid3022326 ,
tox21_111945
dtxcid802326
cas-153-18-4
NCGC00260150-01
tox21_202602
rutoside (rutin)
CCG-100999
rutin (quercetin-3-o-rutinoside) (constituent of ginkgo) [dsc]
rutin [mi]
quercetin 3-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucopyranoside
rutin [inci]
rutin [vandf]
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-chromen-4-one-3-yl 6-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucoside
rutin [usp-rs]
3-rhamnoglucoside of 5,7,3',4'-tetrahydroxyflavonol
rutoside [who-dd]
rutin [dsc]
rutoside [inn]
AKOS015895432
S2350
AB00374708-09
NC00249
SCHEMBL23243
tox21_111945_1
NCGC00160628-03
Q-201691
4h-1-benzopyran-4-one, 3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
3,3',4',5,7-pentahydroxyflavone-3-rhamnoglucoside
CS-5573
HY-N0148
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4h-chromen-4-one
SR-01000759399-5
sr-01000759399
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
neoisorutin
quercetin 3-o-beta-delta-rutinoside
beta-quercetin-3-rutinoside
4h-1-benzopyran-4-one,3-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
DS-9708
Q407857
rutin (rutoside)
rutin from sophora japonica l.
mfcd00006830
rutin,(s)
methyltetrahydro-2h-pyran-2-yloxy)methyl)
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3
-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-
tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
BRD-K20482099-001-11-0
rutin, powder
EN300-18388402
rutosido (inn-spanish)
rutosidum (inn-latin)
not applicable
rutin (usp-rs)
2-(3,4-dihydroxyphenyl)-4,5-dihydroxy-3-(3,4,5-trihydroxy-6-((3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl)oxymethyl)tetrahydropyran-2-yl)oxy-chromen-7-one
c05ca01
rutin1541
HMS3393B06
rutinoside,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-3-yl
quercetol 3-rhamnoglucodide
3,4',5,7-pentahydroxyflavone-3-rutinoside
flavone,3',4',5,7-pentahydroxy-, 3-(o-rhamnosylglucoside)
nsc9220 ,
quercetin 3-rhamnoglycoside
osyritin
sophorin
rutosid
myticolorin
quercetin 3-o-.beta.-d-rutinoside
wln: t66 bo evj cr cq dq & gq iq do-bt6otj cq dq eq f1o-bt6otj cq dq eq f1
myrticalorin
rutinoside, .beta.-
quercetin, 3-(6-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucopyranoside)
3-rhamnoglycosylquercetin
quercetin-3.beta.-rutinoside
quercetin, 3-(6-0-(6-deoxy-.alpha.-l-mannopyranosyl-.beta.-d-glucopyranoside)
vitamin p
q1
flavone-3-rutinoside, 3,3',4',5,7-pentahydroxy
10163-13-0
rutin, cadmium deriv.
nsc-408168
SMP2_000101
NCGC00142380-01
quercetin-3-o-rutinoside
AKOS001581212
BRD-A34907681-001-01-7
SCHEMBL3764184
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-4-one
STK682155
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxyhexopyranosyl)hexopyranoside
CHEMBL32579
NCGC00017207-02
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{3,4,5-trihydroxy-6-[(3,4,5-trihydroxy -6-methyl(2h-3,4,5,6-tetrahydropyran-2-yloxy))methyl](2h-3,4,5,6-tetrahydropyr an-2-yloxy)}chromen-4-one
ilixathin
FT-0601605
STL455123
2-(3,4-dihydroxyphenyl)-4,5-dihydroxy-7-oxo-7h-chromen-3-yl 6-o-(6-deoxyhexopyranosyl)hexopyranoside
SCHEMBL23244
AKOS021617510
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxy-6-(3,4,5-trihydroxy-6-methyltetrahydro-2h-2-pyranyloxymethyl)tetrahydro-2h-2-pyranyloxy)-4h-4-chromenone
quercetin 3-o-robinobioside
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxyhexopyranosyl)hexopyranoside #
quercetin-3-o-rutinose
949926-49-2
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]-4h-chromen-4-one
CHEBI:91643
HMS3651K20
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl)oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
bdbm237184
Q27163468
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyl-2-oxanyl)oxymethyl]-2-oxanyl]oxy]-1-benzopyran-4-one
dl-rutin
1558680-22-0
SCHEMBL21424757
B0005-190152
CCA52535
DTXSID70859300
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-3-yl 6-o-(6-deoxyhexopyranosyl)hexopyranoside

Research Excerpts

Overview

Rutin (RUT) is a biologically active flavonoid that is reported to modulate radiation-induced brain dysfunctions. Rutin is a natural antioxidant compound with several therapeutic benefits.

ExcerptReferenceRelevance
"Rutin is a common dietary flavonoid that is widely consumed worldwide from plant-derived beverages and foods as traditional and folk medicine remedy as well."( Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
Baldisserotto, A; Bino, A; De Lucia, D; Gambari, R; Lampronti, I; Manfredini, S; Milani, R; Vertuani, S, 2015
)
1.39
"Rutin is a natural antioxidant compound with several therapeutic benefits. "( Nanophytosomes for enhancement of rutin efficacy in oral administration for diabetes treatment in streptozotocin-induced diabetic rats.
Amjadi, S; Azarmi, Y; Ebrahimi, A; Ghanbarzadeh, S; Hamishehkar, H; Kouhsoltani, M; Shahnaz, F; Shokouhi, B; Siahi-Shadbad, M, 2021
)
2.34
"Rutin (RUT) is a biologically active flavonoid that is reported to modulate radiation-induced brain dysfunctions. "( Tailoring of chitosan/diacrylated pluronic system as a versatile nanoplatform for the amelioration of radiation-induced cognitive dysfunction.
Abdel-Naby, DH; Deghiedy, NM; El-Ghazaly, MA; Rashed, RR, 2021
)
2.06
"Rutin is a flavonoid compound with many pharmacological activities, including antioxidation, anti-inflammation and cardiovascular and cerebrovascular protection. "( The protective effect of rutin against lipopolysaccharide induced acute lung injury in mice based on the pharmacokinetic and pharmacodynamic combination model.
Cui, C; Jin, Z; Li, C; Liang, Y; Liu, M; Qu, C; Shao, Y; Sun, S; Tian, C, 2022
)
2.47
"Rutin is a kind of widely distributed dietary flavonoids, which have the ability to resist alcohol-induced liver injury."( Insight into the binding characteristics of rutin and alcohol dehydrogenase: Based on the biochemical method, spectroscopic experimental and molecular model.
Chen, F; Huang, X; Li, N; Li, Y; Tuo, X; Yang, X; Zeng, G; Zhang, S, 2022
)
1.7
"Rutin is a natural flavonoid, with typical effects including interaction with enzymes and scavenging of free radicals. "( The protective effect of rutin against the cisplatin-induced cochlear damage in vitro.
He, Y; Liu, C; Liu, S; Ma, J; Tang, D; Wu, C; Yan, R; Zheng, S; Zheng, Z; Zuo, N, 2022
)
2.47
"Rutin is a natural flavonoid with potential prebiotic effects on regulating the intestinal flora composition that is beneficial for host health."( Intestinal Flora Mediates Antiobesity Effect of Rutin in High-Fat-Diet Mice.
Guan, L; Jiang, J; Liu, H; Peng, L; Qiao, Y; Yan, X; Zhai, Y; Zhou, W, 2022
)
1.7
"Rutin is an anti-inflammatory, anti-oxidant, anti-allergic, and antiviral flavonoid molecule, known to have anti-atherosclerotic and autophagy-inducing properties, but its biological mechanism remains poorly understood."( Rutin Inhibits Ox-LDL-Mediated Macrophage Inflammation and Foam Cell Formation by Inducing Autophagy and Modulating PI3K/ATK Signaling.
Ji, Y; Li, B; Liu, C; Lu, X; Wang, C; Wang, X; Xu, X; Yi, C, 2022
)
2.89
"Rutin is a flavonoid glycoside compound, which is mainly transported via the blood circulation system in the human body. "( MWCNTs-CTAB and HFs-Lac Nanocomposite-Modified Glassy Carbon Electrode for Rutin Determination.
Hong, J; Li, YY; Ma, XX; Meng, X; Moosavi-Movahedi, AA; Song, XY; Xiao, BL, 2022
)
2.39
"Rutin is a natural bioactive flavonoid that is poor in water solubility and chemical stability. "( Degradation kinetics of rutin encapsulated in oil-in-water emulsions: impact of particle size.
Fu, Y; Liu, C; Luo, S; McClements, DJ; Ye, J, 2023
)
2.66
"Rutin (RUT) is a flavonoid with various biological properties."( Molecular and biochemical investigation of the protective effects of rutin against liver and kidney toxicity caused by malathion administration in a rat model.
Gur, C; Kandemir, FM, 2023
)
1.87
"Rutin is a natural flavonol glycoside that is present in various plants and has useful biological effects, such as anti-inflammatory, anticancer, and antioxidative effects."( Rutin alleviates bisphenol A-glycidyl methacrylate-induced generation of proinflammatory mediators through the MAPK and NF-κB pathways in macrophages.
Chang, YC; Huang, FM; Kuan, YH; Lee, MW; Su, NY; Yang, LC, 2023
)
3.07
"Rutin (RUT) is a flavonoid obtained from a natural source and is reported for antithrombotic potential, but its delivery remains challenging because of its poor solubility and bioavailability. "( GPIIb/IIIa Receptor Targeted Rutin Loaded Liposomes for Site-Specific Antithrombotic Effect.
Kumar, S; Mahto, SK; Mehata, AK; Muthu, MS; Priya, V; Revand, R; Singh, SK; Sushmitha, P, 2023
)
2.64
"Rutin is a flavonoid glycoside, well-known for its antioxidant, anticarcinogenic, and cardioprotective properties. "( Fast and selective production of quercetin and saccharides from rutin using microwave-assisted hydrothermal treatment in the presence of graphene oxide.
Issasi, CSC; Kamogawa, R; Kida, T; Manalu, HT; Quitain, AT; Sasaki, M, 2023
)
2.59
"Rutin is a naturally active compound with biological and medical value. "( Synthesis of a magnetic micelle molecularly imprinted polymers to selective adsorption of rutin from Sophora japonica.
Qiu, J; Wang, Z; Yang, X; Zhang, H; Zhao, Q, 2023
)
2.57
"Rutin is a natural anti-inflammatory ingredient widely found in medicinal plants. "( Rutin ameliorates inflammatory pain by inhibiting P2X7 receptor in mast cells.
Jia, K; Jiang, Y; Lv, J; Shen, X; Tang, Z; Yang, Y; Ye, F; Zhang, J; Zhu, C; Zong, Y, 2023
)
3.8
"Rutin is a flavonoid glycoside present in many fruits and plants and has several beneficial properties, including antioxidant effects."( Protective effect of rutin against thiram-induced cytotoxicity and oxidative damage in human erythrocytes.
Arif, A; Mahmood, R; Salam, S; Sharma, M, 2023
)
1.95
"Rutin is a therapeutic flavonol which is massively accumulated in Tartary buckwheat."( A transcriptional complex of FtMYB102 and FtbHLH4 coordinately regulates the accumulation of rutin in Fagopyrum tataricum.
Chen, S; Li, Y; Liu, T; Ma, P; Meng, X; Mi, Y; Qian, G; Shi, Y; Sun, W; Tul-Wahab, A; Vanhaelewyn, L; Viczián, A; Yang, W; Zhang, D, 2023
)
1.85
"Rutin is a polyphenolic compound having a low molecular weight."( An Overview of Biosynthetic Pathway and Therapeutic Potential of Rutin.
Goyal, J; Verma, PK, 2023
)
1.87
"Rutin is a bioflavonoid with antioxidant, anti-inflammatory, anti-hepatotoxic, and antimicrobial properties."( Role of NF-κB/IL-1β Pathway and Caspase 3 in Mediating the Hepatoprotective Effect of Rutin against Paraquat-Induced Liver Toxicity in Male Rats.
Heidarian, E; Nouri, A; Rafiee, S, 2023
)
1.85
"Rutin is a biologically active polyphenol, but its poor water solubility and low bioavailability limit its application to the food industry. "( Effect of ultrasound treatment on interactions of whey protein isolate with rutin.
Guo, N; Pan, S; Wang, Z; Xu, J; Ye, S; Zhang, F; Zhang, Y; Zhou, G; Zhu, G, 2023
)
2.58
"Rutin is a flavonoid glycoside that exhibits nephro-protective and radio-protective properties."( Rutin protects against gamma-irradiation and malathion-induced oxidative stress and inflammation through regulation of mir-129-3p, mir-200C-3p, and mir-210 gene expressions in rats' kidney.
Eassawy, MMT; Ismail, AFM; Salem, AA, 2023
)
3.07
"Rutin is a flavonoid found in various food sources, and previous studies indicate it has protective effects in HD models and acts as a metal chelator."( Toxicity of copper and zinc alone and in combination in Caenorhabditis elegans model of Huntington's disease and protective effects of rutin.
Arantes, LP; Baptista, FBO; Cordeiro, LM; da Silva, AF; da Silveira, TL; de Oliveira, GV; de Souza, LI; Dos Santos, LV; Dressler, VL; Pappis, C; Soares, FAA; Soares, MV; Zheng, F, 2023
)
1.83
"Rutin is a flavonoid polyphenol with excellent biological activity, but due to its instability and poor water solubility, the utilization rate is reduced in vivo. "( Soybean protein isolate/chitosan complex-rutin microcapsules.
Dong, S; Hu, SM; Yu, SJ; Zhou, S; Zhou, T, 2023
)
2.62
"Rutin is a known compound for its neuroprotective effects."( Comprehensive insight into the molecular interaction of rutin with human transferrin: Implication of natural compounds in neurodegenerative diseases.
Furkan, M; Khan, MS; Khan, RH; Shahwan, M; Shamsi, A; Yadav, DK, 2023
)
1.88
"Rutin (RUTIN) is a natural flavonoid with multiple biological activities, and its use in against kidney damage has been widely studied in recent years."( Rutin ameliorate PFOA induced renal damage by reducing oxidative stress and improving lipid metabolism.
Liu, H; Ma, X; Ren, X; Wang, G; Wang, L; Zhang, X, 2024
)
3.61
"Rutin is a bioflavonoid found in many plants and derived foods, accordingly, rutin likely interacts with α-amino acids such as Lys, Ile, His or Glu to give Maillard reaction products (MRPs). "( Enhancing the antioxidative effects of foods containing rutin and α-amino acids via the Maillard reaction: A model study focusing on rutin-lysine system.
Chen, Y; Guan, H; Jiang, Y; Li, D; Li, F; Liu, H; Sun-Waterhouse, D, 2020
)
2.25
"Rutin is a glycoside of the bioactive quercetin with various health-improving effects due to its antioxidant ability."( Formation of a bovine serum albumin diligand complex with rutin and single-walled carbon nanotubes for the reduction of cytotoxicity.
Long, X; Lu, N; Peng, YY; Tian, R; Yang, Z, 2020
)
1.52
"Rutin (RT) is a natural flavonoid with many biological activities."( P38 Signal Transduction Pathway Has More Cofactors on Apoptosis of SGC-7901 Gastric Cancer Cells Induced by Combination of Rutin and Oxaliplatin.
Chen, S; Gu, Z; Li, Q; Qin, M; Ren, L; Tan, Q; Zhang, T; Zhang, Y, 2019
)
1.44
"Rutin is a glycoside of the bioflavonoid quercetin with various protective effects due to its antioxidant ability."( Formation of a bovine serum albumin diligand complex with rutin for the suppression of heme toxicity.
Lu, N; Luo, M; Sui, Y; Tian, R, 2020
)
1.52
"Rutin is a flavonoid found in plants, buckwheat, some teas and also in apples."( Rutin protects Huntington's disease through the insulin/IGF1 (IIS) signaling pathway and autophagy activity: Study in Caenorhabditis elegans model.
Arantes, LP; Cordeiro, LM; da Silva, AF; da Silveira, TL; Machado, ML; Obetine Baptista, FB; Soares, FAA, 2020
)
2.72
"Rutin is a flavonol glycoside present in apple, buckwheat, black tea and green tea."( Longevity-promoting efficacies of rutin in high fat diet fed Drosophila melanogaster.
Chattopadhyay, D; Thirumurugan, K, 2020
)
1.56
"Rutin is a glycoside of the flavonoid quercetin that has been reported to have a beneficial role in controlling various diseases such as hypertension, arteriosclerosis, diabetes, and obesity."( Identification and tissue-specific expression of rutin biosynthetic pathway genes in Capparis spinosa elicited with salicylic acid and methyl jasmonate.
Abdollahi, MR; Dastan, D; Kianersi, F; Mirzaie-Asl, A; Rasheed, F, 2020
)
1.53
"Rutin is a flavonol glycoside that can be found in a wide variety of vegetables and has activity, anti-cancer, anti-inflammatory and anti-diabetic properties."( ORAL RUTIN SUSPENSION INTERVENE IN HEPATIC HYPERPLASIA IN RATS.
Barros, PP; Eisinger, ABC; GonÇalves, GMS; Silva, GHD,
)
2.09
"Rutin is a polyphenolic natural flavonoid which has antioxidant and anti-proliferative activity."( Concomitant administration of sitagliptin and rutin improves the adverse hepatic alterations in streptozotocin-induced diabetes mellitus in albino rats: an overview of the role of alpha smooth muscle actin.
Abdel Fattah, S; Attia, RA; Nasralla, MM, 2021
)
1.6
"Rutin is a polyphenol with excellent therapeutic potential and good safety profile, but the poor bioavailability restricts its application as a functional ingredient. "( Encapsulation of rutin using quinoa and maize starch nanoparticles.
Remanan, MK; Zhu, F, 2021
)
2.4
"Rutin is an important flavonoid consumed in the daily diet. "( Rutin improves glutamate uptake and inhibits glutamate excitotoxicity in rat brain slices.
Castro E Silva, JH; Costa, MFD; Costa, SL; da Silva, AB; da Silva, VDA; de Araújo, FM; de Assis, AM; Dos Santos Souza, C; Ferreira, RS; Moreira, JCF; Nonose, Y; Núñez-Figueredo, Y; Pereira, ÉPL; Souza, DO; Teles-Souza, J, 2021
)
3.51
"Rutin is a metabolic regulator with a poor solubility."( Sodium rutin extends lifespan and health span in mice including positive impacts on liver health.
Chen, J; Cheng, J; Cui, Q; Li, J; Li, S; Pan, R; Yuan, Z, 2022
)
1.9
"Rutin (Rtn) is an antioxidant flavonol that induces apoptosis."( The effectiveness of Rutin for prevention of surgical induced endometriosis development in a rat model.
Farahpour, MR; Hamishehkar, H; Talebi, H, 2021
)
1.66
"Rutin (RUT) is a traditional Chinese medicine reported to have a variety of pharmacological properties, including anticancer properties."( Rutin restrains the growth and metastasis of mouse breast cancer cells by regulating the microRNA-129-1-3p-mediated calcium signaling pathway.
Gu, Z; Huang, P; Li, Q; Li, T; Ren, L; Xu, D, 2021
)
2.79
"Rutin is a flavonoid with antioxidant property. "( Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy.
Asmadi, AY; Jalil, J; Kamisah, Y; Siti, HN, 2021
)
3.51
"Rutin (RUT) is a dietary bioflavonoid with strong antioxidant and anti-inflammatory potential."( Rutin Ameliorates Cadmium-Induced Necroptosis in the Chicken Liver via Inhibiting Oxidative Stress and MAPK/NF-κB Pathway.
Liu, L; Liu, Y; Qiao, X; Yu, X; Zhao, L, 2022
)
2.89
"Rutin is a flavonoid found in various plants, such as buckwheat, some teas, and apples."( Neuroprotective effects of rutin on ASH neurons in
Arantes, LP; Bicca Obetine Baptista, F; Cordeiro, LM; da Silva, AF; da Silveira, TL; Machado, ML; Soares, FAA; Soares, MV, 2022
)
1.74
"Rutin is a natural flavonoid glycoside found in several vegetables and fruits such as buckwheat and onion. "( α-glucosyl-rutin activates immediate early genes in human induced pluripotent stem cells.
Kuge, M; Matsumoto, Y; Miyake, T; Shimada, M, 2021
)
2.45
"Rutin is a natural flavonoid with significant roles in combating cellular oxidative stress and regulating lipid metabolism."( Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
Ding, B; Ding, L; Dou, X; Hu, L; Liu, Q; Pan, R; Xia, Y; Zhang, F; Zhu, L, 2017
)
2.62
"Rutin is a glycosylated flavonoid present in many fruits and plants that has been demonstrated to have anti-inflammatory and antioxidant properties. "( The flavonoid rutin modulates microglial/macrophage activation to a CD150/CD206 M2 phenotype.
Alves de Almeida Carneiro, MM; Alves Oliveira Amparo, J; Amaral da Silva, VD; Bispo da Silva, A; Cerqueira Coelho, PL; Dias Costa, MF; Dos Santos Souza, C; Guaza Rodriguez, C; Lima Costa, S; Mecha, M; Pereira Borges, JM, 2017
)
2.26
"Rutin is a flavonol-type polyphenol which consists of the flavonol quercetin and the disaccharide rutinose."( Rutin as Neuroprotective Agent: From Bench to Bedside.
Budzynska, B; Devi, KP; Faggio, C; Kruk-Slomka, M; Nabavi, SF; Nabavi, SM; Samec, D; Sureda, A, 2019
)
2.68
"Rutin is a flavonoid found in many plants and shows a wide range of biological activities including anti-inflammatory, antioxidant, neuroprotective, nephroprotective, and hepatoprotective effects."( Mechanisms of antidiabetic effects of flavonoid rutin.
Ghorbani, A, 2017
)
1.43
"Rutin (RUT) is an antioxidant flavonoid with well-known metal chelating potentials."( Rutin ameliorates oxidative stress and preserves hepatic and renal functions following exposure to cadmium and ethanol.
Abarikwu, SO; Charles, IA; Ikewuchi, JC; Lawrence, CJ; Njoku, RC, 2017
)
3.34
"Rutin is a glycoside flavonoid which belongs to an important class of flavonoids, abundantly found in plants, such as buckwheat seeds, asparagus, red pepper, apples, citrus fruits and leaves of many herbs such as rosemary, dandelion or sage, and black and green tea.  It is a vital nutritional component of food stuff."( Modulatory Role of Rutin Supplement on Open Space Forced Swim Test Murine Model of Depression.
Abdulkadir, M; Egwuma, JM; Igomu, OJ; Muhammad, UA; Nze, M; Yusha'u, Y, 2017
)
1.5
"Rutin is a strong antioxidant compound used in food and pharmaceutical industries."( Safety and Antioxidant Efficacy Profiles of Rutin-Loaded Ethosomes for Topical Application.
Ariede, MB; Baby, AR; Cândido, TM; De Oliveira, CA; Rosado, C; Velasco, MVR, 2018
)
1.46
"Rutin is a glycoside of the bioflavonoid quercetin with various protective effects due to its antioxidant and anti-inflammatory potential."( Rutin, a quercetin glycoside, alleviates acute endotoxemic kidney injury in C57BL/6 mice via suppression of inflammation and up-regulation of antioxidants and SIRT1.
Baluchnejadmojarad, T; Gholami, L; Hosseini, M; Khajevand-Khazaei, MR; Mohseni-Moghaddam, P; Roghani, M, 2018
)
2.64
"Rutin (RUT) is a flavonoid glycoside from Sophora japonica L."( Effect of rutin on cisplatin-induced damage in human mesangial cells via apoptotic pathway.
Leng, XW; Li, Q; Ren, LQ; Sun, B; Wang, Q; Wang, YD; Zhang, Y, 2019
)
1.64
"Rutin is a bioflavonoid with antioxidant properties. "( Rutin inhibits carfilzomib-induced oxidative stress and inflammation via the NOS-mediated NF-κB signaling pathway.
Afzal, M; Al Rikabi, AC; Al-Harbi, MM; Al-Harbi, NO; Al-Shabanah, OA; Alotaibi, MR; As Sobeai, HM; Imam, F; Kazmi, I, 2019
)
3.4
"Rutin is a polyphenol antioxidant that has been reported to be present in several plant extracts."( Rutin attenuates inflammatory responses induced by lipopolysaccharide in an in vitro mouse muscle cell (C2C12) model.
Adewole, D; Liu, S; O, K; Sid, V; Wang, B; Yang, C; Yu, L, 2019
)
2.68
"Rutin is a quercetin based-flavanoid and a famous dietary supplement."( A quercetin-based flavanoid (rutin) reverses amyloid fibrillation in β-lactoglobulin at pH 2.0 and 358 K.
Al-Shabib, NA; Alsenaidy, AM; Alsenaidy, MA; Choudhry, H; Husain, FM; Khan, JM; Khan, MI; Khan, RH; Malik, A; Sen, P; Shahzad, SA; Zamzami, MA, 2019
)
1.53
"Rutin is a flavonoid commonly found in many vegetables, fruits and other plant species. "( Rutin alleviates cadmium-induced neurotoxicity in Wistar rats: involvement of modulation of nucleotide-degrading enzymes and monoamine oxidase.
Adebayo, AA; Ademosun, AO; Oboh, G; Olowokere, OG, 2019
)
3.4
"Rutin is a kind of antioxidative compound extracted from plants, and might be a protective compound for cardiomyocytes."( Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway.
Duan, Y; Fei, J; Ouyang, P; Sun, Y; Wang, T; Xia, J; Yu, S; Zhang, G, 2019
)
1.55
"Rutin (RT) is a natural flavonoid (vitamin p), which possesses an antioxidant activity with protective potential."( Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat.
Abuohashish, HM; Ahmed, MM; Al-Hosaini, KA; Al-Rejaie, SS; Al-Shabanah, OA; Aleisa, AM; Hafez, MM; Sayed-Ahmed, MM, 2013
)
1.43
"Rutin is a highly potent molecule due to its strong antioxidant properties. "( Rutin : therapeutic potential and recent advances in drug delivery.
Ali, A; Ali, J; Baboota, S; Sahni, JK; Sharma, S, 2013
)
3.28
"Rutin is a well-known flavonoid that exists in various natural sources. "( Rutin inhibits B[a]PDE-induced cyclooxygenase-2 expression by targeting EGFR kinase activity.
Choi, S; Hwang, MK; Jang, TS; Kang, NJ; Kim, J; Kim, YA; Lee, KW; Lim, TG; Park, JS; Yeom, MH, 2013
)
3.28
"Rutin is a common dietary flavonoid that is widely consumed from plant-derived beverages and foods as traditional and folkloric medicine worldwide. "( A review on plant-based rutin extraction methods and its pharmacological activities.
Chua, LS, 2013
)
2.14
"Rutin is an important indicator for evaluating the quality of buckwheat. "( Comparative analysis of flavonoids and polar metabolite profiling of Tanno-original and Tanno-high rutin buckwheat.
Kim, JK; Kim, YB; Lee, S; Li, X; Park, SU; Park, SY; Zhao, S, 2014
)
2.06
"Rutin is a flavonoid that occurs naturally in plant-derived beverages and foods and is used in traditional and folkloric medicine worldwide."( Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells.
Kim, S; Kwon, J; Na, JY; Song, K, 2014
)
2.57
"Rutin is a flavonoid with multiple cardiovascular protective effects."( Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells.
Abdullah Mahdy, Z; Chua, KH; Nordin, NA; Ugusman, A; Zakaria, Z, 2014
)
1.56
"Rutin is a bioflavonoid that has been demonstrated to scavenge superoxide radicals."( Rutin upregulates neurotrophic factors resulting in attenuation of ethanol-induced oxidative stress in HT22 hippocampal neuronal cells.
Kim, S; Kwon, J; Na, JY; Song, K, 2015
)
2.58
"Rutin is a type of flavonoid which exhibits significant scavenging properties on oxygen radicals both in vitro and in vivo."( Antioxidant mechanism of Rutin on hypoxia-induced pulmonary arterial cell proliferation.
Li, Q; Li, S; Li, X; Lv, J; Mao, M; Qiu, Y; Zhang, L; Zheng, X, 2014
)
1.43
"Rutin is a bioflavonoid found in fruits, vegetables and plants used in traditional medicine to alleviate pain. "( Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal grey matter in rats.
Fernández-Guasti, A; González-Trujano, ME; Hernandez-Leon, A, 2016
)
3.32
"Rutin is a major representative of the flavonol subclass of flavonoids and has various pharmacological activities."( Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability.
Cho, YJ; Kang, DH; Kim, DM; Lee, SJ; Yoo, HJ; Yu, JM; Yu, SH, 2016
)
1.44
"Rutin (RUT) is a naturally occurring flavonoid glycoside that has antioxidant and anti-inflammatory properties."( Rutin ameliorates cisplatin-induced reproductive damage via suppression of oxidative stress and apoptosis in adult male rats.
Aksu, EH; Çomaklı, S; Kandemir, FM; Küçükler, S; Ömür, AD; Özkaraca, M, 2017
)
2.62
"Rutin is a natural flavonoid (vitamin p) which is known to have antioxidative properties."( Rutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed Rats.
Abuohashish, HM; Ahmed, MM; Al-Rejaie, SS; AlSharari, SD; Hafez, MM, 2016
)
2.6
"Rutin is a naturally occurring flavonoid having a long history of use in nutritional supplements for its action against oxidative stress, inflammation, and hyperglycemia, the key players involved in the progression of DCM, but remains unexplored for its role in DCM."( Cardioprotective effects of rutin via alteration in TNF-α, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats.
Gupta, SK; Kumar, B; Mathur, R; Mohanty, IR; Saklani, R; Srivastava, S, 2016
)
1.45
"Rutin is a common dietary flavonoid with important antioxidant and pharmacological activities. "( Subcritical Water Induced Complexation of Soy Protein and Rutin: Improved Interfacial Properties and Emulsion Stability.
Chen, XW; Hou, JJ; Qi, JR; Wang, JM; Yang, XQ, 2016
)
2.12
"Rutin is a naturally occurring strong antioxidant molecule with wide therapeutic applications."( Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson's disease model.
Ali, J; Baboota, S; Narang, JK; Sharma, S, 2016
)
1.41
"Rutin is an effective antioxidant flavonoid."( Rutin, an antioxidant flavonoid, induces glutathione and glutathione peroxidase activities to protect against ethanol effects in cadmium-induced oxidative stress in the testis of adult rats.
Abarikwu, SO; Barikuma, AM; Lawrence, CJ; Ochulor, AC; Olufemi, PD; Wekere, FC, 2017
)
2.62
"Rutin is a natural flavonoid with the potential to treat AP via anti-inflammatory, antinociceptive, and antioxidant activities."( Elucidating the role of oxidative stress in the therapeutic effect of rutin on experimental acute pancreatitis.
Abreu, FF; Camargo, EA; Costa, SK; Lauton Santos, S; Muscará, MN; Santana, MT; Soares, AG; Soares, RC; Souza, AC; Teixeira, DF; Teixeira, SA, 2016
)
1.39
"Rutin is a bioflavonoid found in medicinal plants used to reduce anxiety. "( The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala.
Fernández-Guasti, A; González-Trujano, ME; Hernandez-Leon, A, 2017
)
2.19
"Rutin functions as an antioxidant and is oxidized into a quinone that upregulates the Nrf2-mediated endogenous antioxidant response. "( Rutin protects against H
Arnér, ESJ; Bast, A; Bouwman, FG; Haenen, GRMM; Ides, B; Janssen, GM; Johansson, K; Lemmens, KJA; Mariman, EC; Pader, I; Schiffers, PM; Sthijns, MMJPE; Vangrieken, P, 2017
)
3.34
"Rutin is a bioflavonoid with strong antioxidant activity. "( Effects of rutin from Toona sinensis on the immune and physiological responses of white shrimp (Litopenaeus vannamei) under Vibrio alginolyticus challenge.
Hsieh, SL; Hsieh, TJ; Hu, CY; Kuo, CM; Li, CT; Wang, JC, 2008
)
2.18
"Rutin is a flavonoid with various biological activities that are beneficial to human health. "( Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats.
Imai, H; Koda, T; Kuroda, Y, 2008
)
2.11
"Rutin is a potent antioxidant flavonoid."( Gastroprotective effect of rutin against indomethacin-induced ulcers in rats.
Abdel-Raheem, IT, 2010
)
1.38
"Rutin is a flavonoid with antioxidant, vasodilatory, anti-inflammatory and immune-stimulating activities. "( Investigation of cytotoxic, apoptosis-inducing, genotoxic and protective effects of the flavonoid rutin in HTC hepatic cells.
Beatriz Hoffmann-Campo, C; Cabral Luiz, R; Cristina Marcarini, J; Ferreira Tsuboy, MS; Regina Ribeiro, L; Ségio Mantovani, M, 2011
)
2.03
"Rutin is a flavonoid that is an important dietary constituent of foods and plant-based beverages."( The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats.
Abbasi, E; Mortazavi, SR; Nassiri-Asl, M; Safdari, F; Samiee-Rad, F; Saroukhani, S; Zangivand, AA, 2010
)
1.43
"Rutin is a polyphenolic natural flavonoid which possesses antioxidant and anticancer activity. "( CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat.
Khan, MR; Khan, RA; Sahreen, S, 2012
)
2.07
"Rutin is a well-known dietary flavonol glycoside with antioxidant and anti-inflammatory properties."( Influence of long-term administration of rutin on spatial memory as well as the concentration of brain neurotransmitters in aged rats.
Blecharz-Klin, K; Joniec-Maciejak, I; Piechal, A; Pyrzanowska, J; Widy-Tyszkiewicz, E; Zobel, A, 2012
)
1.37
"Rutin is a flavonoid with several pharmacological properties and it has been demonstrated that rutin can modulate glucose homeostasis. "( Rutin potentiates calcium uptake via voltage-dependent calcium channel associated with stimulation of glucose uptake in skeletal muscle.
Kappel, VD; Postal, BG; Silva, FR; Zanatta, L, 2013
)
3.28
"Rutin is a flavonol glycoside with multiple biological activities and it has been demonstrated that rutin modulates glucose homeostasis. "( The role of calcium in intracellular pathways of rutin in rat pancreatic islets: potential insulin secretagogue effect.
Cazarolli, LH; Frederico, MJ; Kappel, VD; Mendes, CP; Postal, BG; Silva, FR, 2013
)
2.09
"Rutin is an antioxidant with many interesting pharmacological effects. "( Rutin in buckwheat herbs grown at different UV-B radiation levels: comparison of two UV spectrophotometric and an HPLC method.
Gaberscik, A; Kreft, I; Kreft, S; Strukelj, B, 2002
)
3.2
"Rutin is a flavonoid found in many plants and has been shown to have some biological activities, but its direct effects on cells of the CNS have not been well studied."( The flavonoid rutin induces astrocyte and microglia activation and regulates TNF-alpha and NO release in primary glial cell cultures.
Costa, MF; Costa, SL; El-Bachá, RS; Freire, SM; Freitas, SR; Pinheiro, AM; Silva, AR; Souza, CS; Tardy, M; Vasconcellos, V; Velozo, ES, 2008
)
1.43
"Rutin is a flavonoid obtained from Dimorphandra mollis (Benth.), a medicinal Brazilian plant used as antioxidative, antihemorrhagic, and blood vessel protector. "( Flavonoid rutin alters the viability and function of mitogen-stimulated splenocytes and thymocytes compared with non stimulated cells.
Clarêncio, J; Costa, MF; Costa, SL; Freire, S; Meyer, R; Nascimento, R; Rocha, DS; Roseghini, R; Schaer, R; Tardy, M; Velozo, E, 2007
)
2.18
"Rutin is a nonmutagenic flavonol glycoside, whereas its aglycone quercetin is mutagenic. "( Potential mutagenic activity of some vitamin preparations in the human gut.
Macdonald, IA; Mader, JA, 1984
)
1.71
"Rutin is a ubiquitous naturally occurring flavonoid, which is used in a number of drugs. "( Negative dose-response study for carcinogenicity of orally administered rutin sulfate in Sprague-Dawley rats.
Berger, MR; Habs, H; Habs, M; Schmähl, D, 1984
)
1.94
"Rutin is a compound with antioxidant activity and aqueous solvents appear to be unsuitable for ultrasonic extractions due to the formation of free radicals from the insonation of the solvent."( The extraction of rutin from flower buds of Sophora japonica.
Beaufoy, E; Lorimer, JP; Mason, TJ; Paniwnyk, L, 2001
)
1.37
"Oxerutin is a member of the flavonoid family and possesses antioxidant properties."( The efficiency of oxerutin on apoptosis and kidney function in rats with renal ischemia reperfusion injury.
Aslan Koşar, P; Bozkurt, KK; Güzel, A; Oksay, T; Özorak, A; Öztürk, SA; Uğuz, AC; Uz, E; Yunusoğlu, S, 2022
)
1.55
"Troxerutin (TRX) is a water-soluble flavonoid which occurs commonly in the edible plants. "( Troxerutin flavonoid has neuroprotective properties and increases neurite outgrowth and migration of neural stem cells from the subventricular zone.
Masood, MI; Meiser, P; Naseem, M; Schäfer, KH; Weyland, M, 2020
)
1.59
"Troxerutin is a natural flavonoid present abundantly in tea, coffee, olives, wheat, and a variety of fruits and vegetables. "( Chemopreventive effect of troxerutin against hydrogen peroxide-induced oxidative stress in human leukocytes through modulation of glutathione-dependent enzymes.
Barreto, FS; Cavalcanti, BC; Ferreira, JRO; Magalhães, HIF; Moraes, MO; Neto, JBA; Nobre Júnior, HV; Ricardo, NMPS; Silva, AAS; Silva, CRD; Vieira, ÍGP, 2021
)
1.42
"Troxerutin is a bioflavonoid, which can be used to treat venous disorders, thrombosis and cerebrovascular diseases. "( Troxerutin protects against diabetic cardiomyopathy through NF‑κB/AKT/IRS1 in a rat model of type 2 diabetes.
Yu, Y; Zheng, G, 2017
)
1.48
"Troxerutin is a flavonoid with pharmacological activity of antioxidation and anti-inflammation."( Troxerutin Reduces Kidney Damage against BDE-47-Induced Apoptosis via Inhibiting NOX2 Activity and Increasing Nrf2 Activity.
Lu, J; Shan, Q; Zhang, Y; Zhang, Z; Zheng, G; Zheng, Y; Zhuang, J, 2017
)
1.42
"Troxerutin (TRX) is a mixture of semisynthetic hydroxyethylrutosides (Hers) arising from hydroxyethylation of rutin, a natural occurring flavonoid. "( Troxerutin, a mixture of O-hydroxyethyl derivatives of the natural flavonoid rutin: Chemical stability and analytical aspects.
Aprile, S; Bianchi, M; Canavesi, R; Del Grosso, E; Grosa, G, 2018
)
1.51
"Troxerutin (Tx) is a natural flavonoid, also called vitamin P4, which is widely present in plants consumed as part of our daily diet, such as cereals, various fruits and vegetables, tea, and coffee, and possesses various biological activities, especially an anti-inflammatory effect."( Troxerutin suppresses the inflammatory response in advanced glycation end-product-administered chondrocytes and attenuates mouse osteoarthritis development.
Chen, B; Chen, Y; Pan, X; Wang, X; Wang, Y; Xue, X; Zhan, J, 2019
)
1.48
"Troxerutin is a natural flavonoid rutin mainly found in extracts of Sophora japonica, and is a well-known antioxidant and anti-inflammatory compound used in experimental mouse models."( Troxerutin induces protective effects against ultraviolet B radiation through the alteration of microRNA expression in human HaCaT keratinocyte cells.
Ahn, KJ; An, IS; An, S; Bae, S; Cha, HJ; Hong, JT; Lee, GT; Lee, KK; Lee, KS, 2014
)
1.37
"Troxerutin is a trihydroxyethylated derivative of the flavonoid, rutin. "( Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat.
Karundevi, B; Sampath, S, 2014
)
1.27
"Troxerutin (TXER) is a derivative of naturally occurring bioflavonoid rutin. "( Spectroscopic and molecular docking studies on the interaction of troxerutin with DNA.
Harikrishna, M; Lokeswara Rao, P; Mareeswaran, R; Ramamurthy, CH; Subastri, A; Sujatha, V; Suresh Kumar, M; Suyavaran, A; Thirunavukkarasu, C, 2015
)
1.16
"Troxerutin (TRX) is a flavonoid present in tea, coffee, cereal grains, various fruits and vegetables have been reported to exhibit radioprotective, antithrombotic, nephro and hepato-protective effects. "( Troxerutin, a plant flavonoid, protects cells against oxidative stress-induced cell death through radical scavenging mechanism.
Ghaskadbi, SS; Maurya, DK; Panat, NA; Sandur, SK, 2016
)
1.46
"Troxerutin is a natural bioflavonoid with nephro- and hepato-protective, antioxidant, and anti-inflammatory properties."( Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
Baluchnejadmojarad, T; Jamali-Raeufy, N; Rabiee, N; Roghani, M; Zabihnejad, S, 2017
)
1.42
"Troxerutin is a naturally fluorescent flavonoid which has been known to improve subjective signs of patients with chronic venous insufficiency."( [Transport and localization of troxerutin in the venous wall].
Carlsson, K; Gerentes, I; Patwardhan, A; Poullain, JC, 1996
)
1.02

Effects

Rutin has a range of pharmacological effects that include anti-oxidant, anti-inflammation, and anti-cancer activities. Troxerutin (TRX) has a beneficial effect on blood viscosity and platelet aggregation.

Rutin has been shown to possess antiapoptotic, antioxidant and anti-inflammatory activities. Rutin has excellent antioxidant activity, but its poor lipid solubility greatly limits its practical application.

ExcerptReferenceRelevance
"Rutin has a certain protective effect on this damage, which may be related to rutin& apos; s activation of AMPKα protein expression to effectively correct TG levels and enhance the activity of antioxidant enzymes."( [Rutin activates AMPKα to ameliorate liver damage caused by perfluorooctanoic acid in mice].
Cheng, J; Liu, F; Liu, H; Tang, Y; Wang, L; Zhou, Y, 2021
)
2.25
"Rutin has a range of pharmacological effects that include anti-oxidant, anti-inflammation, anti-bacterial, and anti-cancer activities."( α-glucosyl-rutin activates immediate early genes in human induced pluripotent stem cells.
Kuge, M; Matsumoto, Y; Miyake, T; Shimada, M, 2021
)
1.73
"Rutin has a wide range of beneficial health properties in the amelioration of multi-organ injury owing to its various biological effects. "( Protective effects of rutin on lipopolysaccharide-induced heart injury in mice.
Lan, Z; Ming, L; Xianchu, L; Yanzhi, M, 2018
)
2.24
"Troxerutin (TRX) has a beneficial effect on blood viscosity and platelet aggregation, and is currently used for the treatment of chronic varicosity. "( Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.
Hüttl, M; Kazdova, L; Malinska, H; Markova, I; Oliyarnyk, O; Poruba, M; Racova, Z; Vecera, R, 2019
)
1.32
"Rutin has been shown to possess antiapoptotic, antioxidant and anti-inflammatory activities, among others, which are crucial in the management of male infertility."( Therapeutic potential of rutin in male infertility: A mini review.
Elebiyo, TC; Ojo, OA; Rotimi, DE, 2023
)
1.93
"Rutin has excellent antioxidant activity, but its poor lipid solubility greatly limits its practical application."( Improved antioxidant activity of rutin via lipase-mediated esterification with oleic acid.
Gong, F; He, WS; Jia, L; Liu, C; Liu, Y; Tan, C; Tao, H; Wang, Q; Yang, H; Zhao, L, 2023
)
1.91
"Rutin has multiple biologic and therapeutic effects both in diabetic complications and muscle functions."( Rutin improves diabetes-induced muscle atrophy in mice.
Ming, L; Xianchu, L, 2023
)
3.07
"Rutin, a flavanol, has been demonstrating excellent antioxidant, anti-inflammatory, anti-diabetic, and anti-carcinogenic properties. "( Formulation of microencapsulated rutin and evaluation of bioactivity and stability upon in vitro digestive and dialysis conditions.
Fernando, CAN; Gunathilake, KDPP; Mel, MMRD, 2020
)
2.28
"Rutin has been found to modulate multiple molecular targets involved in carcinogenesis, such as cell cycle mediators, cellular kinases, inflammatory cytokines, transcription factors, drug transporters, and reactive oxygen species."( The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives.
Atanasov, AG; Corke, H; Farha, AK; Gan, RY; Gul, K; Li, HB; Wu, DT; Yang, QQ; Zhang, JR, 2022
)
1.69
"Rutin has important pharmacological actions, including antioxidant and vasoprotective."( Micro Composite Palmitoylethanolamide/Rutin Reduces Vascular Injury through Modulation of the Nrf2/HO-1 and NF-kB Pathways.
Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Fusco, R; Gomiero, C; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Siracusa, R, 2021
)
1.61
"Rutin has a certain protective effect on this damage, which may be related to rutin& apos; s activation of AMPKα protein expression to effectively correct TG levels and enhance the activity of antioxidant enzymes."( [Rutin activates AMPKα to ameliorate liver damage caused by perfluorooctanoic acid in mice].
Cheng, J; Liu, F; Liu, H; Tang, Y; Wang, L; Zhou, Y, 2021
)
2.25
"Rutin has a range of pharmacological effects that include anti-oxidant, anti-inflammation, anti-bacterial, and anti-cancer activities."( α-glucosyl-rutin activates immediate early genes in human induced pluripotent stem cells.
Kuge, M; Matsumoto, Y; Miyake, T; Shimada, M, 2021
)
1.73
"Rutin has been acknowledged for its protective and beneficial effects on various aspects of the biological system."( Protective effect of rutin on humoral and cell mediated immunity in rat model.
Ganeshpurkar, A; Saluja, AK, 2017
)
1.5
"Rutin has been reported to exert diverse biological effects such as antitumor and antimicrobial mainly associated to its antioxidant and anti-inflammatory activities."( Rutin as Neuroprotective Agent: From Bench to Bedside.
Budzynska, B; Devi, KP; Faggio, C; Kruk-Slomka, M; Nabavi, SF; Nabavi, SM; Samec, D; Sureda, A, 2019
)
2.68
"Rutin has been well documented to show protective effect in various complications, e.g., diabetic neuropathy."( Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
Bishnoi, M; Kumar, A; Mittal, R; Nag, TC; Singh, DP, 2018
)
1.5
"Rutin has a wide range of beneficial health properties in the amelioration of multi-organ injury owing to its various biological effects. "( Protective effects of rutin on lipopolysaccharide-induced heart injury in mice.
Lan, Z; Ming, L; Xianchu, L; Yanzhi, M, 2018
)
2.24
"Rutin (vitamin P1) has many properties, including as antioxidant, anticancer, antidiabetic, antimicrobial, antiulcer, and tissue renewal properties."( The effect of rutin on cisplatin-induced oxidative cardiac damage in rats.
Altuner, D; Bilgin, Y; Keskin Çimen, F; Kurt, N; Özbek Bilgin, A; Özçiçek, A; Süleyman, Z; Topal, İ, 2018
)
1.56
"Rutin, a flavonoid, has been well documented for its beneficial and pharmacological activities against diverse targets."( Amelioration of oxidative stress in differentiated neuronal cells by rutin regulated by a concentration switch.
Krishnan, U; Rajendiran, V; Sivanantham, B, 2018
)
1.44
"Rutin (RUT) has been found to exhibit both anti-oxidative stress and anti-inflammatory properties."( Rutin abrogates manganese-Induced striatal and hippocampal toxicity via inhibition of iron depletion, oxidative stress, inflammation and suppressing the NF-κB signaling pathway.
Kponee, KZ; Nkpaa, KW; Onyeso, GI, 2019
)
2.68
"Rutin has been enzymatically oligomerized by laccase from Trametes versicolor. "( Cytotoxic, genotoxic and antigenotoxic potencies of oligorutins.
Chebil, L; Chékir-Ghédira, L; Ghedira, K; Ghoul, M; Krifa, M; Mustapha, N; Rhouma, GB, 2013
)
2.08
"Rutin has been shown to possess beneficial health effects, including hepatoprotection. "( Protective effects of rutin on liver injury induced by biliary obstruction in rats.
Chen, CJ; Chen, WY; Chuang, YH; Lin, SY; Pan, PH; Wang, YY; Wu, CC, 2014
)
2.16
"Rutin has been suggested to have potential in weed management, but its mode of action at physiological level is unknown."( Higher peroxidase activity, leaf nutrient contents and carbon isotope composition changes in Arabidopsis thaliana are related to rutin stress.
Hussain, MI; Reigosa, MJ, 2014
)
1.33
"Rutin has potential beneficial effects including anti-inflammation, antioxidation, anti-hyperlipidemia, and anti-platelet aggregation."( Rutin improves endotoxin-induced acute lung injury via inhibition of iNOS and VCAM-1 expression.
Chen, ST; Horng, CT; Huang, YC; Kuan, YH; Kuo, WH; Lee, CY; Lee, SS; Yang, ML; Yeh, CH, 2016
)
2.6
"Rutin-zinc(II) has not shown any cytotoxicity against normal cells (fibroblasts and HUVECs) or toxicity in BALB/c mice, but has shown antioxidant activity in vitro and cytotoxicity against leukemia (KG1, K562 and Jurkat), multiple myeloma (RPMI8226) and melanoma (B16F10 and SK-Mel-28) cell lines in vitro."( Synthesis, characterization and biological evaluation of Rutin-zinc(II) flavonoid -metal complex.
Ikeda, NE; Maria, DA; Novak, EM; Pereira, RM; Velosa, AS, 2015
)
1.38
"Rutin has extensive pharmacological activities, including antibacterial and anti-inflammatory activities, cooling of the blood to inhibit bleeding, reducing capillary wall fragility and anti-influenza activities. "( Effect of rutin on spinal cord injury through inhibition of the expression of MIP-2 and activation of MMP-9, and downregulation of Akt phosphorylation.
Ma, X; Zhang, P, 2015
)
2.26
"Rutin, a flavonoid, has chemical and functional stability in topical vehicles exerting a synergistic effect in association with ultraviolet (UV) filters."( Safety and efficacy evaluation of gelatin-based nanoparticles associated with UV filters.
Baby, AR; Dario, MF; Mariz, IFA; Oliveira, CA; Rosado, C; Sarruf, FD; Velasco, MVR, 2016
)
1.16
"Rutin has been reported to have significant anti-inflammatory, antioxidant along with antiulcer properties."( Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects.
Gautam, R; Gautam, S; Kaithwas, G; Rawat, JK; Saraf, SA; Singh, M, 2016
)
2.6
"Rutin has also been suggested to have potential therapeutic applications for the treatment of Alzheimer's disease."( Buckwheat phenolic metabolites in health and disease.
Kreft, M, 2016
)
1.16
"Rutin SNEDDS have been successfully prepared and they can serve as an effective tool in enhancing the oral bioavailability and efficacy of rutin, thus helping in ameliorating oxidative stress in neurodegenerative disorders like Parkinson's disease."( Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson's disease model.
Ali, J; Baboota, S; Narang, JK; Sharma, S, 2016
)
2.13
"Rutin has beneficial effects on diabetic nephropathy, but the exact mechanisms of its protective effect remain elusive."( Rutin Prevents High Glucose-Induced Renal Glomerular Endothelial Hyperpermeability by Inhibiting the ROS/Rhoa/ROCK Signaling Pathway.
Feng, T; Jin, G; Li, Z; Wang, X; Zhao, X, 2016
)
2.6
"Rutin has been described in possessing comprehensive pharmacological activities, but the mechanism involved in endothelial protection through regulating oxidative stress and damage is still ambiguous."( Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome.
Qiu, X; Sui, Y; Wang, W; Wang, Y; Wu, QH, 2017
)
2.62
"Rutin has several pharmacological properties including antioxidant and cardioprotective activities."( Effects of rutin on lipid profile in hypercholesterolaemic rats.
Abbasi, E; Nassiri-Asl, M; Zamansoltani, F; Ziaee, A, 2009
)
1.46
"Rutin has been shown to have antioxidant and anti-inflammatory actions, and thus was tested for its beneficial effects using 6-OHDA-induced PD rat model."( Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.
Ahmad, A; Islam, F; Javed, H; Khan, A; Khan, MM; Raza, SS; Safhi, MM, 2012
)
2.54
"Rutin and esculin have been polymerised by laccase. "( Evaluation of mutagenic and antimutagenic activities of oligorutin and oligoesculin.
Ben Rhouma, G; Chebil, L; Chekir-Ghedira, L; Ghoul, M; Krifa, M, 2012
)
2.06
"Rutin also has specific action because it exerts a vasodilator influence on the PAs but not MAs."( Mechanisms that underlie the induction of vasodilation in pulmonary artery by rutin.
Li, Q; Li, Y; Niu, S; Wang, R; Zhang, R; Zhu, D, 2012
)
1.33
"Rutin alone has been shown to protect LDL against oxidation."( Synergistic inhibition of low-density lipoprotein oxidation by rutin, gamma-terpinene, and ascorbic acid.
Elstner, EF; Grassmann, J; Milde, J, 2004
)
1.28
"Rutin has been found to accelerate the lymph flow and to raise cholesterol resorption from the interstitial space."( [Effect of rutin on the cholesterol content of the lymph, blood and tissues of the dog].
Shaĭkemeleva, US, 1983
)
1.38
"Rutin has been reported to exert numerous biochemical and pharmacological activities, though information about its absorption and metabolism is scarce."( Intestinal absorption of rutin in free and conjugated forms.
Andlauer, W; Fürst, P; Stumpf, C, 2001
)
1.34
"Rutin has no activity whatsoever."( Genetic toxicology of flavonoids: the role of metabolic conditions in the induction of reverse mutation, SOS functions and sister-chromatid exchanges.
Borba, H; Chaveca, T; Gomes, MI; Halpern, M; Laires, A; Rueff, J, 1986
)
0.99
"Rutin has no effect on the pathological process in the cheek pouch, and arrests the first phase of inflammation in the foot."( [Dynamics of the inflammatory process caused by carrageenin administration during experimental therapy].
Aleksandrov, PN; Bobkov, IuG; Speranskaia, TV; Zagorevskiĭ, VA; Zykov, DA, 1986
)
0.99
"Troxerutin (TRX) has a beneficial effect on blood viscosity and platelet aggregation, and is currently used for the treatment of chronic varicosity. "( Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome.
Hüttl, M; Kazdova, L; Malinska, H; Markova, I; Oliyarnyk, O; Poruba, M; Racova, Z; Vecera, R, 2019
)
1.32
"Troxerutin has attracted much attention owing to its favorable properties, including antihyperglycemic, anti-inflammatory, and antiapoptotic effects."( Can troxerutin pretreatment prevent testicular complications in prepubertal diabetic male rats?
Ahmadi, M; Bavil, FM; Ghadiri, A; Hamidian, GR; Keyhanmanesh, R; Oghbaei, H; Oskuye, ZZ, 2020
)
1.43
"Troxerutin has been reported to have cardioprotective functions."( Troxerutin attenuates oxygen‑glucose deprivation and reoxygenation‑induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF‑1α signaling pathway in H9C2 cardiomyocytes.
Hua, X; Li, C; Li, J; Sheng, XS; Yu, HQ; Yu, ZP, 2020
)
1.53

Actions

Rutin can suppress the activation of TGF-β/Smad pathway, hence repressing the cellular inflammatory response after SCI. Rutin can generate a pair of well-defined redox peaks at the PABSA/GC located at 0.440 V and 0.396 V (E(pc)

ExcerptReferenceRelevance
"Rutin was seen to lower the generation of oxidative stress in a dose-dependent manner."( Rutin impedes human low-density lipoprotein from non-enzymatic glycation: A mechanistic insight against diabetes-related disorders.
Hashmi, MA; Moin, S; Salman, KA; Siddiqui, S; Wani, MJ, 2023
)
3.07
"MH+Rutin can suppress the activation of TGF-β/Smad pathway, hence repressing the cellular inflammatory response after SCI."( The effect of mild hypothermia plus rutin on the treatment of spinal cord injury and inflammatory factors by repressing TGF-β/smad pathway.
Chen, Q; Lu, T; Luo, C; Pu, X; Wang, L; Yao, S, 2021
)
1.52
"Rutin can inhibit the pulmonary inflammation and increase the expression of alveolar epithelial sodium channel protein to alleviate LPS-induced acute lung injury in mice."( [Protective effect of rutin against lipopolysaccharide-induced acute lung injury in mice].
Feng, L; He, J; Qi, D; Wang, D, 2014
)
2.16
"Mtx+Rutin group showed lower histological injury compared to Mtx group, MDA and ALT levels were increased, while SOD and GSH-Px were decreased in Mtx group compared with Control-saline group. "( Rutin ameliorates methotrexate induced hepatic injury in rats.
Erdogan, E; Gurgor, PN; Ilgaz, Y; Oztas, E; Oztas, Y; Topal, T, 2015
)
2.42
"Rutin can generate a pair of well-defined redox peaks at the PABSA/GC located at 0.440 V (E(pa)) and 0.396 V (E(pc)) (vs."( Determination of rutin on the poly(p-aminobenzene sulfonic acid) modified glassy carbon electrode.
Chen, X; Li, Y; Wang, Z; Xia, Y; Zhang, F; Zhu, L, 2010
)
1.42
"Rutin can increase the expression of PPARγ in skeletal muscles of db/db mice."( Effects of rutin on the expression of PPARγ in skeletal muscles of db/db mice.
Cai, Y; Fan, C; Ma, X; Tian, N; Yan, J, 2012
)
1.49
"Rutin could inhibit PAF induced platelet aggregation, 5-HT release and the increase of intraplatelet free calcium."( [Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits].
Chen, WM; Jin, M; Wu, W, 2002
)
2.02
"Rutin was shown to inhibit this reaction, but could not serve as an enhancer of DRC toxicity in MTT tests."( Modulation of daunorubicin toxicity by liposomal encapsulation and use of specific inhibitors in vitro.
Iffert, T; Maser, E; Moeller, A; Soldan, M, 2000
)
1.03

Treatment

Treatment with rutin prevented the loss of α crystallin chaperone property, and protein insolubilization prevailed during selenite-induced cataract. Pretreatment could decrease serum creatinine and urea as well as urine protein concentrations when compared with HCBD treated rats.

ExcerptReferenceRelevance
"Rutin treatment reduced the hematoma size, ROS production and decreased apoptosis in the zebrafish larvae brains."( Rutin protects hemorrhagic stroke development via supressing oxidative stress and inflammatory events in a zebrafish model.
Rana, AK; Saini, SK; Sharma, S; Singh, D, 2022
)
2.89
"Rutin treatments were performed at the following temperature and pressure conditions: 200 °C/15 bar, 300 °C/100 bar, and 400 °C/250 bar."( Antioxidant and Skin Whitening Activities of Sub- and Super-Critical Water Treated Rutin.
Jeong, HS; Jo, YJ; Lee, IC; Lee, J; Yoo, DH, 2022
)
1.67
"Rutin was treated with metal magnetic nanocomposites, GQD-MFe"( Preparation and characterization of Rutin loaded on magnetic graphene quantum dot nano career with metals (Ag, Zn, Mg, Co, and Fe) and study of antioxidant and electrochemical properties.
Abri, A; Salehpour, P, 2022
)
1.72
"Rutin treatment improves gout and reduces inflammatory expression in quail."( Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.
Huang, J; Li, Y; Lin, Z; Wang, Y; Wu, H; Zhang, B, 2023
)
3.07
"Rutin treatment significantly improved liver function tests [alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT)], and increased activities of antioxidant defense system [catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx)] and glutathione (GSH) content. "( Rutin ameliorates mercuric chloride-induced hepatotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
Caglayan, C; Darendelioğlu, E; Dortbudak, MB; Kandemir, FM; Kucukler, S; Yıldırım, S, 2019
)
3.4
"Rutin treatment significantly (p < 0.001) lowered retinal vascular endothelial growth factor, tumor necrosis factor-α, and aldose reductase. "( Effect of rutin on retinal VEGF, TNF-α, aldose reductase, and total antioxidant capacity in diabetic rats: molecular mechanism and ocular pharmacokinetics.
Das, U; Gupta, SK; Saklani, R; Sharma, HP; Velpandian, T, 2020
)
2.4
"Rutin treatment significantly arrested the biochemical disturbances of diabetic retinopathy. "( Effect of rutin on retinal VEGF, TNF-α, aldose reductase, and total antioxidant capacity in diabetic rats: molecular mechanism and ocular pharmacokinetics.
Das, U; Gupta, SK; Saklani, R; Sharma, HP; Velpandian, T, 2020
)
2.4
"Rutin treatment restored the brain function by attenuating colistin-induced oxidative stress, apoptosis, inflammation, histopathological and immunohistochemical alteration suggesting that rutin supplementation mitigated colistin-induced neurotoxicity in male rats."( Neuroprotective effect of rutin against colistin-induced oxidative stress, inflammation and apoptosis in rat brain associated with the CREB/BDNF expressions.
Caglayan, C; Çelik, H; Çomaklı, S; Kandemir, FM; Kucukler, S; Özdemir, S; Yardım, A, 2020
)
1.58
"Rutin treatment exhibited reduced cell viability with increased cell accumulation in G0/G1 phase of cell cycle in HeLa cell lines."( Elucidation of rutin's role in inducing caspase-dependent apoptosis via HPV-E6 and E7 down-regulation in cervical cancer HeLa cells.
Farhan, M; Jafri, A; Khan, F; Pandey, P, 2021
)
1.7
"Rutin treatment resulted in a significant reduction in hepatic ferritin protein expression and serum transferrin saturation."( The effect of the flavonol rutin on serum and liver iron content in a genetic mouse model of iron overload.
Hawula, ZJ; Rishi, G; Secondes, ES; Subramaniam, VN; Wallace, DF, 2021
)
1.64
"Rutin treatment significantly improved all examined parameters and restored the liver and kidney histopathological and immunohistochemical alterations."( Protective effects of rutin against deltamethrin-induced hepatotoxicity and nephrotoxicity in rats via regulation of oxidative stress, inflammation, and apoptosis.
Caglayan, C; Çomaklı, S; Kandemir, FM; Küçükler, S; Özdemir, S, 2021
)
1.66
"Rutin treatment was applied to male C57BL/6 mice maintained on a high-fat diet and HepG2 cells challenged with oleic acid."( Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
Ding, B; Ding, L; Dou, X; Hu, L; Liu, Q; Pan, R; Xia, Y; Zhang, F; Zhu, L, 2017
)
2.62
"Rutin treatment also increased the levels of ERα, ERβ, brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), tropomyosin receptor kinase A (TrkA), TrkB, and phospho-cAMP-responsive element binding protein (p-CREB) in rat hippocampus and cerebral cortex."( Rutin attenuates cerebral ischemia-reperfusion injury in ovariectomized rats via estrogen-receptor-mediated BDNF-TrkB and NGF-TrkA signaling.
Li, J; Liu, H; Liu, X; Zhang, Y; Zhong, L, 2018
)
2.64
"Rutin co-treatment with NaF normalized blood pressure, lowered Kim-1 and NF-κB expressions, and improved nitric oxide bioavailability."( Ameliorative effect of Rutin on sodium fluoride-induced hypertension through modulation of Kim-1/NF-κB/Nrf2 signaling pathway in rats.
Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Asenuga, ER; Ayodeji, F; Falayi, OO; Hassan, FO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018
)
1.51
"Rutin co-treatment resulted in reversing cisplatin effect on DNA damage, sperm count, histological and biochemical parameters."( Ameliorative effects of rutin against cisplatin-induced reproductive toxicity in male rats.
Abulmeaty, M; Afsar, T; Ain, QU; Almajwal, A; Anam, S; Jahan, S; Munawar, A; Razak, S; Ullah, H, 2018
)
1.51
"The rutin treatment decreased IL-6 mRNA abundance induced by LPS in a dose-dependent manner (P < 0.05)."( Rutin attenuates inflammatory responses induced by lipopolysaccharide in an in vitro mouse muscle cell (C2C12) model.
Adewole, D; Liu, S; O, K; Sid, V; Wang, B; Yang, C; Yu, L, 2019
)
2.44
"Rutin pretreatment also protected cells from vancomycin-induced caspase activation, mitochondrial membrane depolarization, and subsequent apoptosis."( Rutin attenuates vancomycin-induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress.
Dai, C; Guo, H; Hao, Z; Qu, S; Tang, Q; Wang, C; Wang, H; Zhang, Y, 2019
)
2.68
"Rutin treatment starting 1h after injury attenuated BBB disruption during photothrombotic focal ischemia, which was partly, at least, achieved through inhibitory effects on MMP-9 expression and activity. "( Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Hur, H; Jang, JW; Joo, SP; Kim, TW; Lee, JK; Piao, MS, 2014
)
3.29
"Rutin treatment blocked PrP (106-126)-mediated increases in reactive oxygen species production and nitric oxide release and helped slowing the decrease of neurotrophic factors that results from PrP accumulation."( Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells.
Kim, S; Kwon, J; Na, JY; Song, K, 2014
)
2.57
"Rutin treatment also improved histo-architecture of beta islets and reversed hypertrophy of hepatocytes."( Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: an effect mediated through cytokines, antioxidants and lipid biomarkers.
Ansari, AA; Naik, SR; Niture, NT, 2014
)
1.41
"Rutin-pretreated PC12 attenuated the Park2, Park5, Park7, Casp3, and Casp7 genes which were expressed significantly in the 6-OHDA-treated PC12 cells."( Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.
Haleagrahara, N; Magalingam, KB; Radhakrishnan, A; Ramdas, P, 2015
)
1.14
"Rutin pretreatment offers protective effect against TMT-induced learning and memory impairment in mice possibly by antagonizing decreased synaptophysin in the hippocampus and cortex."( [Rutin protects against trimethyltin-induced learning and memory impairment in BALB/c mice by antagonizing down-regulated synaptophysin expression].
Chen, CH; Qin, QZ; Yu, ZP; Zhao, Q; Zhou, Z, 2015
)
2.77
"Rutin pretreatment attenuated nephrotoxicity induced by gentamicin by reducing the urea, creatinine, and MDA levels and increasing the SOD, CAT, and GPx activity, and the GSH levels."( Rutin attenuates gentamicin-induced renal damage by reducing oxidative stress, inflammation, apoptosis, and autophagy in rats.
Aktas, E; Benzer, F; Hanedan, B; Kandemir, FM; Kilic, K; Kirbas, A; Ozkaraca, M; Yildirim, BA, 2015
)
2.58
"Rutin pretreatment (50 mg/kg, single injection, i.p.) was done before commencement of the study."( Protective effect of rutin on impairment of cognitive functions of due to antiepileptic drugs on zebrafish model.
Bansal, D; Dubey, N; Dubey, S; Ganeshpurkar, A,
)
1.17
"Rutin pretreatment protected HLE cells from H2O2-induced cell viability decrease and apoptosis. "( Protective Effect of Rutin Against H2O2-Induced Oxidative Stress and Apoptosis in Human Lens Epithelial Cells.
Guo, B; Li, SL; Liao, RF; Ye, MJ; Zhou, YF, 2016
)
2.2
"Rutin treatment notably increased Akt and IRS-1 phosphorylation in the livers of old rats."( Rutin protects against aging-related metabolic dysfunction.
Chen, S; Dong, J; Feng, T; Li, H; Li, T; Li, Y, 2016
)
2.6
"Rutin pretreatment caused a significant reduction in lipid peroxidation and LDH activity; increased glutathione content; restored antioxidant enzyme activity; reduced DNA strand breaks and fragmentation; modulated the expression of inflammatory, and apoptotic markers and restored the histopathological structure."( Attenuation of genotoxicity, oxidative stress, apoptosis and inflammation by rutin in benzo(a)pyrene exposed lungs of mice: plausible role of NF-κB, TNF-α and Bcl-2.
Ali, N; Ali, R; Hasan, SK; Majed, F; Rashid, S; Shahid, A; Sultana, S, 2016
)
1.38
"Rutin treatment resulted in the downregulation of caspase-3 expression in a reduced number of positive cells under terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay, and also the improved survival of neurons."( Rutin Acid Ameliorates Neural Apoptosis Induced by Traumatic Brain Injury via Mitochondrial Pathways in Mice.
Ding, Y; Li, F; Wang, Q; Zhai, X; Zhang, H, 2016
)
2.6
"Rutin treatment significantly impaired all the parameters that were altered by AP induction, but increased catalase and SOD activities in the pancreas compared with the vehicle-treated group."( Elucidating the role of oxidative stress in the therapeutic effect of rutin on experimental acute pancreatitis.
Abreu, FF; Camargo, EA; Costa, SK; Lauton Santos, S; Muscará, MN; Santana, MT; Soares, AG; Soares, RC; Souza, AC; Teixeira, DF; Teixeira, SA, 2016
)
1.39
"Rutin treatment exerted a protective effect on l-arginine-induced AP by mechanisms involving the reduction of oxidative stress, which suggests that this flavonoid has a potential for future approaches designed for the management of AP."( Elucidating the role of oxidative stress in the therapeutic effect of rutin on experimental acute pancreatitis.
Abreu, FF; Camargo, EA; Costa, SK; Lauton Santos, S; Muscará, MN; Santana, MT; Soares, AG; Soares, RC; Souza, AC; Teixeira, DF; Teixeira, SA, 2016
)
2.11
"Rutin treatment also significantly increased early/late-stage apoptosis in HEPG2 cells (28.9 %, p < 0.001)."( Modulatory effects of rutin on the expression of cytochrome P450s and antioxidant enzymes in human hepatoma cells.
Karakurt, S, 2016
)
1.47
"Rutin treatment significantly reduced adiposity, increased energy expenditure, and improved glucose homeostasis in both genetically obese (Db/Db) and diet-induced obesity (DIO) mice."( Rutin ameliorates obesity through brown fat activation.
Cheng, J; Cui, C; Dong, M; Hu, T; Huang, W; Huang, Y; Jin, W; Lee, HJ; Li, D; Lin, J; Liu, Q; Liu, S; Liu, X; Qi, X; Wei, G; Xie, W; Ye, R; You, Y; Yuan, X; Yuan, Z; Zhai, B; Zhan, J; Zhang, C; Zhang, H; Zhou, H, 2017
)
2.62
"Rutin pretreatment prevented deteriorative effects induced by cisplatin through a protective mechanism that involved reduction of increased oxidative stress as well as caspase-3, TNF-α and NFκB protein expression levels."( Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats.
Arjumand, W; Seth, A; Sultana, S, 2011
)
2.53
"Rutin pretreatment (25 mg/kg, orally, once daily for 3 weeks) significantly attenuated thiobarbituric acid reactive substances (TBARS), activity of poly ADP-ribosyl polymerase, and nitrite level and decreased level of reduced glutathione (GSH) and activities of its dependent enzymes (glutathione peroxidase [GPx] and glutathione reductase [GR]) and catalase in the hippocampus of ICV-STZ rats."( Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type.
Ahmad, A; Ahmad, ME; Ashafaq, M; Islam, F; Javed, H; Khan, A; Khan, MM; Safhi, MM; Siddiqui, MS; Vaibhav, K, 2012
)
2.54
"Rutin treatment significantly increased caecal bacterial beta-glucosidase activity (responsible for the conversion of rutin to the flavonoid quercetin) and there was an associated increase in the capacity of hepatic fractions (S-9) to activate the food pyrolysis products IQ, MeIQ and MeIQx to bacterial mutagens in vitro."( Modified mutagen activation in hepatic fractions from rats fed dietary rutin--interaction between gut flora and host metabolism.
Bearne, CA; Lake, BG; Mallett, AK; Rowland, IR, 1989
)
1.23
"Troxerutin treatment attenuated oxidative stress in the hippocampus of diabetic rats, as evidenced by the decreased MDA level and the increased SOD activity."( Troxerutin attenuates cognitive decline in the hippocampus of male diabetic rats by inhibiting NADPH oxidase and activating the Nrf2/ARE signaling pathway.
Gao, M; Kang, Y; Li, H; Liu, L; Luan, X; Qu, C; Zhang, L; Zhang, S, 2020
)
1.53
"Troxerutin and insulin treatments were begun immediately on the day of diabetes confirmation."( Can troxerutin pretreatment prevent testicular complications in prepubertal diabetic male rats?
Ahmadi, M; Bavil, FM; Ghadiri, A; Hamidian, GR; Keyhanmanesh, R; Oghbaei, H; Oskuye, ZZ, 2020
)
1.43
"Troxerutin treatment improved these alterations compared to the diabetic group."( Can troxerutin pretreatment prevent testicular complications in prepubertal diabetic male rats?
Ahmadi, M; Bavil, FM; Ghadiri, A; Hamidian, GR; Keyhanmanesh, R; Oghbaei, H; Oskuye, ZZ, 2020
)
1.43
"Troxerutin-pretreatment may play an essential role in the management of the type-1 diabetes-induced testicular disorders by decreasing blood glucose and modulating apoptosis."( Can troxerutin pretreatment prevent testicular complications in prepubertal diabetic male rats?
Ahmadi, M; Bavil, FM; Ghadiri, A; Hamidian, GR; Keyhanmanesh, R; Oghbaei, H; Oskuye, ZZ, 2020
)
1.49
"Troxerutin pretreatment alleviated OGD/R‑induced oxidative stress, as demonstrated by the reduced generation of reactive oxygen species and malonaldehyde content, and the increased activities of superoxide dismutase and glutathione peroxidase, which were reduced by HIF‑1α‑siRNA."( Troxerutin attenuates oxygen‑glucose deprivation and reoxygenation‑induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF‑1α signaling pathway in H9C2 cardiomyocytes.
Hua, X; Li, C; Li, J; Sheng, XS; Yu, HQ; Yu, ZP, 2020
)
1.53
"Troxerutin treatment significantly suppressed STAT3/RNF6 signaling."( The bioflavonoid troxerutin prevents gestational hypertension in mice by inhibiting STAT3 signaling.
Duan, B; Li, Y; Sun, Q; Wang, Y; Yang, X, 2021
)
1.39
"Troxerutin treatment reduced the blood glucose and glycosylated hemoglobin levels in high-cholesterol-induced insulin-resistant mice and in type-2 diabetic patients."( Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat.
Karundevi, B; Sampath, S, 2014
)
1.21
"Troxerutin was treated by daily oral administration at doses of 150 mg/kg/day for 20 weeks."( Troxerutin Attenuates Enhancement of Hepatic Gluconeogenesis by Inhibiting NOD Activation-Mediated Inflammation in High-Fat Diet-Treated Mice.
Fan, S; Lu, J; Shan, Q; Su, W; Sui, J; Sun, C; Wang, X; Wu, D; Zhang, C; Zhang, Z; Zheng, G; Zheng, Y, 2016
)
1.4
"Oxerutin treatment and the combined NAC plus taurine treatment resulted in reduced accumulation of collagen-linked fluorescence in skin in comparison with untreated diabetic rats."( Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes.
Cosso, L; Cottalasso, D; Maineri, EP; Marinari, UM; Menini, S; Odetti, P; Patriarca, S; Pesce, C; Pronzato, MA; Traverso, N; Valentini, S, 2003
)
1.08
"Pretreatment with rutin inhibited the BisGMA-induced generation of proinflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and PGE2, in macrophages."( Rutin alleviates bisphenol A-glycidyl methacrylate-induced generation of proinflammatory mediators through the MAPK and NF-κB pathways in macrophages.
Chang, YC; Huang, FM; Kuan, YH; Lee, MW; Su, NY; Yang, LC, 2023
)
2.68
"Treatment with rutin reduced the factors as mentioned above."( Role of NF-κB/IL-1β Pathway and Caspase 3 in Mediating the Hepatoprotective Effect of Rutin against Paraquat-Induced Liver Toxicity in Male Rats.
Heidarian, E; Nouri, A; Rafiee, S, 2023
)
1.47
"Pre-treatment with rutin restored both neuronal and endothelial dependent relaxations in diabetic animals towards the values achieved in control euglycemic tissues."( Rutin ameliorates nitrergic and endothelial dysfunction on vessels and corpora cavernosa of diabetic animals.
Cabral, PHB; da Silva, AG; de Morais Campos, R; do Nascimento, NRF; Fonteles, MC; Lima, LMALL; Paz, IA; Santiago, RO; Santos, CF, 2023
)
2.67
"Treatment with rutin and metformin in combination significantly reduced PE-induced contraction and increased ACh-induced and SNP-induced relaxation in diabetes when compared to rutin or metformin alone."( Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes.
Chakravarthi, S; Chellian, J; David, SR; Lai, PPN; Rajabalaya, R, 2023
)
1.62
"Pretreatment with rutin did not significantly alter Dox's tumor suppression potential, suggesting that it does not influence Dox's anticancer activity."( Rutin Protects against Doxorubicin-Induced Cognitive Dysfunction While Retaining the Anticancer Potential of Dox in a Murine Model of N-Methyl-N-Nitrosourea - Induced Mammary Carcinoma.
Alnaseer, SM; Gourishetti, K; Hussain, SM; Kishore, A; Nandakumar, K; Nayak, PG; Ramalingayya, GV; Rao, CM, 2019
)
2.28
"Treatment with rutin resulted in improvement in liver function by the decline in serum AST and ALT activities and reduction in serum ammonia level."( Ameliorative effects of rutin on hepatic encephalopathy-induced by thioacetamide or gamma irradiation.
El-Marakby, SM; Mansour, SZ; Moawed, FSM, 2017
)
1.1
"Treatment with rutin and dexrazoxane resulted in an increase in Bcl-2/Bax ratio (p < 0.05) and reduction in JNK and Caspase-3 protein levels, compared to the pirarubicin group (all p < 0.05)."( Cardioprotective effects of rutin in rats exposed to pirarubicin toxicity.
Leng, XW; Li, YJ; Ren, LQ; Sun, B; Wang, YD; Zhang, Y, 2018
)
1.11
"Treatment with rutin (100 and 200 mg/kg) and nimesulide (5 and 10 mg/kg) significantly attenuates these alterations as compared to DN control rats."( Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
Bishnoi, M; Kumar, A; Mittal, R; Nag, TC; Singh, DP, 2018
)
1.12
"Treatment with rutin prevented the loss of α crystallin chaperone property, and protein insolubilization prevailed during selenite-induced cataract."( Rutin ameliorates free radical mediated cataract by enhancing the chaperone activity of α-crystallin.
Abraham, A; Rooban, BN; Sahasranamam, V; Sasikala, V, 2013
)
2.19
"Treatment with rutin reversed all the altered genes induced by HCD nearly to the control levels. "( Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat.
Abuohashish, HM; Ahmed, MM; Al-Hosaini, KA; Al-Rejaie, SS; Al-Shabanah, OA; Aleisa, AM; Hafez, MM; Sayed-Ahmed, MM, 2013
)
1.06
"Pretreatment with rutin could decrease serum creatinine (p < 0.001) and urea (p < 0.001) as well as urine protein (p < 0.001) concentrations when compared with HCBD treated rats."( Protective effect of rutin on hexachlorobutadiene-induced nephrotoxicity.
Asadpour, E; Boroushaki, MT; Ghorbani, A; Rashidfar, M; Sadeghnia, HR; Yousefsani, BS, 2013
)
1.03
"Treatment with rutin and quercetin ameliorated the effects of high salt diet on these biochemical indices."( Rutin and quercetin show greater efficacy than nifedipin in ameliorating hemodynamic, redox, and metabolite imbalances in sodium chloride-induced hypertensive rats.
Akindahunsi, AA; Akinmoladun, AC; Crown, OO; Olaleye, MT, 2014
)
2.18
"Pretreatment with rutin inhibited not only histopathological changes in lung tissues but also infiltration of polymorphonuclear granulocytes into bronchoalveolar lavage fluid in lipopolysaccharide (LPS)-induced ALI."( Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway.
Kuan, YH; Li, YC; Yang, JJ; Yang, ML; Yeh, CH, 2014
)
2.17
"Treatment with rutin resulted in a decrease of PMA-stimulated phosphorylation of p38, extracellular regulated kinases 1/2, and c-Jun N-terminal kinase."( Inhibitory effects of rutin on the endothelial protein C receptor shedding in vitro and in vivo.
Bae, JS; Han, MS; Ku, SK; Lee, IC, 2014
)
1.06
"Pre-treatment with rutin inhibited LPS-induced neutrophil infiltration in the lungs."( Rutin improves endotoxin-induced acute lung injury via inhibition of iNOS and VCAM-1 expression.
Chen, ST; Horng, CT; Huang, YC; Kuan, YH; Kuo, WH; Lee, CY; Lee, SS; Yang, ML; Yeh, CH, 2016
)
2.2
"Treatment with rutin also led to increased gene and protein expression of basic fibroblast growth factor (bFGF) in HUVEC."( Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells.
Abdullah Mahdy, Z; Chua, KH; Nordin, NA; Ugusman, A; Zakaria, Z, 2014
)
1.18
"Treatment with rutin improved colitis at the dose of 57mg/kg/day, while no effect was noted with 28.5mg/kg/day."( Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis.
Aranda, C; de Medina, FS; Marín, JJ; Martínez-Augustin, O; Mascaraque, C; Monte, MJ; Ocón, B; Suárez, MD; Zarzuelo, A, 2014
)
2.18
"Treatment with rutin effectively ameliorated the alterations in the studied parameters of rat through its antioxidant nature."( Rutin potentially attenuates fluoride-induced oxidative stress-mediated cardiotoxicity, blood toxicity and dyslipidemia in rats.
Lakshmi, BV; Muvvala, S; Ramesh, A; Sravanthi, N; Umarani, V, 2015
)
2.2
"Treatment with rutin reverted the locomotor behavior to normal. "( Protective effect of rutin on impairment of cognitive functions of due to antiepileptic drugs on zebrafish model.
Bansal, D; Dubey, N; Dubey, S; Ganeshpurkar, A,
)
0.8
"Treatment with rutin decreased the carfilzomib-induced changes in cardiac enzymes such as lactate dehydrogenase, creatine kinase (CK) and CK-MB."( Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.
Afzal, M; Al-Harbi, NO; Al-Harbia, MM; Ansari, MA; Bahashwan, S; Imam, F; Iqbal, M; Kazmi, I; Khalid Anwer, M; Korashy, HM; Nagi, MN; Sayed-Ahmed, MM, 2017
)
2.24
"Pretreatment of rutin was given by oral gavage at doses of 40 and 80 mg/kg body weight (b.wt.) for 7 days before the administration of a single oral dose of B(a)P (125 mg/kg b.wt.). "( Attenuation of genotoxicity, oxidative stress, apoptosis and inflammation by rutin in benzo(a)pyrene exposed lungs of mice: plausible role of NF-κB, TNF-α and Bcl-2.
Ali, N; Ali, R; Hasan, SK; Majed, F; Rashid, S; Shahid, A; Sultana, S, 2016
)
1.01
"The treatment with rutin elicited noticeable inhibition of free acidity (26.20%), total acidity (22.05%) and CMDI (1.16%) in the experimental animals similar to control."( Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects.
Gautam, R; Gautam, S; Kaithwas, G; Rawat, JK; Saraf, SA; Singh, M, 2016
)
2.2
"Treatment with rutin and/or ozone, however, improved the aforementioned parameters."( Therapeutic effect of ozone and rutin on adriamycin-induced testicular toxicity in an experimental rat model.
Hellstrom, WJ; Salem, EA; Salem, NA, 2017
)
1.08
"Treatment by rutin significantly inhibited protein expressions of cytochrome P450-dependent CYP3A4 (75.3 %, p < 0.0001), elevated CYP1A1 enzymes (1.7-fold, p = 0.0084) and increased protein expressions of antioxidant and phase II reaction catalyzing enzymes, NQO1 (2.42-fold, p < 0.0001) and GSTP1 (2.03-fold, p < 0.0001)."( Modulatory effects of rutin on the expression of cytochrome P450s and antioxidant enzymes in human hepatoma cells.
Karakurt, S, 2016
)
1.1
"Treatment with rutin significantly decreased the elimination half-life of S-warfarin by 37% as a result of the 69% increase in unbound clearance of the S-enantiomer."( Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan, E; Chen, X; Hegde, A, 2009
)
1.1
"Pre-treatment with rutin protected gastric tissues against indomethacin-induced gastropathy as demonstrated from reduction in the ulcer index, attenuation of histopathological changes and amelioration of the altered oxidative stress and biochemical parameters."( Gastroprotective effect of rutin against indomethacin-induced ulcers in rats.
Abdel-Raheem, IT, 2010
)
0.98
"Pretreatment with rutin at the dose of 80 mg/kg daily for 42 days to isoproterenol-induced rats prevented all the biochemical alterations."( Protective effects of rutin on mitochondrial damage in isoproterenol-induced cardiotoxic rats: an in vivo and in vitro study.
Prince, PS; Punithavathi, VR; Shanmugapriya, K, 2010
)
1
"Pretreatment with rutin daily for a period of 42 days to isoproterenol induced cardio toxic rats prevented the changes in the activities of these enzymes."( Preventive effects of rutin on lysosomal enzymes in isoproterenol induced cardio toxic rats: biochemical, histological and in vitro evidences.
Priya, S; Stanely Mainzen Prince, P, 2010
)
1
"Post-treatment with rutin significantly reduced ulcerogen-induced gastric damage in all models."( Comparative gastroprotective effect of post-treatment with low doses of rutin and cimetidine in rats.
Akinmoladun, AC; Olaleye, MT, 2013
)
0.94
"Pretreatment with rutin and, to a lesser extent, with quercetin significantly reduced the activity of plasma transaminases and improved the histological signs of acute liver damage in CCl(4)-intoxicated mice. "( Differential hepatoprotective mechanisms of rutin and quercetin in CCl(4)-intoxicated BALB/cN mice.
Cvijanović, O; Domitrović, R; Jakovac, H; Rahelić, D; Romić, Z; Tadić, Z; Vasiljev Marchesi, V; Vladimir-Knežević, S, 2012
)
0.97
"Treatment with rutin effectively ameliorated the alterations in the studied parameters of rat."( Protective effects of rutin against potassium bromate induced nephrotoxicity in rats.
Khan, MR; Khan, RA; Sahreen, S, 2012
)
1.03
"Pretreatment with rutin (40 or 80 mg kg(-1)) to isoproterenol-treated rats orally for a period of 42 days daily caused a significant effect."( Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats.
Karthick, M; Stanely Mainzen Prince, P, 2006
)
0.98
"Pretreatment with rutin at doses of 40 or 80 mg/kg to ISO-treated rats showed a significant (p < 0.05) effect in all the parameters studied."( Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats.
Karthick, M; Stanely Mainzen Prince, P, 2007
)
0.98
"Pretreatment with rutin reversed these behavioural changes."( Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi, M; Chopra, K; Kulkarni, SK, 2007
)
0.98

Toxicity

L-Lysine increased the oral LD50 of ethanol, while diethanolamine-rutin decreased the intraperitoneal LD50. In MTX treated toxic group, the levels of oxidative markers and immunoregulatory cytokines significantly increased in comparison to control.

ExcerptReferenceRelevance
" L-Lysine increased the oral LD50 of ethanol, while diethanolamine-rutin decreased the intraperitoneal LD50 of ethanol."( Effect of lysine and diethanolamine-rutin on blood levels, withdrawal reaction, and acute toxicity of ethanol in mice.
Dorato, MA; Lynch, VD; Ward, CO, 1977
)
0.77
" However, no adverse effect on body weight gain, food or water consumption, ophthalmoscopic or electrocardiographic examinations were noted in any other animals during this study."( Toxicity of venalot (a mixture of coumarin and troxerutin) in the baboon.
Heywood, R; Majeed, SK; Pulsford, AH; Street, AE, 1983
)
0.52
"As a conclusion : CYCLO 3 FORT was safe and more effective than rutoside in the treatment of venous lymphatic insufficiency."( An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino, R; Buceta, AM; Penenory, A, 1999
)
0.3
" Cyclo 3 Fort was safe and more effective than rutoside in the treatment of venous lymphatic insufficiency, and the Cyclo 3 Fort efficacy is probably associated with its unique mechanism of action."( An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino, R; Buceta, AM; Penenory, A, 2000
)
0.31
" Adverse drug reactions were assessed regarding causality."( Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.
Becker, EW; Henneicke-von Zepelin, HH; Naser-Hijazi, B; Schmeck-Lindenau, HJ; Schnitker, J, 2003
)
0.6
"No serious adverse drug reactions occurred."( Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.
Becker, EW; Henneicke-von Zepelin, HH; Naser-Hijazi, B; Schmeck-Lindenau, HJ; Schnitker, J, 2003
)
0.6
"Cardiotoxicity is the main dose-limiting side effect of doxorubicin in the clinic."( A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro.
Abou-El-Hassan, MA; Bast, A; Hoeben, RC; Rabelink, MJ; van der Vijgh, WJ, 2003
)
0.32
" From a study in human volunteers, we conclude that an intravenous dose of 1500 mg/m(2) of 7-monohydroxyethylrutoside is feasible and is safe to be investigated as protection against doxorubicin-induced cardiotoxicity."( Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
Bast, A; den Hartog, GJ; Haenen, GR; Kaiserová, H; van der Vijgh, WJ, 2007
)
0.34
"'Healer' is a promising effective and safe line of treatment in acute and chronic anal fissure."( Study of efficacy and safety of a new local cream ('healer') in the treatment of chronic anal fissure: a prospective, randomized, single-blind, comparative study.
Abdel Salaam, M; Yakoot, M,
)
0.13
" Based on the above findings, the no observed adverse effect level (NOAEL) was estimated to be 1% in both sexes (542."( Fifty-two week chronic toxicity of enzymatically decomposed rutin in Wistar rats.
Hayashi, M; Kasahara, H; Kobayashi, S; Kuroda, J; Mitsumori, K; Muto, S; Nagasawa, T; Okuhara, Y; Onozato, T; Tamura, T,
)
0.37
"Thiabendazole (TBZ), an antihelminthic and antifungal agent, is associated with a host of adverse effects including nephrotoxicity, hepatotoxicity, and teratogenicity."( Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: a possible mechanism of thiabendazole toxicity.
Dalvie, DK; Jamieson, JD; Smith, EB; Stevens, GJ; Yanochko, GM, 2011
)
0.37
" No observed toxic level of vanadium-rutin complex at 20 ppm dose level could be good for further study."( Synthesis, Characterization, Antioxidant Status, and Toxicity Study of Vanadium-Rutin Complex in Balb/c Mice.
Chakraborty, T; Ghosh, B; Ghosh, N; Majumdar, S; Mallick, S; Manna, S; Roy, S; Singh, AK, 2015
)
0.92
" In the acute toxicity study, no toxic symptoms were observed and no rats died during the test."( Acute and Subacute Toxicity Studies on Rutin-Rich Tartary Buckwheat Dough in Experimental Animals.
Ishiguro, K; Morishita, T; Noda, T; Suzuki, T, 2015
)
0.69
" In MTX treated toxic group, the levels of oxidative markers and immunoregulatory cytokines significantly increased in comparison to control, which was subsequently restored after rutin treatment."( Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects.
Gautam, R; Gautam, S; Kaithwas, G; Rawat, JK; Saraf, SA; Singh, M, 2016
)
2.07
" Ozone therapy alone almost completely reversed the toxic effects of ADR and restored all parameters to normal levels."( Therapeutic effect of ozone and rutin on adriamycin-induced testicular toxicity in an experimental rat model.
Hellstrom, WJ; Salem, EA; Salem, NA, 2017
)
0.74
" The aim of this work was to evaluate antidiabetic activity in Streptozotocin (STZ)-induced diabetic rats and the antioxidant effects of 3',4'-Di-O-acetyl-cis-khellactone (DOAcK), as well as its toxic potential."( Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
Burgueño-Tapia, E; Cornejo-Garrido, J; Domínguez-Mendoza, EA; Ordaz-Pichardo, C, 2016
)
0.43
" Collectively, our findings suggest that suppression of autophagy and apoptosis by administration of rutin could attenuate doxorubicin-induced cardiotoxicity, which enhances our knowledge to explore new drugs and strategies for combating this devastating side effect induced by doxorubicin."( Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis.
Lu, L; Ma, J; Ma, Y; Ren, J; Wang, X; Yang, J; Yang, L, 2017
)
2.11
" Strikingly, oral administration of rutin counterbalanced the toxic effects triggered by Ag-NPs."( Neurotoxic effects of silver nanoparticles and the protective role of rutin.
Ahmed, MM; Hussein, MMA, 2017
)
0.96
" Toxic concentration ranges were determined by the brine shrimp lethality test on Artemia salina."( Cytotoxic Effects of Resveratrol, Rutin and Rosmarinic Acid on ARH-77 Human (Multiple Myeloma) Cell Line.
Artagan, O; Canturk, Z; Dikmen, M; Ozarda, MG; Ozturk, N, 2016
)
0.71
" UD inhibited cell proliferation in the selected cells, while no toxic effects were observed in normal lung cells."( Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis.
Ciaramella, V; Ciardiello, F; D'Abrosca, B; Della Corte, CM; Fiorentino, A; Graziani, V; Morgillo, F; Papaccio, F; Potenza, N, 2019
)
0.51
"Cisplatin, used in cancer treatment, has toxic and apoptotic effects on the peripheral nervous system."( Peripheral neurotoxic effects of cisplatin on rats and treatment with rutin.
Arslan, YK; Cimen, FK; Ersoy, A; Kurt, N; Mammadov, R; Yaşar, H, 2019
)
0.75
"Antioxidant and antiapoptotic effectiveness of rutin was detected against the toxic effects caused by cisplatin in the peripheral nerve tissue."( Peripheral neurotoxic effects of cisplatin on rats and treatment with rutin.
Arslan, YK; Cimen, FK; Ersoy, A; Kurt, N; Mammadov, R; Yaşar, H, 2019
)
1
"Serum albumin binds avidly to heme to form heme-serum albumin complex and can protect against the potentially toxic effects of heme."( Formation of a bovine serum albumin diligand complex with rutin for the suppression of heme toxicity.
Lu, N; Luo, M; Sui, Y; Tian, R, 2020
)
0.8
" At present, dexrazoxane (DZR) is the only cardioprotective agent used to treat anthracycline drug-induced cardiotoxicity, but it may reduce the anticancer effect of anthracycline drugs, causing severe granulocytopenia and other adverse reactions."( Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway.
Gu, Z; Huang, P; Li, Q; Li, T; Qin, M; Ren, L; Tan, Q, 2020
)
2
" Obtained results demonstrate that the CESR did not present significant toxic effects when administrated orally to male and female rats in acute and repeated doses."( Preclinical safety assessment of the crude extract from Sida rhombifolia L. aerial parts in experimental models of acute and repeated-dose 28 days toxicity in rats.
Cristina da Costa Araldi, I; Danesi, CC; de Andrade Fortes, T; de Freitas Bauermann, L; de Souza Vencato, M; Dornelles, GL; Emanuelli Mello, CB; Gindri, AL; Machado, AK; Maciel, RM; Melazzo de Andrade, C; Piber de Souza, T; Sorraila de Oliveira, J, 2021
)
0.62
" No serious adverse events or toxicity were reported in the clinical or experimental animal studies we reviewed."( United States Pharmacopeia comprehensive safety review of Styphnolobium japonicum flower and flower bud.
Calderón, AI; Madden, E; McLachlan, C; Oketch-Rabah, H, 2022
)
0.72
" Simultaneously, no toxicity was detected after acute or subacute treatment of KFWD, providing valuable evidence for the traditional safe use of KF."( Kochiae Fructus: Evaluation on the antioxidant properties and oral safety of its water decoction.
Chen, XL; Han, M; Li, B; Li, LH; Wang, HL; Zhang, K; Zhang, YM; Zhao, X, 2022
)
0.72
" Overall, TEGDMA induces various toxic effects in macrophages, including cytotoxicity, apoptosis, and genotoxicity."( Protective Effect of Rutin on Triethylene Glycol Dimethacrylate-Induced Toxicity through the Inhibition of Caspase Activation and Reactive Oxygen Species Generation in Macrophages.
Chang, YC; Huang, FM; Kuan, YH; Su, NY; Yang, LC; Yeh, KL, 2022
)
1.04
" As a result, it was observed that MLT had a toxic effect on the liver and kidney tissues of rats, and it was determined that this toxicity could be alleviated by RUT treatment."( Molecular and biochemical investigation of the protective effects of rutin against liver and kidney toxicity caused by malathion administration in a rat model.
Gur, C; Kandemir, FM, 2023
)
1.14
"The wastewater discharge from the process of chrome plating, which contains 6:2 chlorinated polyfluorinated ether sulfonate (F-53B) and chromium (Cr), may be toxic to biofilm."( Repairing of rutin to the toxicity of combined F-53B and chromium pollution on the biofilm formed by Pseudomonas aeruginosa.
Qian, Y; Qiao, W; Zhang, M; Zhang, Y, 2023
)
1.28
" Also, pre-treatment for 14 days with the extract in the mice model before a single toxic dose (5 g/kg body weight) reduced the liver injury by bringing the levels of liver function enzymes, lipid profile and bilirubin to near normal."( Artabotrys odoratissimus Bark Extract Restores Ethanol Induced Redox Imbalance and Toxicity in Hepatocytes and In Vivo Model.
C, IM; H M, K; J U, SK; N D, S; N, P; P, M; R, R; R, S; R, SKJ, 2023
)
0.91

Pharmacokinetics

Treatment with rutin significantly decreased the elimination half-life of S-warfarin by 37% as a result of the 69% increase in unbound clearance of the S-enantiomer. Time to reach Cmax (tmax) was significantly shorter after the quercetin aglycone treatment than after the rutsin treatment.

ExcerptReferenceRelevance
" The maximal pharmacodynamic effects appeared simultaneous with the plasma drug peak."( Pharmacodynamics of troxerutine in patients with chronic venous insufficiency: correlations with plasma drug levels.
Auteri, A; Blardi, P; de Lillo, L; di Perri, T; Frigerio, C, 1990
)
0.58
" However, time to reach Cmax (tmax) was significantly shorter after the quercetin aglycone treatment than after the rutin treatment (1."( Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers.
Alfthan, G; Aro, A; Erlund, I; Kenraali, J; Kosonen, T; Mäenpää, J; Parantainen, J; Perttunen, K, 2000
)
0.76
" There was no significant difference in the bioavailability and pharmacokinetic parameters between the onion supplement and quercetin-4'-O-glucoside."( Pharmacokinetics and bioavailability of quercetin glycosides in humans.
Derendorf, H; Drewelow, B; Graefe, EU; Jacobasch, G; Mueller, S; Pforte, H; Riethling, AK; Uehleke, B; Veit, M; Wittig, J, 2001
)
0.31
" The primary objective was to evaluate the pharmacokinetic parameters, in particular the rate and extent of absorption (bioavailability) of two markers of Venoruton: mono-3'-HR and mono-4'-HR derivatives [glucuroconjugated forms (HG)], analysed in their deconjugated form as O-(beta-hydroxyethyl)-quercetin (HQ): mono-3'-HQ and mono-4'-HQ, and to investigate dose proportionality."( Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
Ghika, A; Kienzler, JL; Sallin, D; Schifflers, MH, 2002
)
0.31
" Time to peak concentration of both Venoruton derivatives remained unaffected by the administered dose."( Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
Ghika, A; Kienzler, JL; Sallin, D; Schifflers, MH, 2002
)
0.31
" The rate of appearance and the elimination half-life of both molecules were not modified with the administered dose."( Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
Ghika, A; Kienzler, JL; Sallin, D; Schifflers, MH, 2002
)
0.31
" The aim of the present study was to determine whether there is a pharmacokinetic interaction between monoHER and doxorubicin which may be involved in monoHER cardioprotection."( The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice.
Abou El Hassan, MA; Bast, A; Kedde, MA; van der Vijgh, WJ; Zwiers, UT, 2003
)
0.32
" No changes were observed in pharmacokinetic parameters such as initial and final half-lives, mean residence time, clearance and volume of distribution of monoHER and doxorubicin(ol) after single or combined administration."( The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice.
Abou El Hassan, MA; Bast, A; Kedde, MA; van der Vijgh, WJ; Zwiers, UT, 2003
)
0.32
"The cardioprotection of monoHER in mice is not caused by a pharmacokinetic interaction between monoHER and doxorubicin."( The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice.
Abou El Hassan, MA; Bast, A; Kedde, MA; van der Vijgh, WJ; Zwiers, UT, 2003
)
0.32
" Treatment with rutin significantly decreased the elimination half-life of S-warfarin by 37% as a result of the 69% increase in unbound clearance of the S-enantiomer."( Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan, E; Chen, X; Hegde, A, 2009
)
1.1
"Concurrent rutin administration is likely to reduce the anticoagulant effect of racemic warfarin, reflecting a significant decrease in the elimination half-life of the more potent S-enantiomer."( Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan, E; Chen, X; Hegde, A, 2009
)
1.15
" Pharmacokinetic parameters were calculated using the software WinNonlin Standard Edition Version."( Lymphatic absorption of quercetin and rutin in rat and their pharmacokinetics in systemic plasma.
Chen, IL; Huang, CM; Tsai, TH; Tsai, YJ, 2010
)
0.63
" In the single-dose pharmacokinetic study (SDS), blood samples were collected on 1st day whereas on 15th day in the multiple-dose pharmacokinetic study (MDS)."( Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats.
Babu, PR; Gnananath, K; Kumar, KK; Priyanka, L; Sujatha, S, 2015
)
0.67
" Pharmacokinetic study was investigated in the two groups of rats (n = 6) for pharmacokinetic interactions between the Quercetin and Rutin (2."( Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin.
Agrawal, A; Chintala, J; Dubey, GP; Kaliappan, I; Kammalla, AK; Ramasamy, MK, 2015
)
0.87
" This developed method was successfully used for determination of rutin in rat plasma for pharmacokinetic study."( Determination of rutin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and application to pharmacokinetic study.
Chen, M; Hu, G; Lin, B; Wang, H; Wang, S; Zhang, X, 2015
)
0.99
" The pharmacokinetic parameters were analyzed using the drug and statistics software."( A Simple and Rapid UPLC Method for the Determination of Rosavin in Rat Plasma and Its Application to a Pharmacokinetic Study.
Chen, D; Hu, S; Igor, LP; Shen, J; Sun, H; Xiang, Z; Zheng, X, 2016
)
0.43
"This work reports the safety profiling, in vivo hypoglycemic and pharmacokinetic studies of three phytoceuticals viz."( In Vivo Hypoglycemic Studies of Polyherbal Phytoceuticals, Their Pharmacokinetic Studies and Dose Extrapolation by Allometric Scaling.
Bhandari, K; De, B; Katakam, P; Mitra, A, 2017
)
0.46
" Plasma concentrations of the active constituent rutin (pharmacologically active compound of PHC) were determined by HPLC and other pharmacokinetic parameters using PK Solver."( In Vivo Hypoglycemic Studies of Polyherbal Phytoceuticals, Their Pharmacokinetic Studies and Dose Extrapolation by Allometric Scaling.
Bhandari, K; De, B; Katakam, P; Mitra, A, 2017
)
0.71
" The values of the pharmacokinetic parameters for different doses of phytoceuticals showed that the active concentration was maintained in plasma level and each formulation complied with their relevant quality criteria."( In Vivo Hypoglycemic Studies of Polyherbal Phytoceuticals, Their Pharmacokinetic Studies and Dose Extrapolation by Allometric Scaling.
Bhandari, K; De, B; Katakam, P; Mitra, A, 2017
)
0.46
" Animal to human dose extrapolation and prediction of human pharmacokinetic parameters by allometry was convenient."( In Vivo Hypoglycemic Studies of Polyherbal Phytoceuticals, Their Pharmacokinetic Studies and Dose Extrapolation by Allometric Scaling.
Bhandari, K; De, B; Katakam, P; Mitra, A, 2017
)
0.46
"In order to research and enhance bioavailability of chlorogenic acid and rutin(CA-R) via the oral route, chitosan coated composite phospholipid liposomes (C-CPLs) were applied to study on preparation, permeability and pharmacokinetic of C-CA-R-CPLs."( Chitosan coated chlorogenic acid and rutincomposite phospholipid liposomes: Preparation, characterizations, permeability and pharmacokinetic.
He, C; Jiang, W; Li, J; Xing, J; Zeng, C; Zheng, R, 2018
)
0.99
" All these compounds not only showed excellent pharmacokinetic properties, absorption, metabolism, minimal toxicity and bioavailability but were also remain stabilized at the active site of proteins during the MD simulation."( Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik, D; Jagadeesan, R; Kumar, D; Kumar, N; Nandi, R; Prakash, A, 2020
)
0.56
"The boronate affinity-based oriented and double-shelled surface molecularly imprinted polymers on 96-well microplates (BDMIPs) were designed and applied to high-specific and high-throughput pharmacokinetic (PK) study of rutin and its metabolites from rat plasma without concentration and redissolution."( Boronate Affinity-Based Oriented and Double-Shelled Surface Molecularly Imprinted Polymers on 96-Well Microplates for a High-Throughput Pharmacokinetic Study of Rutin and Its Metabolites.
Liu, S; Liu, Z; Pi, Z; Song, F; Xing, J; Zhao, N; Zheng, Z, 2021
)
1
" In this study, a pharmacokinetic and pharmacodynomic model was adopted to study the correlation of the pharmacokinetics and pharmacodynomics of rutin in lipopolysaccharide-induced acute lung injury mice."( The protective effect of rutin against lipopolysaccharide induced acute lung injury in mice based on the pharmacokinetic and pharmacodynamic combination model.
Cui, C; Jin, Z; Li, C; Liang, Y; Liu, M; Qu, C; Shao, Y; Sun, S; Tian, C, 2022
)
1.23
"The present study investigated the pharmacodynamic material basis of Laportea bulbifera in the treatment of rheumatoid arthritis."( [Potential pharmacodynamic substances of Laportea bulbifera in treatment of rheumatoid arthritis based on serum pharmacochemistry and pharmacology].
Chen, SY; Chen, Y; Gong, ZP; Huang, Y; Lan, YY; Li, YT; Tang, J; Wang, YL; Wu, D; Zhang, Q; Zheng, L, 2022
)
0.72

Compound-Compound Interactions

The present work examined the effect of oral administration of rutin and its combination with metformin, an antidiabetic drug on blood glucose, total cholesterol and triglycerides level and vascular function in diabetic rats. Globally, our findings suggest that r Rutin may have a beneficial impact against RCC.

ExcerptReferenceRelevance
"Controlled experiments confirmed the therapeutic usefulness in gynecology of a phlebokinetic drug, in which EPL (polyunsaturated phosphatidylcholine) was combined with escine and rutine."( [Gynecological use of a phlebokinetic drug with special reference to its combination with oral contraceptives].
Cazzola, D, 1975
)
0.45
"The effect of 7-mono-hydroxyethylrutoside and its combination with acetylsalicylic acid was evaluated in a controlled clinical trial, performed in 105 patients with obliterative atherosclerosis of the lower limbs, and using non-invasive measurement of peripheral haemodynamic parameters--blood flow during reactive hyperaemia and ankle systolic blood pressure."( The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
Linhart, J; Oliva, I; Prerovský, I; Roztocil, K, 1989
)
0.28
"Short-term and long-term results with HR + AC indicated that patients with severe CLI and very poor prognosis benefited in terms of survival and limb salvage from initial therapy with HR infusion combined with long-term oral anticoagulation."( Intravenous hydroxyethylrutosides combined with long-term oral anticoagulation in atherosclerotic nonreconstructable critical leg ischemia: a retrospective study.
Glenne, PO; Inácio, J; Larsson, UB; Lavstedt, S; Lund, F; Qian, Z; Schiötz, J; Tillgren, C, 1999
)
0.3
" This method was successfully applied to the drug interaction study of Shuang-huang-lian freeze-dried powder combined with levofloxacin injection after intravenous administration to rats."( Development of an LC-MS method for determination of three active constituents of Shuang-huang-lian injection in rat plasma and its application to the drug interaction study of Shuang-huang-lian freeze-dried powder combined with levofloxacin injection.
Bi, K; Chen, X; Geng, L; Liu, Z; Song, X; Ye, J; Zhao, X, 2012
)
0.38
" Paclitaxel (40 mg/kg) was administered orally alone and in combination with apigenin and rutin (10, 20, and 40 mg/kg) for 15 consecutive days."( Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats.
Babu, PR; Gnananath, K; Kumar, KK; Priyanka, L; Sujatha, S, 2015
)
0.89
"The aim of this study was to: (a) develop a simple, high performance thin layer chromatographic (HPTLC) method combined with direct 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay to rapidly assess and compare free radical scavenging activity or anti-oxidant activity for major classes of polyphenolics present in wines; and (b) to investigate relationship between free radical scavenging activity to the total polyphenolic content (TPC) and total antioxidant capacity (TAC) in the wine samples."( Development and validation of a simple high performance thin layer chromatography method combined with direct 1,1-diphenyl-2-picrylhydrazyl assay to quantify free radical scavenging activity in wine.
Agatonovic-Kustrin, S; Morton, DW; Yusof, AP, 2016
)
0.43
" Overall, combination with chemometrics and quantitative analysis would provide a useful and simple method for quality control of FCP in the future."( Combination with Chemometrics and Quantification for Quality Evaluation and Variety Identification of Flos Chimonanthi Praecocis by HPLC.
Gu, BR; Su, JH; Sun, L; Xing, YW; Zhang, C, 2016
)
0.43
" Globally, our findings suggest that rutin may have a beneficial impact against RCC and that its combination with ILs ensures that this poorly soluble drug is successfully incorporated into ILs-nanoparticles hybrid systems, allowing controlled drug delivery."( Anticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells.
Araújo, MEM; Baby, AR; Caparica, R; Costa, JG; Fonte, P; Júlio, A; Santos de Almeida, T, 2020
)
1.14
"Colorectal cancer (CRC) can be either prevented or alleviated using conventional drugs combined with natural treatments."( Andean berry (Vaccinium meridionale Swartz) juice, in combination with Aspirin, displayed antiproliferative and pro-apoptotic mechanisms in vitro while exhibiting protective effects against AOM-induced colorectal cancer in vivo.
Arango-Varela, SS; Luzardo-Ocampo, I; Maldonado-Celis, ME, 2022
)
0.72
"The present work examined the effect of oral administration of rutin and its combination with metformin, an antidiabetic drug on blood glucose, total cholesterol and triglycerides level and vascular function in streptozotocin (STZ) -induced diabetic rats."( Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes.
Chakravarthi, S; Chellian, J; David, SR; Lai, PPN; Rajabalaya, R, 2023
)
1.52

Bioavailability

Rutin is a biologically active polyphenol. SCR microcapsules developed in this study effectively enhanced the bioavailability of rutin.

ExcerptReferenceRelevance
" The encapsulated particles showed higher dissolution rate and bioavailability but lower ulcerogenic activity as compared with the drug alone."( A new approach to encapsulating non-steroidal anti-inflammatory drugs. V. Biopharmaceutical study of microcapsules of azapropazone coated with pectin and rutin.
el-Dien, EZ; Luzzi, LA; Meshali, MM; Omar, SA,
)
0.33
" The relative bioavailability of the drug from Venelbin was 97."( [HPLC determination of troxerutin in plasma and urine following oral administration in man].
Beubler, E; Dittrich, P; Kukovetz, W; Ostrowski, J; Schraven, E, 1985
)
0.56
"We studied the bioavailability and the plasma transport of flavonols in rats fed quercetin or rutin diets."( Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin.
Agullo, G; Demigné, C; Favier, ML; Manach, C; Morand, C; Régérat, F; Rémésy, C; Texier, O, 1995
)
0.75
" The bioavailability of the rutinoside was only 20% of that of the glucoside."( The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man.
Bijsman, MN; Cnossen, EP; de Vries, JH; Hollman, PC; Katan, MB; van Gameren, Y, 1999
)
0.6
"The object of this study was to enhance the solubility, dissolution rate, and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD)."( Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Arima, H; Hirayama, F; Horikawa, T; Miyake, K; Noda, S; Sumiyoshi, H; Uekama, K; Yamamoto, M, 2000
)
0.77
" The oral bioavailability of monoHER is <1%."( Stability of monoHER in an aqueous formulation for i.v. administration.
Abou El Hassan, MA; Bast, A; Touw, DJ; van der Vijgh, WJ; Wilhelm, AJ, 2000
)
0.31
"In clinical trials, studying the effects of quercetin from rutin, bioavailability must be taken into consideration and plasma quercetin concentrations monitored."( Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers.
Alfthan, G; Aro, A; Erlund, I; Kenraali, J; Kosonen, T; Mäenpää, J; Parantainen, J; Perttunen, K, 2000
)
0.79
" However, data on the bioavailability of quercetin after oral intake are scarce and contradictory."( Pharmacokinetics and bioavailability of quercetin glycosides in humans.
Derendorf, H; Drewelow, B; Graefe, EU; Jacobasch, G; Mueller, S; Pforte, H; Riethling, AK; Uehleke, B; Veit, M; Wittig, J, 2001
)
0.31
"The bioavailability of both Venoruton derivatives (mono-3'-HQ and mono-4'-HQ) tended to be proportional to the dose."( Pharmacokinetics of mono-3'- and mono-4'-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers.
Ghika, A; Kienzler, JL; Sallin, D; Schifflers, MH, 2002
)
0.31
" To the best of our knowledge, this is the first study demonstrating naringenin bioavailability in humans after consumption of a meal containing cooked tomato paste."( Naringenin from cooked tomato paste is bioavailable in men.
Bugianesi, R; Catasta, G; D'Uva, A; Maiani, G; Spigno, P, 2002
)
0.31
" On the length basis, the absorption rate of quercetin was colon > ileum > duodenum > jejunum."( [Study on the absorption of quercetin and rutin at different segments of intestine].
Guo, C; Su, J; Wei, J; Yang, J, 2002
)
0.58
" However, adequate intakes and absorption rate of phenolic compounds are necessary for these beneficial effects."( Influence of cooking process on phenolic marker compounds of vegetables.
Andlauer, W; Fürst, P; Hubert, M; Rings, A; Stumpf, C, 2003
)
0.32
"The pharmacokinetics and bioavailability of monoHER, a promising protector against doxorubicin-induced cardiotoxicity, were determined after different routes of administration."( Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice.
Abou El Hassan, MA; Bast, A; Haenen, GR; Kedde, MA; Tourn, E; van der Vijgh, WJ; Zwiers, UT, 2003
)
0.32
"Recent investigations suggest that the bioavailability of quercetin depends on the glycoside moiety of the quercetin glycosides present in the diet."( The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors.
Cermak, R; Landgraf, S; Wolffram, S, 2003
)
0.32
" However, the actual bioavailability of these compounds in vivo, especially in the prevalent glycosidic form, remains a controversial point in making an assessment of their biological importance."( Absorption of quercetin and rutin in rat small intestine.
Carbonaro, M; Grant, G,
)
0.43
"The bioavailability of quercetin and rutin (quercetin-3-rutinoside) was assessed in vivo, with single-meal experiments with rats and by an in vitro method with ligated loops of rat small intestine."( Absorption of quercetin and rutin in rat small intestine.
Carbonaro, M; Grant, G,
)
0.7
" The bioavailability of flavonoids is influenced by the metabolism of the microflora in the intestine."( Metabolism of quercetin and rutin by the pig caecal microflora prepared by freeze-preservation.
Hein, EM; Humpf, HU; Keppler, K, 2006
)
0.63
" Pectin might thus enhance the bioavailability of quercetin from rutin by altering the metabolic activity of the intestinal flora and/or gut physiological function."( Effect of pectin enhancement on plasma quercetin and fecal flora in rutin-supplemented mice.
Hirayama, K; Itoh, K; Nakagawa, H; Tamura, M; Tsushida, T, 2007
)
0.81
"The use of a high quercetin dose to demonstrate its absorption and bioavailability does not reflect the real dietary situation because quercetin glycosides are usually present in small amounts in the human diet."( Phenylacetic acids were detected in the plasma and urine of rats administered with low-dose mulberry leaf extract.
Cheng, HM; Lee, CY; Sim, SM, 2008
)
0.35
" The improving dissolution behavior of the rutin nanocrystal-loaded tablet should lead to a better bioavailability of the poorly soluble rutin in the body."( Development of an oral rutin nanocrystal formulation.
Keck, CM; Mauludin, R; Müller, RH, 2009
)
0.93
" It was concluded that suppression of degrading quercetin aglycone in the large intestine has a major role for increasing alpha G-rutin bioavailability by DFA III and FOS feedings."( Oligosaccharide promotes bioavailability of a water-soluble flavonoid glycoside, alpha G-rutin, in rats.
Chiji, H; Hara, H; Matsukawa, N; Matsumoto, M, 2009
)
0.78
"The effect of apple pectin (AP) on quercetin and rutin bioavailability was investigated."( Chronic ingestion of apple pectin can enhance the absorption of quercetin.
Iwai, K; Matsue, H; Nishijima, T; Saito, Y; Takida, Y, 2009
)
0.61
" This system was used for fermentation of tomato pulp, with the aim of improving the bioavailability of flavonoids in processed tomato products."( Characterization of Rhamnosidases from Lactobacillus plantarum and Lactobacillus acidophilus.
Beekwilder, J; de Vos, R; Francke, C; Hall, RD; Janssen, P; Marcozzi, D; van Hylckama Vlieg, J; Vecchi, S, 2009
)
0.35
" However, low oral bioavailability of quercetin due to insolubility in water has limited its use as a food additive or dietary supplement."( Enzymatically modified isoquercitrin, alpha-oligoglucosyl quercetin 3-O-glucoside, is absorbed more easily than other quercetin glycosides or aglycone after oral administration in rats.
Kanemaru, M; Makino, T; Mizukami, H; Moriwaki, M; Shimizu, R; Suzuki, Y, 2009
)
0.35
"Although the flavonol quercetin is used as a supplement in commercial dog food, data on quercetin bioavailability in dogs are not available."( Oral bioavailability of quercetin from different quercetin glycosides in dogs.
Abraham, G; Cermak, R; Reinboth, M; Ungemach, FR; Wolffram, S, 2010
)
0.36
" Co-effectors in the extract improve the bioavailability of active constituents such as hypericin (1) (pharmacokinetic synergy)."( Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Butterweck, V; Nahrstedt, A, 2010
)
0.36
" We examined the effect of alpha-oligoglucosylation of the sugar moiety of quercetin monoglucoside on its bioavailability in humans."( alpha-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans.
Fujikura, Y; Kashino, Y; Kato, Y; Koda, T; Matsuda, N; Murota, K; Nakamura, T; Okuyama, S; Sekido, K; Shimizu, R; Tanaka, H; Terao, J, 2010
)
0.36
"The flavonol quercetin in plants and foods occurs predominantly in the form of glycoside whose sugar moiety affects the bioavailability and the mechanism of its biological activities."( Transformation of rutin to antiproliferative quercetin-3-glucoside by Aspergillus niger.
Ahn, HJ; Ji, GE; You, HJ, 2010
)
0.69
" In conclusion, quercetin and rutin decreased the bioavailability of CSP through activating P-gp and CYP3A."( Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4.
Chao, PD; Chen, CT; Hou, YC; Lin, SP; Tsai, SY; Wu, PP; Yu, CP, 2011
)
1.02
" Based on the results, it can be concluded that the phospholipid complex may be considered as a promising drug delivery system for improving the overall absorption and bioavailability of the rutin molecule."( Rutin-phospholipid complex: an innovative technique in novel drug delivery system- NDDS.
Rawat, MS; Semalty, A; Semalty, M; Singh, D, 2012
)
2.01
"The bioavailability of quercetin has been intensively investigated in monogastric species, but knowledge about its bioavailability in ruminants does not exist."( Bioavailability of the flavonol quercetin in cows after intraruminal application of quercetin aglycone and rutin.
Berger, LM; Blank, R; Metges, CC; Wein, S; Wolffram, S, 2012
)
0.59
" Bioavailability in plasma was done by chromatographic analysis."( Therapeutic potential of treatment with the flavonoid rutin after cortical focal ischemia in rats.
Frazão Muzitano, M; Giraldi-Guimarães, A; Marcilio, Fdos S; Rodrigues, AM, 2013
)
0.64
" It has been shown recently that bioavailability of quercetin is low after ruminal administration in cows because of degradation by the ruminal microbiota."( Bioavailability of quercetin from its aglycone and its glucorhamnoside rutin in lactating dairy cows after intraduodenal administration.
Gohlke, A; Ingelmann, CJ; Metges, CC; Nürnberg, G; Starke, A; Wolffram, S, 2013
)
0.62
" However, the low water solubility of quercetin limits its bioavailability to exhibit activity in vivo."( Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.
Kanemaru, M; Makino, T; Mizukami, H; Okuyama, S; Shimizu, R; Tanaka, H, 2013
)
0.59
" In addition, this review will also focus on the challenges associated with the drug and various approaches to improve the oral bioavailability of rutin."( Rutin : therapeutic potential and recent advances in drug delivery.
Ali, A; Ali, J; Baboota, S; Sahni, JK; Sharma, S, 2013
)
2.03
" In the near future, enhancing its bioavailability using novel drug delivery methods having minimum side effects will bring this promising natural molecule to the forefront of therapy for the treatment of various chronic human diseases."( Rutin : therapeutic potential and recent advances in drug delivery.
Ali, A; Ali, J; Baboota, S; Sahni, JK; Sharma, S, 2013
)
1.83
" Our results suggest that polyphenolic compounds might be potential structural bases and source to find and project nature-based, safe, orally bioavailable direct thrombin inhibitors."( Thrombin inhibitory activity of some polyphenolic compounds.
Bijak, M; Krotkiewski, H; Nowak, P; Pawlaczyk, I; Ponczek, M; Saluk, J; Wachowicz, B; Ziewiecki, R, 2014
)
0.4
" However, it shows poor bioavailability when administered orally."( Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
Ali, J; Baboota, S; Sahni, JK; Sharma, S, 2015
)
0.64
" The bioavailability of Quercetin was lowered from the polyherbal formulation when compared with the co-administration, whereas the Rutin bioavailability has increased from the polyherbal formulation when compared with the co-administration."( Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin.
Agrawal, A; Chintala, J; Dubey, GP; Kaliappan, I; Kammalla, AK; Ramasamy, MK, 2015
)
0.87
"Tranilast (TL) composite particles with α-glucosyl rutin (Rutin-G) were developed to improve the solubility and oral bioavailability of TL."( Absorption improvement of tranilast by forming highly soluble nano-size composite structures associated with α-glucosyl rutin via spray drying.
Fujimori, M; Kadota, K; Onoue, S; Sato, H; Shirakawa, Y; Suzuki, H; Tozuka, Y, 2015
)
0.88
" The aim of this study was to investigate the oral bioavailability of the flavonol quercetin, applied either as quercetin aglycone (QA) or as its glucorhamnoside rutin (RU), in newborn dairy calves."( Bioavailability of the flavonol quercetin in neonatal calves after oral administration of quercetin aglycone or rutin.
Bruckmaier, RM; Hammon, HM; Kanitz, E; Maciej, J; Schäff, CT; Tuchscherer, A; Wolffram, S, 2015
)
0.82
" pseudocatenulatum may contribute to the release of the aglycone from certain rutinose-conjugated polyphenols, such as hesperidin, it remains to be clarified whether this species may exert a role in affecting the bioavailability of the rutinoside in vivo."( Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria.
Amaretti, A; Leonardi, A; Quartieri, A; Raimondi, S; Rossi, M, 2015
)
0.98
" The W/O microemulsion can significantly promote the intestinal absorption of troxerutin in rats in vivo, and the relative bioavailability of the microemulsion was about 205."( Development and in vitro-in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin.
Chen, W; Jin, Y; Lin, Y; Xu, M; Yu, Q; Zhao, Q, 2016
)
0.87
"These results suggest that novel W/O microemulsion could be used as an effective formulation for improving the oral bioavailability of troxerutin."( Development and in vitro-in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin.
Chen, W; Jin, Y; Lin, Y; Xu, M; Yu, Q; Zhao, Q, 2016
)
0.84
" The effect of rutin resulting from its physicochemical features related to effects like metal chelation and bioavailability are also discussed."( Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action.
Habtemariam, S, 2016
)
2.23
" The simple and rapid UPLC method was successfully applied to the pharmacokinetic and bioavailability study of rosavin in rats."( A Simple and Rapid UPLC Method for the Determination of Rosavin in Rat Plasma and Its Application to a Pharmacokinetic Study.
Chen, D; Hu, S; Igor, LP; Shen, J; Sun, H; Xiang, Z; Zheng, X, 2016
)
0.43
"69%) showed enhanced bioavailability for RUT in brain as compared to intravenous administration."( Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
Ahmad, FJ; Ahmad, N; Ahmad, R; Alam, MA; Ashafaq, M; Iqbal, Z; Naqvi, AA; Samim, M, 2016
)
1.88
"The instability and low bioavailability of polyphenols limit their applications in food industries."( Epigallocatechin Gallate (EGCG) Decorating Soybean Seed Ferritin as a Rutin Nanocarrier with Prolonged Release Property in the Gastrointestinal Tract.
Blanchard, C; Li, Q; Strappe, P; Sun, G; Yang, R; Zhang, M; Zhou, Z, 2016
)
0.67
" It suffers from the problem of low oral bioavailability which is due to its poor aqueous solubility."( Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson's disease model.
Ali, J; Baboota, S; Narang, JK; Sharma, S, 2016
)
0.69
"Rutin SNEDDS have been successfully prepared and they can serve as an effective tool in enhancing the oral bioavailability and efficacy of rutin, thus helping in ameliorating oxidative stress in neurodegenerative disorders like Parkinson's disease."( Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson's disease model.
Ali, J; Baboota, S; Narang, JK; Sharma, S, 2016
)
2.13
" Hence in the present study, an attempt has been made to load both these drugs into a single nanoparticlulate system to enhance their bioavailability and efficacy."( Formulation and characterization of chitosan encapsulated phytoconstituents of curcumin and rutin nanoparticles.
Dwarampudi, LP; Kadiyala, M; Kumar, CKA; Kuppuswamy, G; Paranjothy, M; Ramaswamy, S; Veera Venkata Satyanarayana Reddy, K, 2017
)
0.68
"Drug nanosuspension is one of the established methods to improve the bioavailability of poorly soluble drugs."( Production of drug nanosuspensions: effect of drug physical properties on nanosizing efficiency.
Liu, T; Möschwitzer, JP; Müller, RH, 2018
)
0.48
" In the present work, the biological in vitro and in vivo effects and the potential therapeutic applications of rutin in neurodegenerative processes are reviewed, as well as their bioavailability and pharmacokinetics, which are essential for a better understanding of its biological effectiveness."( Rutin as Neuroprotective Agent: From Bench to Bedside.
Budzynska, B; Devi, KP; Faggio, C; Kruk-Slomka, M; Nabavi, SF; Nabavi, SM; Samec, D; Sureda, A, 2019
)
2.17
"The drug with poor oral bioavailability necessitates the development of novel carrier for efficient drug delivery."( Rutin-phospholipid complex in polymer matrix for long-term delivery of rutin via skin for the treatment of inflammatory diseases.
Das, MK; Kalita, B, 2018
)
1.92
" Nanocrystals can be used to improve the bioavailability of poorly soluble actives not only for oral, but also for topical application."( Nanocrystals for improved dermal drug delivery.
Dietrich, H; Geisel, N; Gerst, M; Huang, J; Keck, CM; Pelikh, O; Scholz, P; Stahr, PL, 2018
)
0.48
"A facile and efficient whole-cell biocatalysis method was developed to synthesize troxerutin-acylated derivatives, markedly enhancing the bioavailability and antioxidant activities of troxerutin in cells."( Biocatalytic synthesis of acylated derivatives of troxerutin: their bioavailability and antioxidant properties in vitro.
Lai, F; Li, X; Xin, X; Zhang, M; Zhao, G, 2018
)
0.95
"In order to research and enhance bioavailability of chlorogenic acid and rutin(CA-R) via the oral route, chitosan coated composite phospholipid liposomes (C-CPLs) were applied to study on preparation, permeability and pharmacokinetic of C-CA-R-CPLs."( Chitosan coated chlorogenic acid and rutincomposite phospholipid liposomes: Preparation, characterizations, permeability and pharmacokinetic.
He, C; Jiang, W; Li, J; Xing, J; Zeng, C; Zheng, R, 2018
)
0.99
"Recent studies on flavonoids forming complexes with macromolecules attract researchers due to their enhanced bioavailability as well as chemo-preventive efficacy."( A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis.
Babu, MD; Deepika, MS; Jeganathan, K; Sasirekha, R; Sheena, TS; Sivasubramanian, S; Thangam, R; Thirumurugan, R, 2019
)
0.95
" According to these results, SEDDS containing PDMSHEPMS might be a promising strategy to increase the oral bioavailability of rutin."( Development and in vitro characterization of an oral self-emulsifying delivery system (SEDDS) for rutin fatty ester with high mucus permeating properties.
Aragón, DM; Bernkop-Schnürch, A; Cardona, MI; Nguyen Le, NM; Zaichik, S, 2019
)
0.94
" Also the ability of each classification system to predict and determine the extent of absorption of the Chinese herbal compound was investigated based on the absolute bioavailability of representative components."( Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Cao, X; Dou, Z; Li, H; Liu, T; Liu, Y; Ren, X; Wang, M, 2019
)
0.51
" Nuciferine is the best of the five components, with absolute bioavailability reaching 61."( Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Cao, X; Dou, Z; Li, H; Liu, T; Liu, Y; Ren, X; Wang, M, 2019
)
0.51
"The five representative components (except for nuciferine) are all class III/IV, which correlates well with the absolute bioavailability results and demonstrates that they are poorly absorbed substances."( Establishment of modified biopharmaceutics classification system absorption model for oral Traditional Chinese Medicine (Sanye Tablet).
Cao, X; Dou, Z; Li, H; Liu, T; Liu, Y; Ren, X; Wang, M, 2019
)
0.51
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" However, there is a dearth of information on the effect of rutin on the cadmium bioavailability in the brain of rats exposed to cadmium."( Rutin restores neurobehavioral deficits via alterations in cadmium bioavailability in the brain of rats exposed to cadmium.
Adebayo, AA; Ademosun, AO; Oboh, G; Olowokere, OG, 2020
)
2.24
"05) antioxidant activity of consumers' blood compared to control bread consumption, indicating good bioavailability of flavonols."( Thermal stability and bioavailability of bioactive compounds after baking of bread enriched with different onion by-products.
Bedrníček, J; Jirotková, D; Kadlec, J; Laknerová, I; Samková, E; Smetana, P; Tříska, J; Vrchotová, N, 2020
)
0.56
" However, the low bioavailability and low water solubility limit its application and remain to be resolved."( Rutin-loaded cellulose acetate/poly(ethylene oxide) fiber membrane fabricated by electrospinning: A bioactive material.
Li, B; Yang, X, 2020
)
2
" However, bioavailability is low due to low stability, solubility, digestion, and absorption by the intestine."( Formulation of microencapsulated rutin and evaluation of bioactivity and stability upon in vitro digestive and dialysis conditions.
Fernando, CAN; Gunathilake, KDPP; Mel, MMRD, 2020
)
0.84
"The current study aimed to investigate the ability of chitosan/poly (acrylic acid) nanogel (CAN) to improve the bioavailability and anticancer potential of rutin."( Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma.
Ali, HE; Radwan, RR, 2021
)
1.03
" All these compounds not only showed excellent pharmacokinetic properties, absorption, metabolism, minimal toxicity and bioavailability but were also remain stabilized at the active site of proteins during the MD simulation."( Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik, D; Jagadeesan, R; Kumar, D; Kumar, N; Nandi, R; Prakash, A, 2020
)
0.56
" However, poor solubility and rapid metabolism have led to its low bioavailability in biological systems, and hence limit its application."( Rutin loaded liquid crystalline nanoparticles inhibit lipopolysaccharide induced oxidative stress and apoptosis in bronchial epithelial cells in vitro.
Chellappan, DK; Dua, K; Hansbro, PM; Mehta, M; Paudel, KR; Wadhwa, R, 2020
)
2
" Recent strategies in drug delivery significantly contribute to overcoming the low bioavailability of flavonoids."( Antiviral Properties of Flavonoids and Delivery Strategies.
Antonelli, A; Magnani, M; Ninfali, P; Scarpa, ES, 2020
)
0.56
" Improving the bioavailability of rutin using novel drug-delivery methods will help the investigators to use its useful effects in the treatment of various chronic human diseases."( Therapeutic benefits of rutin and its nanoformulations.
Ahmadian, E; Bohlouli, S; Gorbani Jahandizi, N; Jafari, S; Khezri, K; Maleki Dizaj, S; Negahdari, R; Raeesi, S; Rahbar Saadat, Y; Sharifi, S, 2021
)
1.21
" However, more investigations should be conducted to confirm the improved bioavailability of the rutin nanoformulations."( Therapeutic benefits of rutin and its nanoformulations.
Ahmadian, E; Bohlouli, S; Gorbani Jahandizi, N; Jafari, S; Khezri, K; Maleki Dizaj, S; Negahdari, R; Raeesi, S; Rahbar Saadat, Y; Sharifi, S, 2021
)
1.15
"Rutin is a polyphenol with excellent therapeutic potential and good safety profile, but the poor bioavailability restricts its application as a functional ingredient."( Encapsulation of rutin using quinoa and maize starch nanoparticles.
Remanan, MK; Zhu, F, 2021
)
2.4
" The discrepancy between the in vitro and in vivo studies was probably due to a poor bioavailability of flavonoids in the intestine."( Rutin and Quercetin Decrease Cholesterol in HepG2 Cells but Not Plasma Cholesterol in Hamsters by Oral Administration.
Chen, ZY; Hao, W; He, WS; He, Z; Kwek, E; Li, YM; Liang, N; Liu, J; Ma, KY; Zhao, Y; Zhu, H, 2021
)
2.06
" However, the low bioavailability and poor water solubility limit its clinical application."( [Research progress on rutin derivatives].
Feng, YL; Lyu, ZY; Mao, YJ; Wang, MJ; Zhai, GY, 2021
)
0.94
"54 times more bioavailability than free rutin, resulting in more internalization of rutin in systemic circulation."( Formulation and Characterization of Rutin Loaded Chitosan-alginate Nanoparticles: Antidiabetic and Cytotoxicity Studies.
Palei, NN; Surendran, V, 2022
)
1.26
" However, RUT's poor water solubility and low brain bioavailability limit its clinical use."( Tailoring of chitosan/diacrylated pluronic system as a versatile nanoplatform for the amelioration of radiation-induced cognitive dysfunction.
Abdel-Naby, DH; Deghiedy, NM; El-Ghazaly, MA; Rashed, RR, 2021
)
0.62
" However, these gels have low solubility and limited bioavailability due to their decreased lipid solubility."( Synthesis of Rutin Derivatives to Enhance Lipid Solubility and Development of Topical Formulation with a Validated Analytical Method.
Abualhasan, M; Assali, M; Mahmoud, A; Malkieh, N; Zaid, AN, 2022
)
1.09
"Rutin was nano-encapsulated in date [En-Ru(D)] and mushroom [En-Ru(M)] β-glucan matrix to protect it from the harsh gastrointestinal environment and to enhance its bioavailability and biological activity upon digestion."( β-Glucan from mushrooms and dates as a wall material for targeted delivery of model bioactive compound: Nutraceutical profiling and bioavailability.
Gani, A; Masoodi, FA; Shah, A; Ul Ashraf, Z, 2022
)
2.16
" However, quercetin's low solubility and poor bioavailability have restricted its applicability; as a result, researchers have attempted to design and synthesize numerous novel quercetin derivatives using various methodologies in order to modify quercetin's constraints; the physico-chemical properties of quercetin's molecular scaffold make it appealing for drug development; low molecular mass and chemical groups are two of these characteristics."( Quercetin derivatives: Drug design, development, and biological activities, a review.
Alizadeh, SR; Ebrahimzadeh, MA, 2022
)
0.72
"Poor water solubility and low bioavailability of hydrophobic flavonoids such as rutin remain as substantial challenges to their oral delivery via functional foods."( The Effect of pH and Sodium Caseinate on the Aqueous Solubility, Stability, and Crystallinity of Rutin towards Concentrated Colloidally Stable Particles for the Incorporation into Functional Foods.
Jameson, GB; Rashidinejad, A; Singh, H, 2022
)
1.17
" However, additional studies are still required to confirm the therapeutic properties of rutin in a clinical setting, including the enhancement of it low bioavailability profile."( Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature.
Dludla, PV; Mazibuko-Mbeje, SE; Mthembu, SXH; Mthiyane, F; Muvhulawa, N; Nkambule, BB; Ziqubu, K, 2022
)
2.39
" Antioxidants' bioavailability has become one of the main research topics in bio-nanomedicine."( Plant-Derived Nanoscale-Encapsulated Antioxidants for Oral and Topical Uses: A Brief Review.
Kim, SH; Lee, YC, 2022
)
0.72
" Among the 12 main components identified, five main compounds were well absorbed with Papp in the order of benzoic acid > chlorogenic acid > astragaloside > hyperoside > rutin."( The transported active mulberry leaf phenolics inhibited adipogenesis through PPAR-γ and Leptin signaling pathway.
Li, E; Li, Q; Liao, S; Liu, F; Liu, T; Pang, D; Zou, Y, 2022
)
0.92
"Antiproliferative capabilities of rutin, benzoic acid (BA) and triazolofluoroqunolone (TFQ) derivatives were reported; hence chemosensitizing effects of rutin or its polymeric micelles (of improved solubility and bioavailability via direct dissolution using the amphiphilic copolymer Pluronic P123) in co-incubations with 5 BAs or 3 TFQ derivatives in a panel of 6 cancer cell lines were verified."( Preparation and Characterization of Rutin-Encapsulated Polymeric Micelles and Studies of Synergism with Bioactive Benzoic Acids and Triazolofluoroquinolones as Anticancer Nanomedicines.
Alhiari, Y; Alkhateeb, R; Ibrahim, R; Kasabri, V; Shalabi, D; Sunoqrot, S, 2023
)
1.46
"Rutin is a biologically active polyphenol, but its poor water solubility and low bioavailability limit its application to the food industry."( Effect of ultrasound treatment on interactions of whey protein isolate with rutin.
Guo, N; Pan, S; Wang, Z; Xu, J; Ye, S; Zhang, F; Zhang, Y; Zhou, G; Zhu, G, 2023
)
2.58
" Overall, SCR microcapsules developed in this study effectively enhanced the bioavailability of rutin."( Soybean protein isolate/chitosan complex-rutin microcapsules.
Dong, S; Hu, SM; Yu, SJ; Zhou, S; Zhou, T, 2023
)
1.39

Dosage Studied

The results of the presented double-blind trial proved that the benzopyrone compound Venalot, a combination of coumarin and troxerutin used in the treatment of local inflammatory oedemas.

ExcerptRelevanceReference
" Vaccinium myrtillus anthocyanosides by oral route inhibited carrageein paw oedema in rats showing a dose-response relationship."( Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity.
Cristoni, A; Lietti, A; Picci, M, 1976
)
0.26
" dosage and 4% following oral administration."( The metabolism and excretion of 7-mono-0-(beta-hydroxyethyl) rutoside in the dog.
Griffiths, LA; Hackett, AM, 1979
)
0.26
" Animals killed 72 h after dosage of either compound contained less than 7% of dose, mostly in the colon and caecal contents."( The disposition and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl)rutoside and 7-mono-O-(beta-hydroxyethyl)rutoside in the mouse.
Griffiths, LA; Hackett, AM, 1977
)
0.26
" Administration of a second oral dose of [14C]-HR to each of the three subjects following extended dosage of nonlabelled HR did not result in any increase in urinary [14C] excretion over that observed after administration of a single oral dose."( Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man.
Griffiths, LA; Hackett, AM; Luyckx, AS; van Cauwenberge, H, 1976
)
0.26
" These data were confirmed by excellent acceptability as well as subjective assessment by patients after 4 months' treatment at the dosage of 4 g/d."( [Clinical and rheological efficacy of troxerutin in obstetric gynecology].
Marhic, C, 1991
)
0.54
" All flavonoids gave a dose-response relationship and induced a number of AraR mutants considered statistically significant."( Study on the mutagenic activity of 13 bioflavonoids with the Salmonella Ara test.
Alejandre-Durán, E; Alonso-Moraga, A; Jurado, J; Pueyo, C, 1991
)
0.28
" Antigen-induced experimental arthritis of rabbits, fed different amounts of a therapeutically used mixture of enzymes at different times, could be inhibited by this treatment, in dependence of dosage and time of feeding."( [Basic studies on enzyme therapy of immune complex diseases].
Menzel, J; Steffen, C, 1985
)
0.27
" A dosage adjusted to the gravity of the venous involvement improves the venous pump of the leg and therefore the venous return."( [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
Furderer, CR; Stemmer, R,
)
0.13
"In a double-blind study the effect of a high dosage of O-(beta-hydroxyethyl)-rutosides (HR) was tested in women taking oral contraceptives and suffering from venous insufficiency of the lower limbs."( Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli, R; Di Perri, T; Forconi, S; Oberhauser, V; Pecchi, S, 1987
)
0.27
" Blood levels of DHT, mHPAA, DHPAA, and HVA started to increase at 4 to 8 h after the oral dosage of the rutoside formulation, Esberiven (further active ingredient: coumarin)."( Serum concentrations of rutoside metabolites after oral administration of a rutoside formulation to humans.
Ando, K; Kohsaka, K; Nishiyama, Y; Sawai, Y, 1987
)
0.27
" We conclude that this intravenous dosage of HR has no adverse effect on central haemodynamics in patients with advanced coronary disease."( The effect of O-(beta-hydroxyethyl)-rutosides on central haemodynamics during and after aortocoronary bypass surgery.
Ekeström, S; Lund, F; Sonnenfeld, T, 1984
)
0.27
" These data indicate that the intraarterial infusion of Venoruton at this dosage does not inhibit the ability of simultaneously infused histamine or bradykinin to increase transvascular fluid and macromolecular efflux in the canine forelimb perfused at constant arterial inflow."( O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
Dabney, JM; Dobbins, DE; Soika, CY, 1984
)
0.27
" Increased levels of liver function (serum leucine amino-peptidase (LAP), and serum ornithine carbamyl transferase (OCT) were noted during the dosing period, together with slightly increased liver weights terminally for animals receiving 1000 mg/kg/day; however, as no morphological or ultrastructural changes were noted, these findings were considered to be attributable to hypertrophy."( Toxicity of venalot (a mixture of coumarin and troxerutin) in the baboon.
Heywood, R; Majeed, SK; Pulsford, AH; Street, AE, 1983
)
0.52
"The agonistic actions of angiotensin II and prostaglandin E2 (PGE2) were plotted on the guinea-pig ileum as cumulative dose-response curves."( Non-competitive inhibition of angiotensin II and PGE2 on guinea-pig ileum with streptomycin, vitamin K3 and rutin.
Abacioglu, N; Altinkurt, O, 1980
)
0.47
" At the same time, the peripheral venous resistance decreases in a dose-response relationship."( Effect of a combination of coumarin derivatives and rutoside on venous and lymphatic circulations during severe constriction of the caudal vena cava in rabbits.
Angignard, J; Borzeix, MG; Dedieu, F; Dupont, JM; Leutenegger, E; Miloradovich, T, 1995
)
0.29
" Three different dosages were used due to slight differences in the registered dosage in various countries: (1) 250 mg 4 times daily (1 g/day), UK, n = 19 patients; (2) 300 mg 3 times daily (900 mg/day), FRG and Belgium, n = 55, and (3) 300 mg 4 times daily (1,200 mg/day), The Netherlands, n = 30."( Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Dikland, WJ; MacLennan, WJ; Moriau, M; Rattenhuber, V; Vanderdonckt, J; Wilson, J, 1994
)
0.29
" Cholesterol, cholesterol HDL, and triacylglycerols have been dosed after retreat of blood, following the administration of the compounds dissolved in propylene glycol by intraperitoneal route in doses of 5 mg kg-1 body wt."( Hypolipidaemic effects of naringenin, rutin, nicotinic acid and their associations.
Nagem, TJ; Oliveira, MG; Oliveira, TT; Pinto, AS; Santos, KF, 1999
)
0.57
" Such a dosing schedule would be very inconvenient in clinical practice."( 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.
Bast, A; Haenen, GR; Kramer, K; van Acker, FA; van Acker, SA; van der Vijgh, WJ, 2000
)
0.31
"The group of patients with systemic enzyme therapy were treated by Phlogenzym in the dosage 3 times 3 tablets in the first three days after operation and subsequently 3 times 2 tablets in the remaining follow-up period."( [Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling].
Franĕk, P; Holán, P; Kamenícek, V, 2001
)
0.31
" The dosage of Trihydroxyethylrutosides was 1 tablet of 300 milligrams twice daily for the first 2 weeks."( Trihydroxyethylrutosides in the treatment of hemorrhoids of pregnancy: a double-blind placebo-controlled trial.
Boonnuch, W; Indrasukhsri, B; Lekprasert, V; Titapant, V, 2001
)
0.31
" The antioxidant capacity of Gala apples and seven phenolic standards, determined by both ABTS(*)(-) and DPPH(*) scavenging assays, showed a dose-response of the first-order."( Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals.
Kim, DO; Lee, CY; Lee, HJ; Lee, KW, 2002
)
0.31
" Body weight gain was reduced from week 10 to the end of the experiment in the 5% dosed males as compared to the 0% controls."( Evaluation of the toxicity of enzymatically decomposed rutin with 13-weeks dietary administration to Wistar rats.
Hasumura, M; Hirose, M; Imai, T; Mitsumori, K; Tamura, T; Yasuhara, K, 2004
)
0.57
" The method was used for the determination of routine in mass-produced dosage form: Rutin 250 tablets á 50 mg, (firm Nature's Bounty, USA)."( [Oxidative determination of rutin in tablets using flow injection analysis and chemiluminescence].
Dolejsová, J; Karlícek, R; Polásek, M; Solich, P; Tůmová, L, 2004
)
0.84
"This paper describes a validated high-performance liquid chromatographic (HPLC) - photodiode array (PDA) detection method to quantitate five flavonol components as markers; rutin, quercitrin, quercetin, kaempferol and isorhamnetin for use in the quality control of Ginkgo biloba dosage forms."( High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber, MJ; Kanfer, I, 2004
)
0.52
"A suitable method was developed to identify and quantitate five relevant flavonol marker compounds and was successfully used to assay some commercially available solid oral dosage forms of Ginkgo biloba ."( High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber, MJ; Kanfer, I, 2004
)
0.32
" The systemic enzyme preparation Wobenzym was administered with a dosage of 1 tablet for 6 kg weight."( Wobenzym in treatment of recurrent obstructive bronchitis in children.
Chkhaidze, I; Kandelaki, E; Lanchava, N; Nareklishvili, N; Nemsadze, K, 2005
)
0.33
" Dose-response curves were established for each flavonol in the presence and absence of external metabolizing systems."( In vitro basal and metabolism-mediated cytotoxicity of flavonoids.
Raddi, MS; Soares, VC; Varanda, EA, 2006
)
0.33
" This proposed method was successfully applied to the detection of troxerutin in pharmaceutical dosage forms and satisfying results had been obtained."( The electrochemical oxidation of troxerutin and its sensitive determination in pharmaceutical dosage forms at PVP modified carbon paste electrode.
Hu, S; Wang, F; Yang, X, 2006
)
0.84
"A rapid and sensitive assay for quantitative determination of rutin in oral dosage forms based on isocratic reversed phase high performance liquid chromatography (RP-HPLC) was developed and validated."( Isocratic RP-HPLC method for rutin determination in solid oral dosage forms.
Ilić, K; Ivković, B; Kuntić, V; Mićić, S; Pejić, N; Vujić, Z; Vukojević, V, 2007
)
0.87
" The concentrations required to result in a 50% reduction in cell death (EC(50) value) were calculated from their dose-response curves."( Free radical scavenging and cytoprotective activities of phenolic antioxidants.
Adaim, A; Melton, LD; Skinner, MA; Stanley, RA; Zhang, J, 2006
)
0.33
" Among them, rutin was the most effective in suppressing adipocyte differentiation in a dosage dependant manner."( Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with high-fat diet.
Choi, H; Choi, I; Lee, EH; Park, Y, 2006
)
1
" The results demonstrated that the extract at dosage of 40-225 mg/100 g significantly increased the activity of SOD (superoxide dismutase) and reduced the lipid peroxidation in both blood and liver of rat."( In vitro and vivo antioxidant activities of daylily flowers and the involvement of phenolic compounds.
Mao, L; Que, F; Zheng, X, 2007
)
0.34
"05) were obtained in the group using the higher dosage and the associated treatment."( Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study.
Bavera, P; Belcaro, G; Cesarone, MR; Corsi, M; Dugall, M; Hosoi, M; Ippolito, E; Ledda, A; Luzzi, R; Pellegrini, L; Ricci, A; Stuard, S, 2010
)
0.36
" The relationship of dose and AUC of RDS was linear within the dosage range."( Pharmacokinetics and plasma protein binding of rutin deca (H-) sulfate sodium.
Lu, SJ; Wang, XJ; Yao, TW; Zeng, S, 2009
)
0.61
" Timecourse experiments with MPO showed complete turnover of 5OH-TBZ within 15 min and a dramatic leftward shift in dose-response curves after 12h."( Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: a possible mechanism of thiabendazole toxicity.
Dalvie, DK; Jamieson, JD; Smith, EB; Stevens, GJ; Yanochko, GM, 2011
)
0.37
"05) in the HR-treated groups with a significant decrease in edema score and ankle circumference in the higher dosage group."( Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
Bavera, P; Belcaro, G; Cesarone, MR; Corsi, M; Dugall, M; Errichi, BM; Errichi, S; Feragalli, B; Gizzi, G; Hosoi, M; Ippolito, E; Ledda, A; Luzzi, R; Pellegrini, L; Ricci, A, 2011
)
0.37
" Oral treatments of quercetin and αOR at this dosage exhibited no anti-allergic effect, and IQC showed less effect than EMIQ."( Anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin, when administered orally to mice.
Kanemaru, M; Makino, T; Mizukami, H; Okuyama, S; Shimizu, R; Tanaka, H, 2013
)
0.59
" Even though rutin has been proven to be effective in numerous pharmacological activities, the dosage and toxicity of rutin for such activities are still unknown."( A review on plant-based rutin extraction methods and its pharmacological activities.
Chua, LS, 2013
)
1.07
" Our results suggest that rutin may be useful in the management of inflammatory bowel disease in appropriate dosage conditions."( Rutin has intestinal antiinflammatory effects in the CD4+ CD62L+ T cell transfer model of colitis.
Aranda, C; de Medina, FS; Marín, JJ; Martínez-Augustin, O; Mascaraque, C; Monte, MJ; Ocón, B; Suárez, MD; Zarzuelo, A, 2014
)
2.15
"Four simple, accurate, sensitive and precise spectrophotometric methods were developed and validated for simultaneous determination of Troxerutin (TXN) and Carbazochrome (CZM) in their bulk powders, laboratory prepared mixtures and pharmaceutical dosage forms."( Validated spectrophotometric methods for simultaneous determination of troxerutin and carbazochrome in dosage form.
Al-Ghobashy, MA; Ghoniem, NS; Hegazy, MA; Khattab, FI; Ramadan, NK, 2015
)
0.85
" graveolens produced rightward parallel displacement of carbachol dose-response curves and reduced over 35 % of the maximum smooth muscle contraction."( Relaxant effects of a hydroalcoholic extract of Ruta graveolens on isolated rat tracheal rings.
Águila, L; de Campos, RR; Mansilla, K; Ordenes, J; Romero, F; Ruedlinger, J; Salvatici, R, 2015
)
0.42
" The effects of spectrophotometric reaction were studied by analyzing the wavelength, the dosage of color development reagent, reaction time, temperature and pH."( [Research on the Spectrophotometry for Determination of Flavonoids in Waste Residue of Stevia Rebaudiana].
Fang, HB; Guo, YY; Huang, RY; Liu, RY; Luo, XY; Zhao, DF; Zhu, D; Zhu, T, 2015
)
0.42
"Six groups of rats (n = 6) were dosed with normal saline (3 ml/kg,i."( Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects.
Gautam, R; Gautam, S; Kaithwas, G; Rawat, JK; Saraf, SA; Singh, M, 2016
)
1.88
" Hence, rationalising dosage and diet regimens should be taken into account in clinical application of PMT."( Studies on the interaction between promethazine and human serum albumin in the presence of flavonoids by spectroscopic and molecular modeling techniques.
Gao, YP; He, LL; Liu, B; Liu, XP; Wang, X; Wang, YX; Wang, ZX; Yang, YJ, 2016
)
0.43
"A simple, rapid, sensitive and selective high performance liquid chromatographic (HPLC) method with ultraviolet detection has been developed for simultaneous determination of ascorbic acid and rutin in pure forms and pharmaceutical dosage form."( Simultaneous determination of rutin and ascorbic acid mixture in their pure forms and combined dosage form.
Attia, TZ, 2016
)
0.91
" Increasing the genome dosage (i."( Hybridity has a greater effect than paternal genome dosage on heterosis in sugar beet (Beta vulgaris).
Brychkova, G; Curley, E; Deletre, M; Dupouy, G; Fernandez-Tendero, E; Fort, A; Hallahan, BF; Ryder, P; Schulz, B; Spillane, C, 2018
)
0.48
"Comparisons of parental lines to diploid (EA, EB) and triploid (EAA, EBB) F1 hybrids for total yield, root yield, and sugar yield indicated that there was no effect of paternal genome dosage increases on heterosis levels, indicating that hybridity is the main contributor to the heterosis levels observed."( Hybridity has a greater effect than paternal genome dosage on heterosis in sugar beet (Beta vulgaris).
Brychkova, G; Curley, E; Deletre, M; Dupouy, G; Fernandez-Tendero, E; Fort, A; Hallahan, BF; Ryder, P; Schulz, B; Spillane, C, 2018
)
0.48
"Overall, our study indicates that; (1) increasing the paternal genome dosage does not enhance heterosis in F1 hybrids, and; (2) increasing multi-locus heterozygosity using highly heterozygous paternal genomes to generate F1 triploid hybrids does not enhance heterosis."( Hybridity has a greater effect than paternal genome dosage on heterosis in sugar beet (Beta vulgaris).
Brychkova, G; Curley, E; Deletre, M; Dupouy, G; Fernandez-Tendero, E; Fort, A; Hallahan, BF; Ryder, P; Schulz, B; Spillane, C, 2018
)
0.48
" 90% lethality of IJs at concentrations higher than 1200 ppm and the remaining live IJs did not develop further, and they also totally inhibited strongyle L3 exsheathment in a dose-response fashion."( Can an entomopathogenic nematode serve, as proxy for strongyles, in assessing the anthelmintic effects of phenolic compounds?
Awwad, S; Azaizeh, H; Glazer, I; Haj-Zaroubi, M; Landau, SY; Markovics, A; Muklada, H; Salame, L; Santhi, VS, 2020
)
0.56
" Group I (control group), group II (rotenone treated group): the rats were injected subcutaneously with a single rotenone dosage of 3 mg/kg repeated every 48 hours for 60 days to trigger retinal neurodegeneration."( Troxerutin downregulates C/EBP-β gene expression via modulating the IFNγ-ERK1/2 signaling pathway to ameliorate rotenone-induced retinal neurodegeneration.
El-Esawy, RO; El-Sakaa, MH; Ibrahim, RR, 2020
)
1.07
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."(
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022
)
0.72
" An ultraviolet (UV) analytical method was developed in our laboratories to quantify rutin derivatives both as raw materials and in final dosage forms."( Synthesis of Rutin Derivatives to Enhance Lipid Solubility and Development of Topical Formulation with a Validated Analytical Method.
Abualhasan, M; Assali, M; Mahmoud, A; Malkieh, N; Zaid, AN, 2022
)
1.31
" melo seeds had a dose-dependent relaxant effect for potassium chloride (80 mM)-induced spastic contraction and exhibited calcium antagonistic response in calcium dose-response curves."( Mechanistic insights of Cucumis melo L. seeds for gastrointestinal muscle spasms through calcium signaling pathway-related gene regulation networks in WGCNA and in vitro, in vivo studies.
Akhtar, S; Ali, A; Saqib, F; Simal-Gandara, J; Tallei, TE; Wahid, M, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (48 Product(s))

Product Categories

Product CategoryProducts
Vitamins & Supplements29
Active Lifestyle & Fitness1
Professional Supplements17
Herbs, Botanicals & Homeopathy1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Amazing Nutrition Rutin -- 500 mg - 200 TabletsAmazing NutritionVitamins & SupplementsRutin2024-11-29 10:47:42
American Health Super Chewable Acerola Plus® Natural Vitamin C Berry -- 500 mg - 100 WafersAmerican HealthVitamins & SupplementsVitamin C, Rutin2024-11-29 10:47:42
Beverly International Super Pak -- 30 PacketsBeverly InternationalActive Lifestyle & FitnessPara-Aminobenzoic Acid, Vitamin C, Betaine HCl, Biotin, Chloride, Vitamin D3, Choline, Chromium, Vitamin E, Folate, Vitamin E, L-Glutamic Acid, Pepsin, Inositol, Iodine, Manganese, Niacin, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Bluebonnet Nutrition Rutin -- 500 mg - 50 Vegetable CapsulesBluebonnet NutritionVitamins & SupplementsRutin2024-11-29 10:47:42
Bluebonnet Nutrition Super Quercetin -- 90 Vegetable CapsulesBluebonnet NutritionVitamins & SupplementsVitamin C, Hesperidin, Quercetin, Rutin2024-11-29 10:47:42
Codeage Teen Daily Multivitamin - Vitamins A B C D E K Zinc Biotin & Probiotics Vegan Supplement -- 60 CapsulesCodeageProfessional SupplementsVitamin C, Astaxanthin, Biotin, Boron, Omega-3, Vitamin D3, Chromium, Coenzyme Q10, Vitamin E, Vitamin E, Inositol, Iodine, Lutein, Lycopene, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Pantothenic Acid, Phosphorus, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, Vitamin B12, Vitamin B6, Zeaxanthin2024-11-29 10:47:42
Codeage Teen Daily Multivitamin - Vitamins A B C D E K Zinc Biotin & Probiotics Vegan Supplement -- 60 Capsules Each / Pack of 2CodeageProfessional SupplementsVitamin C, Astaxanthin, Biotin, Boron, Omega-3, Vitamin D3, Chromium, Coenzyme Q10, Vitamin E, Vitamin E, Inositol, Iodine, Lutein, Lycopene, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Pantothenic Acid, Phosphorus, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, Vitamin B12, Vitamin B6, Zeaxanthin2024-11-29 10:47:42
Country Life Chewable Acerola Vitamin C Complex Berry -- 500 mg - 180 WafersCountry LifeVitamins & SupplementsRutin2024-11-29 10:47:42
Country Life Chewable Acerola Vitamin C Complex -- 500 mg - 90 WafersCountry LifeVitamins & SupplementsVitamin C, Rutin2024-11-29 10:47:42
DaVinci Laboratories Nattokinase Plus™ -- 60 CapsulesDaVinci LaboratoriesProfessional SupplementsRutin2024-11-29 10:47:42
DaVinci Laboratories Poten-C® 500 -- 90 CapsulesDaVinci LaboratoriesProfessional Supplements Orange, Vitamin C, Hesperidin, Manganese, Rutin2024-11-29 10:47:42
DaVinci Laboratories Spectra Man Multi -- 120 TabletsDaVinci LaboratoriesProfessional Supplements Lipase, Octacosanol, PABA, Vitamin C, L-Aspartic Acid, Betaine HCl, Biotin, Boron, Vitamin D3, Choline, Chromium, L-Cysteine, Vitamin E, Folic Acid, Gamma Linolenic Acid, Vitamin E, L-Glutamine, Hesperidin, Inositol, Iodine, Lycopene, Manganese, Molybdenum, Niacin, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Silicon, Thiamin, Alpha-Lipoic Acid, Vanadium, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
DaVinci Laboratories Spectra™ Multivitamins for Adults -- 240 TabletsDaVinci LaboratoriesProfessional Supplements Lipase, Octacosanol, PABA, Vitamin C, L-Aspartic Acid, Betaine HCl, Biotin, Boron, Vitamin D3, Choline, Chromium, L-Cysteine, Vitamin E, Folic Acid, Vitamin E, L-Glutamine, Hesperidin, Inositol, Iodine, Linoleic Acid, Manganese, Molybdenum, Niacin, Nickel, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Silicon, Thiamin, Vanadium, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
DaVinci Laboratories Spectra™ Senior Multi -- 180 TabletsDaVinci LaboratoriesProfessional Supplements lipase, Octacosanol, PABA, Vitamin C, L-Aspartic Acid, Betaine HCl, Biotin, Boron, Vitamin D3, Choline, Chromium, Coenzyme Q10, L-Cysteine, Vitamin E, Folic Acid, Gamma Linolenic Acid, Vitamin E, Glutamic Acid, Hesperidin, Inositol, Iodine, Lutein, Lycopene, Manganese, Molybdenum, Niacin, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Silicon, Thiamin, Alpha-Lipoic Acid, Vanadium, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
DaVinci Laboratories Spectra™ Woman -- 120 TabletsDaVinci LaboratoriesProfessional Supplements lipase, Octacosanol, PABA, Vitamin C, L-Aspartic Acid, Biotin, Boron, Vitamin D3, Choline, Chromium, L-Cysteine, Vitamin E, Folic Acid, Gamma Linolenic Acid, Vitamin E, L-Glutamine, Hesperidin, Inositol, Iodine, Manganese, Molybdenum, Niacin, Nickel, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Silicon, Thiamin, Vanadium, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
DaVinci Laboratories Ultimate Prenatal Multi -- 150 TabletsDaVinci LaboratoriesProfessional Supplements lipase, Octacosanol, PABA, Vitamin C, L-Aspartic Acid, Betaine HCl, Biotin, Boron, Vitamin D3, Choline, Chromium, L-Cysteine, Vitamin E, Folic Acid, Vitamin E, L-Glutamine, Hesperidin, Inositol, Iodine, Linoleic Acid, Manganese, Molybdenum, Niacin, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Silicon, Thiamin, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
Designs for Sport Hydration Complex - NSF Certified for Sport Lemon-Orange -- 30 ServingsDesigns for SportProfessional SupplementsVitamin C, Calcium Ascorbate, Chloride, Potassium Bicarbonate, Quercetin, D-Ribose, Rutin, Taurine2024-11-29 10:47:42
Deva Vegan Multivitamin & Mineral Supplement -- 90 Coated TabletsDevaVitamins & SupplementsVitamin C, Beta Carotene, Betaine HCL, Biotin, Boron, Choline, Chromium, Vitamin E, Folic Acid, Vitamin E, Inositol, Iodine, Calcium Carbonate, Lutein, Manganese, Molybdenum, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin A, Vitamin B2, Rutin, Selenium, Vitamin B1, Vitamin B12, Vitamin B6, Vitamin D22024-11-29 10:47:42
Deva Vegan Multivitamin and Mineral Supplement Iron Free -- 90 Coated TabletsDevaVitamins & SupplementsVitamin C, Beta Carotene, Biotin, Boron, Choline, Chromium, Vitamin E, Folic Acid, Vitamin E, Inositol, Iodine, Lutein, Manganese, Molybdenum, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin A, Vitamin B2, Rutin, Selenium, Vitamin B1, Vitamin B12, Vitamin B6, Vitamin D22024-11-29 10:47:42
Dr. Mercola Whole Food Multivitamin Plus -- 240 TabletsDr. MercolaProfessional SupplementsPABA, Ascorbyl Palmitate, Vitamin C, Betaine, Biotin, Boron, Vitamin D3, Choline, Chromium, Folate, Glutamic Acid, Hesperidin, Inositol, Iodine, Manganese, Molybdenum, Niacin, Niacinamide, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Strontium, Thiamin, Vanadium, Vitamin B12, Vitamin B62024-11-29 10:47:42
Dr. Mercola Whole-Food Multivitamin for Women -- 240 TabletsDr. MercolaProfessional SupplementsPABA, Ascorbyl Palmitate, Vitamin C, Betaine, Biotin, Boron, Vitamin D3, Choline, Chromium, Folate, Glutamic Acid, Hesperidin, Inositol, Iodine, Manganese, Molybdenum, Niacin, PABA, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Strontium, Thiamin, Vanadium, Vitamin B12, Vitamin B62024-11-29 10:47:42
Emerald Labs CoEnzymated Complete plus 2-Daily Multi -- 60 Vegetable CapsulesEmerald LabsVitamins & SupplementsLipase, Beta Carotene, Biotin, Boron, Cellulase, Vitamin D3, Chromium, Inositol, Iodine, Lutein, Lycopene, Manganese, Molybdenum, Vitamin B3, Vitamin B5, P-5-P, Pyridoxine HCl, Vitamin B6, Vitamin A, Vitamin B2, R-5-P, Rutin, Selenium, Vitamin B1, Alpha Lipoic Acid, Vanadium, Vitamin B12, Vitamin B62024-11-29 10:47:42
Emerald Labs Complete Clinical Plus Multi -- 120 Vegetable CapsulesEmerald LabsVitamins & SupplementsBeta Carotene, Biotin, Boron, Vitamin D3, Chromium, CoQ10, Inositol, Iodine, Lutein, Lycopene, Manganese, Molybdenum, Vitamin B3, Vitamin B5, P-5-P, Pyridoxine HCl, Vitamin B6, Vitamin A, Vitamin B2, R-5-P, Rutin, Selenium, Vitamin B1, Alpha Lipoic Acid, Vanadium, Vitamin B12, Vitamin B62024-11-29 10:47:42
Emerald Labs Prenatal 1-Daily Multi -- 30 Vegetable CapsulesEmerald LabsVitamins & SupplementsBiotin, Boron, Vitamin D3, Chromium, Inositol, Iodine, Lutein, Lycopene, Manganese, Molybdenum, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin A, Vitamin B2, Rutin, Selenium, Vitamin B1, Alpha-Lipoic Acid, Vanadium, Vitamin B12, Vitamin B62024-11-29 10:47:42
Emerald Labs Prenatal 1-Daily Multi -- 60 Vegetable CapsulesEmerald LabsVitamins & SupplementsLipase, Beta Carotene, Biotin, Boron, cellulase, Vitamin D3, Chromium, Vitamin E, Vitamin E, Inositol, Iodine, Lutein, Lycopene, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin A, Vitamin B2, Rutin, Selenium, Vitamin B1, Alpha-Lipoic Acid, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
Enzyme Science MyoMend -- 120 CapsulesEnzyme ScienceProfessional SupplementsRutin2024-11-29 10:47:42
Enzyme Science MyoMend -- 60 CapsulesEnzyme ScienceProfessional SupplementsRutin2024-11-29 10:47:42
Futurebiotics Hair, Skin and Nails® -- 75 TabletsFuturebioticsVitamins & SupplementsPara Aminobenzoic Acid, Vitamin C, Betaine, Biotin, Vitamin E, Folic Acid, Vitamin E, Inositol, Iodine, Manganese, Methionine, Niacin, Pantothenic Acid, Phosphorus, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Futurebiotics Pressur-Lo® -- 270 TabletsFuturebioticsVitamins & SupplementsVitamin C, Betaine HCl, Chloride, Chromium, CoQ10, calcium carbonate, Manganese, Niacin, Pantothenic Acid, potassium chloride, Vitamin B6, Resveratrol, Vitamin A, Riboflavin, Rutin, Selenium, citrate, citrate, L-Taurine, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Futurebiotics Pressur-Lo™ -- 90 TabletsFuturebioticsVitamins & SupplementsVitamin C, Betaine HCl, Chloride, Chromium, CoQ10, calcium carbonate, Manganese, Niacin, Pantothenic Acid, potassium chloride, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, citrate, citrate, L-Taurine, Thiamin, Vitamin B12, Vitamin B62024-11-29 10:47:42
Innate Response Formulas C Complete Powder -- 2.9 ozInnateProfessional Supplements Citric acid, Vitamin C, beta carotene, calcium ascorbate, Citric acid, Quercetin Dihydrate, Rutin2024-11-29 10:47:42
Innerzyme Pain & Inflammation Blend -- 250 TabletsInnerzymeHerbs, Botanicals & HomeopathyChymotrypsin, Dicalcium phosphate, ethylcellulose, microcrystalline cellulose, maltodextrin, oleic acid, Rutin, stearic acid2024-11-29 10:47:42
Little DaVinci Kids Enz-flame Kids Powdered Drink Mix Natural Orange -- 30 ServingsLittle DaVinciProfessional Supplementscitric acid, Cetyl Myristoleate, citric acid, Pepsin, Luteolin, Quercetin, Rutin, tricalcium phosphate2024-11-29 10:47:42
Macro Life Naturals Macro Greens Superfood -- 10 ozMacro Life NaturalsVitamins & SupplementsLipase, Policosanol, Vitamin C, Cellulase, Vitamin E, Vitamin E, Stevia, Vitamin A, Rutin, Vitamin B122024-11-29 10:47:42
Mt Angel Vitamins Good C -- 180 Vegetarian CapsulesMt Angel VitaminsProfessional SupplementsVitamin C, cellulose, Hesperidin, Rutin2024-11-29 10:47:42
Natural Factors Fruit-Flavor Chew C Blueberry Raspberry and Boysenberry -- 500 mg - 180 Chewable WafersNatural FactorsVitamins & Supplementscitric acid, Vitamin C, citric acid, fructose, rutin2024-11-29 10:47:42
NutriCology Quercetin Bioflavonoids -- 100 Vegetarian CapsulesNutriCologyVitamins & Supplementscellulose, Hesperidin, Quercetin, Rutin2024-11-29 10:47:42
Solgar Ester-C® Plus Vitamin C -- 1000 mg - 180 TabletsSolgarVitamins & SupplementsVitamin C, dicalcium phosphate, microcrystalline cellulose, Rutin2024-11-29 10:47:42
Solgar Ester-C® Plus Vitamin C -- 500 mg - 100 Vegetable CapsulesSolgarVitamins & SupplementsVitamin C, Rutin2024-11-29 10:47:42
Solgar Ester-C® Plus Vitamin C -- 500 mg - 250 Vegetable CapsulesSolgarVitamins & SupplementsVitamin C, Rutin2024-11-29 10:47:42
Solgar Formula VM-75® Iron-Free -- 180 TabletsSolgarVitamins & Supplementsalpha carotene, Vitamin C, Betaine HCl, Biotin, Boron, Choline, Chromium, cryptoxanthin, Vitamin E, Folic Acid, Vitamin E, Hesperidin, Microcrystalline cellulose, Inositol, Iodine, calcium carbonate, lutein, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, titanium dioxide, Vitamin B12, Vitamin B6, zeaxanthin, zinc oxide2024-11-29 10:47:42
Solgar Quercetin Complex with Ester-C® Plus -- 100 Vegetable CapsulesSolgarVitamins & SupplementsVitamin C, calcium ascorbate, microcrystalline cellulose, Quercetin, Rutin2024-11-29 10:47:42
Source Naturals Life Force™ Multiple No Iron -- 180 CapsulesSource NaturalsVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Astaxanthin, Biotin, Boron, Vitamin D3, Choline, Chromium, Coenzyme Q10, Vitamin E, DMAE, Folate, Vitamin E, microcrystalline cellulose, Inositol, Iodine, calcium carbonate, Lutein, Lycopene, Manganese, Molybdenum, N-Acetyl-L-Tyrosine, Niacin, Pantethine, Pantothenic Acid, Vitamin B6, Quercetin, Vitamin A, Riboflavin, Rutin, Selenium, Thiamin, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
Twinlab OcuGuard Plus -- 120 Veggie CapsulesTwinlabVitamins & SupplementsVitamin C, Chromium, Vitamin E, eriocitrin, Vitamin E, hesperidin, Lutein, Quercetin Dihydrate, Vitamin A, Riboflavin, Rutin, Selenium, Taurine2024-11-29 10:47:42
Twinlab OcuGuard® Plus -- 60 Veggie CapsTwinlabVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Chromium, Vitamin E, eriocitrin, Vitamin E, Lutein, naringin, Quercetin Dihydrate, Vitamin A, Riboflavin, Rutin, Selenium, Taurine, Zeaxanthin2024-11-29 10:47:42
Vitacost-Synergy Eye Defense Formula† -- 120 CapsulesVitacost-SynergyVitamins & SupplementsN-Acetyl L-Cysteine, Vitamin C, Chromium, Vitamin E, Vitamin E, Lutein, Quercetin Dihydrate, Vitamin A, Riboflavin, Rutin, Selenium, Taurine, Zeaxanthin2024-11-29 10:47:42
Vitalzym Extra Strength Enteric Coated Supplement -- 360 Liquid Gel CapsulesVitalzymVitamins & Supplements Lipase, glycerin, Rutin2024-11-29 10:47:42
Vitalzym Systemic and Digestive Formula -- 450 Vegetable CapsulesVitalzymVitamins & SupplementsLipase, cellulose, Rutin2024-11-29 10:47:42

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
rutinoside
disaccharide derivativeA carbohydrate derivative that is formally obtained from a disaccharide.
quercetin O-glucosideA quercetin O-glycoside that is an O-glucosylated derivative of quercetin.
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
glycosideA glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
glycolysis IV (plant cytosol)1347
rutin biosynthesis013
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle2856
rutin degradation (plants)010
superpathway of flavones and derivatives biosynthesis1744
Rubisco shunt632
superpathway of anaerobic sucrose degradation3360
superpathway of cytosolic glycolysis (plants), pyruvate dehydrogenase and TCA cycle2459
Rubisco shunt832
glycolysis IV (plant cytosol)747
superpathway of flavones and derivatives biosynthesis1064
superpathway of anaerobic sucrose degradation2661
rutin degradation230
rutin biosynthesis113

Protein Targets (68)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency25.11890.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency22.33420.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency14.12540.177814.390939.8107AID2147
acetylcholinesteraseHomo sapiens (human)Potency90.08780.002541.796015,848.9004AID1347395
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.00070.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency29.84930.000714.592883.7951AID1259369
Microtubule-associated protein tauHomo sapiens (human)Potency28.18380.180013.557439.8107AID1460
thioredoxin glutathione reductaseSchistosoma mansoniPotency25.11890.100022.9075100.0000AID485364
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency17.35170.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency29.84930.000229.305416,493.5996AID743079
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency10.00000.035520.977089.1251AID504332
thyroid stimulating hormone receptorHomo sapiens (human)Potency69.07820.001628.015177.1139AID1259385
Histone H2A.xCricetulus griseus (Chinese hamster)Potency51.71460.039147.5451146.8240AID1224845; AID1224896
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency3.16230.036619.637650.1187AID2100
DNA polymerase betaHomo sapiens (human)Potency8.91250.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency7.94330.039816.784239.8107AID1454
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency2.41590.000627.21521,122.0200AID743202
DNA polymerase kappa isoform 1Homo sapiens (human)Potency23.77810.031622.3146100.0000AID588579
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency8.93860.00419.962528.1838AID2675; AID493199; AID493205
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency11.22020.060110.745337.9330AID492961
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency14.12540.003245.467312,589.2998AID2517
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency11.22020.177814.390939.8107AID2147
Microtubule-associated protein tauHomo sapiens (human)Potency28.18380.180013.557439.8107AID1460
DNA polymerase kappa isoform 1Homo sapiens (human)Potency6.30960.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency3.16230.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency3.16231.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Genome polyprotein Zika virusIC50 (µMol)104.00001.10001.94004.1000AID1558317
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))IC50 (µMol)68.57500.00000.503510.0000AID366284; AID366285; AID366286; AID455703
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))Ki33.80000.00011.78687.7000AID455703
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)100.00000.03403.987110.0000AID1505136; AID1505138
Lysine-specific histone demethylase 1AHomo sapiens (human)IC50 (µMol)2.16000.00312.16029.6000AID1515260
Chymotrypsinogen ABos taurus (cattle)IC50 (µMol)500.00000.98004.05607.2000AID1510602
AlbuminBos taurus (cattle)IC50 (µMol)41.90003.00003.00003.0000AID721628
NeuraminidaseInfluenza A virus (A/USSR/90/1977(H1N1))IC50 (µMol)96.35000.00140.00550.0130AID1186763; AID1186764
Beta-lactamaseEnterobacter cloacaeIC50 (µMol)500.00000.10001.87457.7000AID1510602
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)13.00000.00041.877310.0000AID335838
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)80.00000.00011.753610.0000AID380506
Alpha-2A adrenergic receptorHomo sapiens (human)Ki9.34000.00010.807410.0000AID478696
SialidaseClostridium perfringensIC50 (µMol)30.90000.00102.45729.8000AID455702
Alpha-2C adrenergic receptorHomo sapiens (human)Ki9.63700.00030.483410.0000AID478695
AcetylcholinesteraseHomo sapiens (human)Ki300.00000.00001.27869.7300AID441660
Dipeptidyl peptidase 4Homo sapiens (human)IC50 (µMol)145.00000.00010.444410.0000AID365675
Substance-P receptorCavia porcellus (domestic guinea pig)IC50 (µMol)52.20000.00002.751810.0000AID366285
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)24.30000.00000.54509.1000AID1126472
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)52.20000.00132.81389.8200AID399340
Prolyl endopeptidaseHomo sapiens (human)IC50 (µMol)200.00000.00111.98969.7500AID365674
Mitogen-activated protein kinase 10Homo sapiens (human)IC50 (µMol)65.90000.00201.703510.0000AID1799639
Mitogen-activated protein kinase 14Homo sapiens (human)IC50 (µMol)65.90000.00010.72667.8000AID1799639
Substance-K receptorCavia porcellus (domestic guinea pig)IC50 (µMol)52.20000.01500.01500.0150AID366285
Prothrombin Bos taurus (cattle)IC50 (µMol)42.20000.00890.88576.0000AID1803131
Urokinase-type plasminogen activatorHomo sapiens (human)IC50 (µMol)42.20000.03703.385910.0000AID1803131
Cationic trypsinBos taurus (cattle)IC50 (µMol)42.20000.00003.479210.0000AID1803131
Chymotrypsin-like elastase family member 1Sus scrofa (pig)IC50 (µMol)42.20002.18525.171310.0000AID1803131
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glycogen synthase kinase-3 beta isoform 1Homo sapiens (human)EC50 (µMol)27.96000.212522.156283.9400AID434954
Neuromedin-U receptor 2Homo sapiens (human)EC50 (µMol)1.20000.00041.31046.6000AID1166579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (284)

Processvia Protein(s)Taxonomy
regulation of double-strand break repair via homologous recombinationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of protein ubiquitinationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of protein localizationLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to UVLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to gamma radiationLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair-dependent chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuroblast proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
protein demethylationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of epithelial to mesenchymal transitionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuron projection developmentLysine-specific histone demethylase 1AHomo sapiens (human)
cerebral cortex developmentLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
neuron maturationLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cell sizeLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-templated transcriptionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
guanine metabolic processLysine-specific histone demethylase 1AHomo sapiens (human)
muscle cell developmentLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of androgen receptor signaling pathwayLysine-specific histone demethylase 1AHomo sapiens (human)
response to fungicideLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to cAMPLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of DNA methylation-dependent heterochromatin formationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cold-induced thermogenesisLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neural precursor cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of stem cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
lactate metabolic processL-lactate dehydrogenase A chainHomo sapiens (human)
pyruvate metabolic processL-lactate dehydrogenase A chainHomo sapiens (human)
glycolytic processL-lactate dehydrogenase A chainHomo sapiens (human)
digestionChymotrypsinogen ABos taurus (cattle)
cellular response to starvationAlbuminBos taurus (cattle)
negative regulation of mitochondrial depolarizationAlbuminBos taurus (cattle)
cellular response to calcium ion starvationAlbuminBos taurus (cattle)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
positive regulation of cytokine productionAlpha-2A adrenergic receptorHomo sapiens (human)
DNA replicationAlpha-2A adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
Ras protein signal transductionAlpha-2A adrenergic receptorHomo sapiens (human)
Rho protein signal transductionAlpha-2A adrenergic receptorHomo sapiens (human)
female pregnancyAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of cell population proliferationAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2A adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-2A adrenergic receptorHomo sapiens (human)
actin cytoskeleton organizationAlpha-2A adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of cell migrationAlpha-2A adrenergic receptorHomo sapiens (human)
activation of protein kinase activityAlpha-2A adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2A adrenergic receptorHomo sapiens (human)
cellular response to hormone stimulusAlpha-2A adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2A adrenergic receptorHomo sapiens (human)
vasodilationAlpha-2A adrenergic receptorHomo sapiens (human)
glucose homeostasisAlpha-2A adrenergic receptorHomo sapiens (human)
fear responseAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of potassium ion transportAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of MAP kinase activityAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion-dependent exocytosisAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretionAlpha-2A adrenergic receptorHomo sapiens (human)
intestinal absorptionAlpha-2A adrenergic receptorHomo sapiens (human)
thermoceptionAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of lipid catabolic processAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of membrane protein ectodomain proteolysisAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion transportAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretion involved in cellular response to glucose stimulusAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of uterine smooth muscle contractionAlpha-2A adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
adenylate cyclase-inhibiting adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
phospholipase C-activating adrenergic receptor signaling pathwayAlpha-2A adrenergic receptorHomo sapiens (human)
positive regulation of wound healingAlpha-2A adrenergic receptorHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAlpha-2A adrenergic receptorHomo sapiens (human)
negative regulation of calcium ion transmembrane transporter activityAlpha-2A adrenergic receptorHomo sapiens (human)
cholesterol biosynthetic processCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
vesicle docking involved in exocytosisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
bicarbonate transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cholesterol transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
response to endoplasmic reticulum stressCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
transepithelial water transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of exocytosisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
sperm capacitationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
multicellular organismal-level water homeostasisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
intracellular pH elevationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
establishment of localization in cellCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
transmembrane transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
membrane hyperpolarizationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of enamel mineralizationCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cellular response to cAMPCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
amelogenesisCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of cyclic nucleotide-gated ion channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride transmembrane transportCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
positive regulation of voltage-gated chloride channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cellular response to forskolinCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
regulation of smooth muscle contractionAlpha-2C adrenergic receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
cell-cell signalingAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of norepinephrine secretionAlpha-2C adrenergic receptorHomo sapiens (human)
regulation of vasoconstrictionAlpha-2C adrenergic receptorHomo sapiens (human)
platelet activationAlpha-2C adrenergic receptorHomo sapiens (human)
activation of protein kinase B activityAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of epinephrine secretionAlpha-2C adrenergic receptorHomo sapiens (human)
receptor transactivationAlpha-2C adrenergic receptorHomo sapiens (human)
positive regulation of MAPK cascadeAlpha-2C adrenergic receptorHomo sapiens (human)
positive regulation of neuron differentiationAlpha-2C adrenergic receptorHomo sapiens (human)
adrenergic receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
adenylate cyclase-activating adrenergic receptor signaling pathwayAlpha-2C adrenergic receptorHomo sapiens (human)
negative regulation of insulin secretionAlpha-2C adrenergic receptorHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
behavioral fear responseDipeptidyl peptidase 4Homo sapiens (human)
response to hypoxiaDipeptidyl peptidase 4Homo sapiens (human)
proteolysisDipeptidyl peptidase 4Homo sapiens (human)
cell adhesionDipeptidyl peptidase 4Homo sapiens (human)
positive regulation of cell population proliferationDipeptidyl peptidase 4Homo sapiens (human)
negative regulation of extracellular matrix disassemblyDipeptidyl peptidase 4Homo sapiens (human)
peptide hormone processingDipeptidyl peptidase 4Homo sapiens (human)
receptor-mediated endocytosis of virus by host cellDipeptidyl peptidase 4Homo sapiens (human)
T cell costimulationDipeptidyl peptidase 4Homo sapiens (human)
regulation of cell-cell adhesion mediated by integrinDipeptidyl peptidase 4Homo sapiens (human)
locomotory exploration behaviorDipeptidyl peptidase 4Homo sapiens (human)
psychomotor behaviorDipeptidyl peptidase 4Homo sapiens (human)
T cell activationDipeptidyl peptidase 4Homo sapiens (human)
endothelial cell migrationDipeptidyl peptidase 4Homo sapiens (human)
symbiont entry into host cellDipeptidyl peptidase 4Homo sapiens (human)
receptor-mediated virion attachment to host cellDipeptidyl peptidase 4Homo sapiens (human)
negative chemotaxisDipeptidyl peptidase 4Homo sapiens (human)
membrane fusionDipeptidyl peptidase 4Homo sapiens (human)
negative regulation of neutrophil chemotaxisDipeptidyl peptidase 4Homo sapiens (human)
glucagon processingDipeptidyl peptidase 4Homo sapiens (human)
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
proteolysisProlyl endopeptidaseHomo sapiens (human)
protein phosphorylationMitogen-activated protein kinase 10Homo sapiens (human)
signal transductionMitogen-activated protein kinase 10Homo sapiens (human)
JNK cascadeMitogen-activated protein kinase 10Homo sapiens (human)
response to light stimulusMitogen-activated protein kinase 10Homo sapiens (human)
Fc-epsilon receptor signaling pathwayMitogen-activated protein kinase 10Homo sapiens (human)
regulation of circadian rhythmMitogen-activated protein kinase 10Homo sapiens (human)
rhythmic processMitogen-activated protein kinase 10Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 10Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 14Homo sapiens (human)
DNA damage checkpoint signalingMitogen-activated protein kinase 14Homo sapiens (human)
cell morphogenesisMitogen-activated protein kinase 14Homo sapiens (human)
cartilage condensationMitogen-activated protein kinase 14Homo sapiens (human)
angiogenesisMitogen-activated protein kinase 14Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
placenta developmentMitogen-activated protein kinase 14Homo sapiens (human)
response to dietary excessMitogen-activated protein kinase 14Homo sapiens (human)
chondrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusMitogen-activated protein kinase 14Homo sapiens (human)
glucose metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
apoptotic processMitogen-activated protein kinase 14Homo sapiens (human)
chemotaxisMitogen-activated protein kinase 14Homo sapiens (human)
signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
skeletal muscle tissue developmentMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myotube differentiationMitogen-activated protein kinase 14Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 14Homo sapiens (human)
fatty acid oxidationMitogen-activated protein kinase 14Homo sapiens (human)
platelet activationMitogen-activated protein kinase 14Homo sapiens (human)
regulation of ossificationMitogen-activated protein kinase 14Homo sapiens (human)
osteoclast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 14Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
response to muramyl dipeptideMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 14Homo sapiens (human)
response to insulinMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of hippo signalingMitogen-activated protein kinase 14Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusMitogen-activated protein kinase 14Homo sapiens (human)
response to muscle stretchMitogen-activated protein kinase 14Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of protein import into nucleusMitogen-activated protein kinase 14Homo sapiens (human)
signal transduction in response to DNA damageMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
glucose importMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of glucose importMitogen-activated protein kinase 14Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
stem cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
striated muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 14Homo sapiens (human)
bone developmentMitogen-activated protein kinase 14Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipoteichoic acidMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to tumor necrosis factorMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to ionizing radiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of brown fat cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 14Homo sapiens (human)
stress-induced premature senescenceMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 14Homo sapiens (human)
regulation of synaptic membrane adhesionMitogen-activated protein kinase 14Homo sapiens (human)
regulation of cytokine production involved in inflammatory responseMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast fusionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
reduction of food intake in response to dietary excessNeuromedin-U receptor 2Homo sapiens (human)
regulation of smooth muscle contractionNeuromedin-U receptor 2Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayNeuromedin-U receptor 2Homo sapiens (human)
neuropeptide signaling pathwayNeuromedin-U receptor 2Homo sapiens (human)
cell-cell signalingNeuromedin-U receptor 2Homo sapiens (human)
central nervous system developmentNeuromedin-U receptor 2Homo sapiens (human)
grooming behaviorNeuromedin-U receptor 2Homo sapiens (human)
feeding behaviorNeuromedin-U receptor 2Homo sapiens (human)
response to painNeuromedin-U receptor 2Homo sapiens (human)
arachidonic acid secretionNeuromedin-U receptor 2Homo sapiens (human)
positive regulation of calcium-mediated signalingNeuromedin-U receptor 2Homo sapiens (human)
chloride transmembrane transportNeuromedin-U receptor 2Homo sapiens (human)
proteolysisProthrombin Bos taurus (cattle)
acute-phase responseProthrombin Bos taurus (cattle)
positive regulation of blood coagulationProthrombin Bos taurus (cattle)
protein polymerizationProthrombin Bos taurus (cattle)
positive regulation of cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisUrokinase-type plasminogen activatorHomo sapiens (human)
chemotaxisUrokinase-type plasminogen activatorHomo sapiens (human)
signal transductionUrokinase-type plasminogen activatorHomo sapiens (human)
blood coagulationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of signaling receptor activityUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesion mediated by integrinUrokinase-type plasminogen activatorHomo sapiens (human)
urokinase plasminogen activator signaling pathwayUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell population proliferationUrokinase-type plasminogen activatorHomo sapiens (human)
fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of wound healingUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisCationic trypsinBos taurus (cattle)
digestionCationic trypsinBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (125)

Processvia Protein(s)Taxonomy
telomeric DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
p53 bindingLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
oxidoreductase activityLysine-specific histone demethylase 1AHomo sapiens (human)
enzyme bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear receptor coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K4 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
identical protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
MRF bindingLysine-specific histone demethylase 1AHomo sapiens (human)
flavin adenine dinucleotide bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear androgen receptor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
telomeric repeat-containing RNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
FAD-dependent H3K4me/H3K4me3 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
promoter-specific chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
L-lactate dehydrogenase activityL-lactate dehydrogenase A chainHomo sapiens (human)
protein bindingL-lactate dehydrogenase A chainHomo sapiens (human)
identical protein bindingL-lactate dehydrogenase A chainHomo sapiens (human)
cadherin bindingL-lactate dehydrogenase A chainHomo sapiens (human)
protein bindingChymotrypsinogen ABos taurus (cattle)
serpin family protein bindingChymotrypsinogen ABos taurus (cattle)
oxygen bindingAlbuminBos taurus (cattle)
DNA bindingAlbuminBos taurus (cattle)
fatty acid bindingAlbuminBos taurus (cattle)
protein bindingAlbuminBos taurus (cattle)
toxic substance bindingAlbuminBos taurus (cattle)
pyridoxal phosphate bindingAlbuminBos taurus (cattle)
metal ion bindingAlbuminBos taurus (cattle)
enterobactin bindingAlbuminBos taurus (cattle)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
alpha2-adrenergic receptor activityAlpha-2A adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2A adrenergic receptorHomo sapiens (human)
protein kinase bindingAlpha-2A adrenergic receptorHomo sapiens (human)
alpha-1B adrenergic receptor bindingAlpha-2A adrenergic receptorHomo sapiens (human)
alpha-2C adrenergic receptor bindingAlpha-2A adrenergic receptorHomo sapiens (human)
thioesterase bindingAlpha-2A adrenergic receptorHomo sapiens (human)
heterotrimeric G-protein bindingAlpha-2A adrenergic receptorHomo sapiens (human)
protein homodimerization activityAlpha-2A adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-2A adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2A adrenergic receptorHomo sapiens (human)
norepinephrine bindingAlpha-2A adrenergic receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityAlpha-2A adrenergic receptorHomo sapiens (human)
chloride channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
intracellularly ATP-gated chloride channel activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
protein bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATP bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
bicarbonate transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
isomerase activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATP hydrolysis activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride channel regulator activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride channel inhibitor activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
enzyme bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
PDZ domain bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
protein-folding chaperone bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
Sec61 translocon complex bindingCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ABC-type transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
ATPase-coupled transmembrane transporter activityCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
alpha2-adrenergic receptor activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein bindingAlpha-2C adrenergic receptorHomo sapiens (human)
alpha-2A adrenergic receptor bindingAlpha-2C adrenergic receptorHomo sapiens (human)
protein homodimerization activityAlpha-2C adrenergic receptorHomo sapiens (human)
protein heterodimerization activityAlpha-2C adrenergic receptorHomo sapiens (human)
epinephrine bindingAlpha-2C adrenergic receptorHomo sapiens (human)
guanyl-nucleotide exchange factor activityAlpha-2C adrenergic receptorHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
virus receptor activityDipeptidyl peptidase 4Homo sapiens (human)
protease bindingDipeptidyl peptidase 4Homo sapiens (human)
aminopeptidase activityDipeptidyl peptidase 4Homo sapiens (human)
serine-type endopeptidase activityDipeptidyl peptidase 4Homo sapiens (human)
signaling receptor bindingDipeptidyl peptidase 4Homo sapiens (human)
protein bindingDipeptidyl peptidase 4Homo sapiens (human)
serine-type peptidase activityDipeptidyl peptidase 4Homo sapiens (human)
dipeptidyl-peptidase activityDipeptidyl peptidase 4Homo sapiens (human)
identical protein bindingDipeptidyl peptidase 4Homo sapiens (human)
protein homodimerization activityDipeptidyl peptidase 4Homo sapiens (human)
chemorepellent activityDipeptidyl peptidase 4Homo sapiens (human)
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
serine-type endopeptidase activityProlyl endopeptidaseHomo sapiens (human)
protein bindingProlyl endopeptidaseHomo sapiens (human)
serine-type peptidase activityProlyl endopeptidaseHomo sapiens (human)
oligopeptidase activityProlyl endopeptidaseHomo sapiens (human)
JUN kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein bindingMitogen-activated protein kinase 10Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 10Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 14Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 14Homo sapiens (human)
mitogen-activated protein kinase p38 bindingMitogen-activated protein kinase 14Homo sapiens (human)
NFAT protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
neuromedin U receptor activityNeuromedin-U receptor 2Homo sapiens (human)
G protein-coupled receptor activityNeuromedin-U receptor 2Homo sapiens (human)
intracellularly calcium-gated chloride channel activityNeuromedin-U receptor 2Homo sapiens (human)
protein bindingNeuromedin-U receptor 2Homo sapiens (human)
GTP bindingNeuromedin-U receptor 2Homo sapiens (human)
neuromedin U bindingNeuromedin-U receptor 2Homo sapiens (human)
neuropeptide receptor activityNeuromedin-U receptor 2Homo sapiens (human)
serine-type endopeptidase activityProthrombin Bos taurus (cattle)
calcium ion bindingProthrombin Bos taurus (cattle)
protein bindingProthrombin Bos taurus (cattle)
fibrinogen bindingProthrombin Bos taurus (cattle)
serine-type endopeptidase activityUrokinase-type plasminogen activatorHomo sapiens (human)
protein bindingUrokinase-type plasminogen activatorHomo sapiens (human)
endopeptidase activityCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityCationic trypsinBos taurus (cattle)
protein bindingCationic trypsinBos taurus (cattle)
metal ion bindingCationic trypsinBos taurus (cattle)
serpin family protein bindingCationic trypsinBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (65)

Processvia Protein(s)Taxonomy
chromatinLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
chromosome, telomeric regionLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
nucleoplasmLysine-specific histone demethylase 1AHomo sapiens (human)
transcription regulator complexLysine-specific histone demethylase 1AHomo sapiens (human)
protein-containing complexLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair complexLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusL-lactate dehydrogenase A chainHomo sapiens (human)
cytosolL-lactate dehydrogenase A chainHomo sapiens (human)
membraneL-lactate dehydrogenase A chainHomo sapiens (human)
extracellular exosomeL-lactate dehydrogenase A chainHomo sapiens (human)
oxidoreductase complexL-lactate dehydrogenase A chainHomo sapiens (human)
mitochondrionL-lactate dehydrogenase A chainHomo sapiens (human)
extracellular regionChymotrypsinogen ABos taurus (cattle)
serine protease inhibitor complexChymotrypsinogen ABos taurus (cattle)
extracellular regionAlbuminBos taurus (cattle)
extracellular spaceAlbuminBos taurus (cattle)
protein-containing complexAlbuminBos taurus (cattle)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
cytoplasmAlpha-2A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
basolateral plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
neuronal cell bodyAlpha-2A adrenergic receptorHomo sapiens (human)
axon terminusAlpha-2A adrenergic receptorHomo sapiens (human)
presynaptic active zone membraneAlpha-2A adrenergic receptorHomo sapiens (human)
dopaminergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
postsynaptic density membraneAlpha-2A adrenergic receptorHomo sapiens (human)
glutamatergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
GABA-ergic synapseAlpha-2A adrenergic receptorHomo sapiens (human)
receptor complexAlpha-2A adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2A adrenergic receptorHomo sapiens (human)
nucleusCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytoplasmCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
lysosomal membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
early endosomeCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
endoplasmic reticulum membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytosolCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cell surfaceCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
endosome membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
apical plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
Golgi-associated vesicle membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
clathrin-coated endocytic vesicle membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
early endosome membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
recycling endosomeCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
recycling endosome membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
protein-containing complexCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
chloride channel complexCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytosolCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
apical plasma membraneCystic fibrosis transmembrane conductance regulatorHomo sapiens (human)
cytoplasmAlpha-2C adrenergic receptorHomo sapiens (human)
endosomeAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2C adrenergic receptorHomo sapiens (human)
plasma membraneAlpha-2C adrenergic receptorHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
extracellular regionDipeptidyl peptidase 4Homo sapiens (human)
lysosomal membraneDipeptidyl peptidase 4Homo sapiens (human)
plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
focal adhesionDipeptidyl peptidase 4Homo sapiens (human)
cell surfaceDipeptidyl peptidase 4Homo sapiens (human)
membraneDipeptidyl peptidase 4Homo sapiens (human)
apical plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
lamellipodiumDipeptidyl peptidase 4Homo sapiens (human)
endocytic vesicleDipeptidyl peptidase 4Homo sapiens (human)
lamellipodium membraneDipeptidyl peptidase 4Homo sapiens (human)
membrane raftDipeptidyl peptidase 4Homo sapiens (human)
intercellular canaliculusDipeptidyl peptidase 4Homo sapiens (human)
extracellular exosomeDipeptidyl peptidase 4Homo sapiens (human)
plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
nucleusProlyl endopeptidaseHomo sapiens (human)
cytoplasmProlyl endopeptidaseHomo sapiens (human)
cytosolProlyl endopeptidaseHomo sapiens (human)
membraneProlyl endopeptidaseHomo sapiens (human)
cytosolProlyl endopeptidaseHomo sapiens (human)
nucleoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 10Homo sapiens (human)
plasma membraneMitogen-activated protein kinase 10Homo sapiens (human)
nucleusMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
spindle poleMitogen-activated protein kinase 14Homo sapiens (human)
extracellular regionMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
nuclear speckMitogen-activated protein kinase 14Homo sapiens (human)
secretory granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
glutamatergic synapseMitogen-activated protein kinase 14Homo sapiens (human)
ficolin-1-rich granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
plasma membraneNeuromedin-U receptor 2Homo sapiens (human)
membraneNeuromedin-U receptor 2Homo sapiens (human)
plasma membraneNeuromedin-U receptor 2Homo sapiens (human)
extracellular regionUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
focal adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
external side of plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
cell surfaceUrokinase-type plasminogen activatorHomo sapiens (human)
specific granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular exosomeUrokinase-type plasminogen activatorHomo sapiens (human)
tertiary granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexUrokinase-type plasminogen activatorHomo sapiens (human)
protein complex involved in cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase complexUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexCationic trypsinBos taurus (cattle)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (449)

Assay IDTitleYearJournalArticle
AID1347389qHTS assay for small molecule disruptors of mitochondrial membrane potential screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347358HPAF-II 12hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347363Firefly luciferase counterscreen qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347355HEK-293 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347379qHTS for Inflammasome Signaling Inhibitors: IL-1-beta AlphaLISA screen against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347402qHTS for inhibitors of Rabies Virus screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347372qHTS for Constitutive Androstane Receptor (CAR) Antagonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347394Vero-766 cells viability qHTS against the NCATS CANVASS Library: Counterscreen for Zika virus inhibition assay2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347346HPAF-II Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347367qHTS for ATAD5 Agonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347370qHTS for ATAD5 Antagonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347387Cytotoxicity qHTS for assessment of Hepg2 cells membrane integrity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347400Viability qHTS for inhibitors of the SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347345OV-KATE Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347361HEK293 12hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347366KB-3-1 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347378qHTS for H2AX Agonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347354UWB1.289-WTBRCA1 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347377DH5-alpha competent E. coli microbial cell viability qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347371J3T Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347351U-118MG Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347356HPAF-II 24hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347359HEK293 24hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347380qHTS for Antimalaria activity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347374qHTS for Hypoxia signaling pathway (HIF-1) antagonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID134737610-beta competent E. coli microbial cell viability qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347375qHTS for Hypoxia signaling pathway (HIF-1) agonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347362Diaphorse counterscreen qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347348OV-SAHO Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347347UWB1.289 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347373qHTS for Constitutive Androstane Receptor (CAR) Agonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347396qHTS for inhibitors of Wild type Zika virus screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347391qHTS for activators of Nrf2/ARE signaling pathway screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347349Panc-1005 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347368G06 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347401Redox Reaction Profiling qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347390Secretion counterscreen for inhibitors of the SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347388qHTS for Activators of p53 Stress Response Pathway screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347350SW1088 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347393qHTS for inhibitors of ER calcium dysfunction: SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347365SDT Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347364KB-8-5-11 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347352COV-362 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347369MCF7 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347353A2780 Cisplatin Sensitive Ovarian Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347357HEK293 18hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347381Inflammasome Signaling qHTS Counterscreen: IL-1-beta AlphaLISA counterscreen against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347392qHTS for activators of dead-cell proteases activity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347360HPAF-II 18hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1871975Antifungal activity against Candida albicans 527/14 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID666855Cytotoxicity against mouse L929 cells after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID1082349Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID481717Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
AID1505137Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins incubation under dark condition2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID750849Metal chelating activity of the compound after 10 mins by spectrophotometric analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Bioactive dimeric carbazole alkaloids from Murraya koenigii.
AID1064283Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ by FRAP assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Natural occurrence of organofluorine and other constituents from Streptomyces sp. TC1.
AID1168660Antiviral activity against Dengue virus assessed as inhibition of viral replication2014European journal of medicinal chemistry, Nov-24, Volume: 87A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
AID1510602Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID395278Antiglycation activity of compound assessed as inhibition of BSA-derived advance glycated end product formation after 7 days by spectrofluorimeter2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Unsymmetrically disubstituted urea derivatives: a potent class of antiglycating agents.
AID336478Inhibition of COX2 at 100 uM by scintillation proximity assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
AID379566Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio relative to TPA2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID455703Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID1071843Antioxidant activity assessed as AAPH-induced alkoxyl radical scavenging activity by ESR spin trapping method2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox.
AID1505136Inhibition of mushroom tyrosinase using L-tyrosine as substrate pretreated for 5 mins followed by substrate addition measured over 30 mins by spectrophotometric method2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID1175999Antifungal activity against Epidermophyton floccosum (Hartz) Langeron and Milochevitch CBS 358.93 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID287079Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 100 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID293297Antioxidant activity assessed as DPPH radical scavenging activity after 20 min2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1424234Antioxidant activity assessed as singlet oxygen scavenging activity by measuring rate constant using VIS irradiation by ESR spin trapping method2017European journal of medicinal chemistry, Jun-16, Volume: 133Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases.
AID1082345Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1616108Inhibition of F1F0-ATP synthase in Escherichia coli after 60 mins relative to control2019European journal of medicinal chemistry, Nov-15, Volume: 182Recent advancements in mechanistic studies and structure activity relationship of F
AID1744548Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL peroxidase activity at 10 uM up to 20 mins in presence of cardiolipin by Amplex red staining based fluorescence assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1186765Inhibition of influenza B virus (B/Brisbane/60/2008) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID1176017Inhibition of NF-kappaB (unknown origin)/32P-labeled oligonucleotide interaction at 0.1 to 10 mM after 20 mins by electrophoretic mobility shift assay2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1176013Antifungal activity against Microsporum gypseum (Bodin) Guiart and Grigorakis IHME 3999 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1377659Antimicrobial activity against Escherichia coli ATCC 25922 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID289333Nitric oxide scavenging activity assessed as inhibition of DAF2 oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID1417094Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells using DHO as substrate measured after 60 secs2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID338024Inhibition of beef heart mitochondrial succinoxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control
AID379569Inhibition of TPA-induced EBV-early antigen activation in human Raji cells relative to TPA2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1668637Inhibition of human liver FBP1 at 200 uM incubated for 5 mins by fluorescence method relative to control2020Journal of natural products, 05-22, Volume: 83, Issue:5
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
AID1527605Anti-colitis activity in ICR mouse model of DSS-induced colitis assessed as reduction in DSS-induced body weight loss at 6 mg, po for 14 days relative to control2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID379097Stimulation of BALB/c mouse cloned 3T3/A31 cells proliferation at 0.01 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379097Stimulation of BALB/c mouse cloned 3T3/A31 cells proliferation at 0.01 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID1176021Induction of apoptosis in human K562 cells assessed as live cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1176019Induction of apoptosis in human K562 cells assessed as live cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1338310Antiviral activity against EV71 infected in human RD cells assessed as reduction in viral plaque formation after 1 hr by crystal violet staining method2016European journal of medicinal chemistry, Nov-29, Volume: 124Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
AID402483Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID1303227Antioxidant activity in human HepG2 cells assessed as reduction in Cu2+ induced oxidative stress at 50 to 200 ug/ml preincubated for 30 mins at 120 degC using DCFH-DA in presence of lysine by fluorescence assay2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1175998Octanol-water partition coefficient, log P of the compound at 5 mg/20 ml after 30 mins by spectrophotometric analysis2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1082358Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID333567Antioxidant activity assessed as DPPH radical scavenging activity2004Journal of natural products, Nov, Volume: 67, Issue:11
Indole glucoalkaloids from Chimarrhis turbinata and their evaluation as antioxidant agents and acetylcholinesterase inhibitors.
AID357253Inhibition of Saccharomyces cerevisiae fatty acid synthase2002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID750848Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometric analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Bioactive dimeric carbazole alkaloids from Murraya koenigii.
AID1176004Antifungal activity against Microsporum gypseum (Bodin) Guiart and Grigorakis IHME 3999 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1193988Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Chemical constituents from Kandelia candel with their inhibitory effects on pro-inflammatory cytokines production in LPS-stimulated bone marrow-derived dendritic cells (BMDCs).
AID478695Binding affinity to adrenergic alpha2c receptor2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID338027Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein
AID1176011Antifungal activity against Trichophyton violaceum Malmsten CBS 459.61 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1243249Anti-inflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 40 uM by Griess reaction based ELISA method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Chemical constituents of Miliusa balansae leaves and inhibition of nitric oxide production in lipopolysaccharide-induced RAW 264.7 cells.
AID551196Inhibition of human HH/Gli1-mediated transcriptional activity in tetracycline-treated human HaCaT cells treated after 12 hrs of tetracycline addition by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha.
AID379573Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID1071676Inhibition of TRAP activity in RANKL-induced Balb/c mouse RAW264.7 cells at 10 uM after 1 hr by ELISA relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID690144Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1510604Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins in presence of Triton X-100 by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1082350Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1071686Antioxidant activity assessed as trolox equivalent of APPH-induced peroxyl radical scavenging activity at 1 uM measured every 2 mins by ORAC fluorescence assay2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1064282Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity after 30 mins by TEAC assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Natural occurrence of organofluorine and other constituents from Streptomyces sp. TC1.
AID360612Antiprotozoal activity against Giardia lamblia IMSS:0989:1 after 48 hrs by MTT/PMS assay2001Journal of natural products, May, Volume: 64, Issue:5
Antiprotozoal activity of the constituents of Conyza filaginoides.
AID1176024Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID1082335Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID441664Cytotoxicity against human HepG2 cells upto 200 umol/L after 24 hrs by MTS assay2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1377664Antimicrobial activity against Cryptococcus neoformans ATCC 208821 at 32 ug/ml after 24 hrs by resazurin dye based assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID334634Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID1377662Antimicrobial activity against Acinetobacter baumannii ATCC 19606 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID168363Superoxide dismutase activity measured as inhibition of Cytochrome C reduction by 50% in isolated rat heart muscle subjected to global ischemia2001Bioorganic & medicinal chemistry letters, Jan-08, Volume: 11, Issue:1
Beneficial effects of different flavonoids, on functional recovery after ischemia and reperfusion in isolated rat heart.
AID1316659Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID399341Antioxidant activity assessed as superoxide-scavenging activity by nitrite method1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1316660Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 30 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1176018Induction of apoptosis in human K562 cells assessed as live cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1235285Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID339128Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID441661Stability in phosphate buffer at pH 7.4 after 90 mins by spectrophotometry2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1166579Agonist activity at human NMU2R transfected in HEK293 cells after 7 hrs by luciferase reporter gene assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor.
AID1185947Antiglycation activity using BSA assessed as inhibition of AGE formation incubated at 37 degC for 9 days by fluorescence assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities.
AID666859Reversal of MRP1-mediated drug resistant in human 2008/MRP1 cells assessed as potentiation of doxorubicin-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID356737Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Antioxidant principles from Bauhinia tarapotensis.
AID478696Binding affinity to adrenergic alpha2A receptor2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID768928Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate at 0.1 to 1000 uM preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis2014Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, , Volume: 23Thrombin inhibitory activity of some polyphenolic compounds.
AID1186766Cytotoxicity against MDCK cells2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID666856Reversal of p-glycoprotein-mediated drug resistant in human LCC-6/MDR cells assessed as potentiation of paclitaxel-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID1082339Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID356577Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2003Journal of natural products, Oct, Volume: 66, Issue:10
New antioxidant C-glucosylxanthones from the stems of Arrabidaea samydoides.
AID1082355Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1405935Antioxidant activity assessed as DPPH radical scavenging activity2018European journal of medicinal chemistry, Aug-05, Volume: 156Current progress on antioxidants incorporating the pyrazole core.
AID406716Photostability of compound assessed as sun protection factor after 120 mins2008Journal of natural products, Jun, Volume: 71, Issue:6
Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method.
AID1082341Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1303233Antioxidant activity in human HepG2 cells assessed as increase in Cu/Zn SOD activity at 200 ug/ml in presence of lysine at 120 degC after 4 hrs relative to control2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1377658Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1071682Antiosteoporotic activity in alpha-MEM-induced C57BL/6 mouse MC3T3-E1 cells assessed as increase in collagen synthesis at 5 uM by Sirius Red-based colorimetric assay relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1176022Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1193989Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Chemical constituents from Kandelia candel with their inhibitory effects on pro-inflammatory cytokines production in LPS-stimulated bone marrow-derived dendritic cells (BMDCs).
AID1071678Inhibition of TRAP activity in RANKL-induced Balb/c mouse RAW264.7 cells at 1 uM after 1 hr by ELISA relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1744554Octanol-water distribution coefficient, log D of the compound at pH 7.4 after 1 hr by UV-VIS spectroscopic analysis2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID455702Inhibition of Clostridium perfringens neuraminidase2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID1071681Antiosteoporotic activity in C57BL/6 mouse MC3T3-E1 cells assessed as increase in mineralization by measuring calcium deposition at 5 uM by Alizarin Red staining assay relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1378832Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins under dark condition2017Journal of natural products, 08-25, Volume: 80, Issue:8
Antarctic Moss Biflavonoids Show High Antioxidant and Ultraviolet-Screening Activity.
AID1176014Antifungal activity against Nannizzia cajetani Ajello CBS 495.70 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID339056Inhibition of Moloney murine leukemia virus reverse transcriptase using (riboadenylic acid)n(deoxythymidylic acid)12-18 as template primer by liquid scintillation counting1992Journal of natural products, Feb, Volume: 55, Issue:2
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
AID334635Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID1176025Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID441659Inhibition of human plasma BChE by Ellman's method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1090647Antifungal activity against Verticillium dahliae assessed as inhibition of mycelial radial growth measured after 350 hr2007Journal of agricultural and food chemistry, May-02, Volume: 55, Issue:9
Dysfunctionality of the xylem in Olea europaea L. Plants associated with the infection process by Verticillium dahliae Kleb. Role of phenolic compounds in plant defense mechanism.
AID1071679Inhibition of TRAP activity in Balb/c mouse RAW264.7 cells at 1 uM after 1 hr by ELISA relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1082327Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1176033Induction of apoptosis in human K562 cells assessed as dead cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID293298Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID365675Inhibition of DPP42008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
AID1377660Antimicrobial activity against Klebsiella pneumoniae ATCC 700603 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1265118Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate at 20 uM incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID379570Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID1176006Antifungal activity against Microsporum canis Bodin CBS 4727 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1176027Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1257225Inhibition of Trichomonas vaginalis adenosine-guanosine preferring ribohydrolase after 40 mins in presence of 0.01% triton X-1002015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
AID1176038Induction of apoptosis in human K562 cells assessed as total apoptotic cells after 3 days by Annexin-V staining-based assay2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1505138Inhibition of mushroom tyrosinase using L-DOPA as substrate measured at 1 min interval by spectrophotometric method2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID515157Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
AID1527604Anti-colitis activity in ICR mouse model of DSS-induced colitis assessed as inhibition of DSS-induced colorectum shortening at 6 mg, po for 14 days relative to control2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID1176029Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1377958Inhibition of human liver LDH5 using pyruvate as substrate and NADH as cofactor measured after 15 mins by fluorescence assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Constituents of Polygala flavescens ssp. flavescens and Their Activity as Inhibitors of Human Lactate Dehydrogenase.
AID462334Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID1186767Selectivity index, ratio of CC50 for MDCK cells to IC50 for influenza A virus (A/Perth/16/2009(H3N2))2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID1176023Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1082357Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1248399Inhibition of alpha-amylase (unknown origin) relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID402262Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity by spectrophotometry2004Journal of natural products, May, Volume: 67, Issue:5
Antioxidative constituents from the leaves of Hypericum styphelioides.
AID402473Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID690143Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID690148Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID696433Inhibition of bovine kidney LMW-PTPase at 400 uM using pNPP substrate2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents.
AID170013Effect of compound on Glutathione peroxidase measured as disappearance of NADPH in isolated rat heart muscle subjected to global ischemia2001Bioorganic & medicinal chemistry letters, Jan-08, Volume: 11, Issue:1
Beneficial effects of different flavonoids, on functional recovery after ischemia and reperfusion in isolated rat heart.
AID399340Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID1176032Induction of apoptosis in human K562 cells assessed as dead cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1316661Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 100 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID403918Displacement of [3H]DPCPX from adenosine A1 receptor in rat forebrain membrane assessed as fraction of receptor bound radioligand at 100 ug/mL1997Journal of natural products, Jun, Volume: 60, Issue:6
Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis.
AID1064281Antioxidant activity assessed as EDTA equivalent of chelating effect after 10 mins by spectrophotometric analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Natural occurrence of organofluorine and other constituents from Streptomyces sp. TC1.
AID1744549Inhibition of cytochrome c (unknown origin) assessed as reduction reduction of cyt c from its ferric state to ferrous state at 10 uM incubated for 20 mins in presence of cardiolipin by UV-vis Spectrophotometric assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1082351Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082342Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1176026Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1303226Antioxidant activity in human HepG2 cells assessed as reduction in Cu2+ induced oxidative stress at 50 to 200 ug/ml preincubated for 30 mins using DCFH-DA by fluorescence assay2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1176041Antioxidant activity assessed as superoxide anion radical scavenging by photochemiluminescence method relative to trolox using formulation containing O/W2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID402263Antioxidant activity assessed as trolox equivalent of free radical scavenging activity by chemiluminescence assay2004Journal of natural products, May, Volume: 67, Issue:5
Antioxidative constituents from the leaves of Hypericum styphelioides.
AID616482Antioxidant activity assessed as DPPH free radical scavenging activity2011Bioorganic & medicinal chemistry letters, Sep-15, Volume: 21, Issue:18
Synthesis and antioxygenic activities of seabuckthorn flavone-3-ols and analogs.
AID1558317Inhibition of Zika virus NS2B (1421 to 1469 residues) - NS3 (1503 to 1688 residues) expressed in Escherichia coli BL21(DE3) cells using Dabcyl-KTSAVLQSGFRKME-Edans as substrate after 11 mins by FRET assay2020Journal of medicinal chemistry, 01-23, Volume: 63, Issue:2
Drugs for the Treatment of Zika Virus Infection.
AID666858Reversal of BCRP-mediated drug resistant in human MCF7-MX100 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID357255Antifungal activity against Cryptococcus neoformans ATCC 901132002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID378763Induction of resting HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control1999Journal of natural products, Mar, Volume: 62, Issue:3
Immunomodulatory principles of Dichrocephala bicolor.
AID1071685Antioxidant activity assessed as trolox equivalent of APPH-induced peroxyl radical scavenging activity measured every 2 mins by ORAC fluorescence assay2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1516972Antifungal activity against Candida parapsilosis after 48 hrs by broth micro dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID378764Induction of phytohemagglutininin-activated HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control1999Journal of natural products, Mar, Volume: 62, Issue:3
Immunomodulatory principles of Dichrocephala bicolor.
AID1071840Antioxidant activity assessed as rosebengal-induced singlet oxygen radical scavenging activity by ESR spin trapping method2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox.
AID1082347Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1235282Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1126476Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1176000Antifungal activity against Trichophyton rubrum (Castellani) Sabouraud IHME 4321 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID293299Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1235286Antimicrobial activity against Streptococcus pyogenes 345/1 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1126478Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1176035Induction of apoptosis in human K562 cells assessed as apoptotic cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1871977Antifungal activity against Candida albicans 13/15 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1516973Antifungal activity against Cryptococcus neoformans after 48 hrs by broth micro dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1303225Drug metabolism assessed as increase in total phenolics at 120 degC after 4 hrs in presence of lysine by Folin-Ciocalteu method2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID339130Inhibition of platelet activity factor-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID287078Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 500 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1082344Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1172639Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID1126472Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1176009Antifungal activity against Trichophyton rubrum (Castellani) Sabouraud IHME 4321 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID339141Inhibition of K(+)/Ca(2+)-induced Wistar rat thoracic aorta contraction at 100 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1082343Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID397831Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry2002Journal of natural products, Dec, Volume: 65, Issue:12
An extract of Tagetes lucida and its phenolic constituents as antioxidants.
AID1446623Neuroprotective activity in rat C6 cells assessed as NGF secretion at 20 uM after 24 hrs by ELISA relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1176003Antifungal activity against Trichophyton mentagrophytes (Robin) Blanchard CBS 160.66 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID338026Inhibition of rat liver mitochondrial ATPase assessed as specific activity at 0.42 mM relative to control
AID1176015Antifungal activity against Microsporum canis Bodin CBS 4727 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1417132Antileishmanial activity against Leishmania amazonensis MHOM/77BR/LTB0016 amastigotes infected in mouse peritoneal macrophages after 48 hrs by Giemsa staining-based assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID1082356Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID517391Cytotoxicity against mouse 3T3L1 cells at 20 uM after 24 hrs2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID1446627Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID468429Solubility in pH 9 buffer2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Soluble polyphenols: synthesis and bioavailability of 3,4',5-tri(alpha-D-glucose-3-O-succinyl) resveratrol.
AID1176007Antifungal activity against Nannizzia gypsea (Bodin) Guiart et Grigoraki CBS 286.63 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1176039Antioxidant activity assessed as superoxide anion radical scavenging by photochemiluminescence method relative to trolox2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1516971Antifungal activity against Candida albicans after 48 hrs by broth micro dilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1071684Antioxidant activity assessed as reduction of Cu2+ to Cu+ at 10 uM2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID339057Inhibition of Moloney murine leukemia virus reverse transcriptase using (ribocytidylic acid)n(deoxyguanylic acid)12-18 as template primer by liquid scintillation counting1992Journal of natural products, Feb, Volume: 55, Issue:2
Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity.
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID750847Antioxidant activity after 30 mins by ABTS+ radical cation decolourization assay2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Bioactive dimeric carbazole alkaloids from Murraya koenigii.
AID750846Antioxidant activity assessed as hydroxyl radical scavenging activity after 15 mins by spectrophotometric analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Bioactive dimeric carbazole alkaloids from Murraya koenigii.
AID1126475Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1126479Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID366285Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID1082352Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1126471Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1446622Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID339129Inhibition of collagen-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1424233Antioxidant activity assessed as hydroxyl radical scavenging activity by measuring rate constant using UV irradiation by ESR spin trapping method2017European journal of medicinal chemistry, Jun-16, Volume: 133Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases.
AID1510607Inhibition of alpha-chymotrypsin in bovine pancreas using SPpNA as substrate pretreated with enzyme for 30 mins followed by substrate addition and measured for 12 mins in presence of Triton X-100 by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1761536Binding affinity to sensorchip-immobilized human His-tagged CFTR F508 deletion mutant by surface plasmon resonance analysis2021European journal of medicinal chemistry, Mar-05, Volume: 213In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library.
AID1176002Antifungal activity against Trichophyton violaceum Malmsten CBS 459.61 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID441665Cytotoxicity against human A549 cells upto 200 umol/L after 24 hrs by MTS assay2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID666857Reversal of BCRP-mediated drug resistant in human HEK293/R2 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID1256763Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate by spectrophotometric analysis2015European journal of medicinal chemistry, Nov-13, Volume: 105Inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis: in silico screening and in vitro validation.
AID1176008Antifungal activity against Epidermophyton floccosum (Hartz) Langeron and Milochevitch CBS 358.93 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1303230Antioxidant activity in human HepG2 cells assessed as reduction in Cu2+ induced oxidative stress at 50 to 200 ug/ml preincubated for 30 mins in presence of lysine using DCFH-DA by fluorescence assay2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1377661Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1303229Induction of Cu/Zn SOD gene expression in human HepG2 cells at 100 to 300 ug/ml at 120 degC after 4 hrs in presence of lysine by western blot analysis2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1303228Antioxidant activity in human HepG2 cells assessed as increase in Cu/Zn SOD activity at 200 ug/ml at 120 degC after 4 hrs relative to control2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID462342Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID357254Antifungal activity against Candida albicans ATCC 900282002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID1510609Inhibition of bovine pancreas alpha-chymotrypsin at concentration of 6 uM using SPpNA as substrate treated with enzyme for 30 mins following enzyme incubation with 0.7 to 2.1 M DMSO for 5 mins followed by substrate addition and measured for 12 mins by DMS2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1243247Anti-inflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 10 uM by Griess reaction based ELISA method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Chemical constituents of Miliusa balansae leaves and inhibition of nitric oxide production in lipopolysaccharide-induced RAW 264.7 cells.
AID690149Reducing activity by cyclic voltammetry2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1176028Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID287081Cell viability of Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID339146Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 100 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID750845Antioxidant activity assessed as nitric oxide scavenging activity after 150 mins by Greiss method2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Bioactive dimeric carbazole alkaloids from Murraya koenigii.
AID1235287Antimicrobial activity against Candida albicans ATCC 10231 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID379571Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID1082334Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID332704Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID1193990Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Chemical constituents from Kandelia candel with their inhibitory effects on pro-inflammatory cytokines production in LPS-stimulated bone marrow-derived dendritic cells (BMDCs).
AID402475Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID452625Antiglycation activity assessed as inhibition of BSA-derived advance glycated end product formation after 9 days by spectrophotometry2009Bioorganic & medicinal chemistry, Nov-15, Volume: 17, Issue:22
Synthesis of bis-Schiff bases of isatins and their antiglycation activity.
AID1082328Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1636348Antidiabetic activity in STZ-induced diabetic albino Wistar rat assessed as increase in body weight at 100 mg/kg, po administered for 45 days relative to control2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
AID379567Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio relative to TPA2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID365674Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
AID1744547Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL complex formation at 10 uM incubated for 15 mins in presence of cardiolipin by Trp-59 fluorescence assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID170014Effect of compound on catalase measured as disappearance of H2O2 in isolated rat heart muscle subjected to global ischemia2001Bioorganic & medicinal chemistry letters, Jan-08, Volume: 11, Issue:1
Beneficial effects of different flavonoids, on functional recovery after ischemia and reperfusion in isolated rat heart.
AID462335Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID332708Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID1377663Antimicrobial activity against Candida albicans ATCC 90028 at 32 ug/ml after 24 hrs by resazurin dye based assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID690145Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1126474Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID332706Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID1871976Antifungal activity against Candida albicans 10/15 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1064278Antioxidant activity assessed as superoxide radical scavenging activity by NBT reduction assay2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Natural occurrence of organofluorine and other constituents from Streptomyces sp. TC1.
AID1510603Inhibition of Enterobacter cloacae beta-lactamase at 500 uM incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis relative to control2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1082346Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID360611Antiprotozoal activity against Entamoeba histolytica HM-1:IMSS trophozoites after 48 hrs by MTT/PMS assay2001Journal of natural products, May, Volume: 64, Issue:5
Antiprotozoal activity of the constituents of Conyza filaginoides.
AID750850Antioxidant activity assessed as ferric ion reducing activity after 30 mins by spectrophotometric analysis2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Bioactive dimeric carbazole alkaloids from Murraya koenigii.
AID1744553Permeability constant, logPe of compound incubated for 2 to 30 hrs by PAMPA assay2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1071680Antiosteoporotic activity in alpha-MEM-induced C57BL/6 mouse MC3T3-E1 cells assessed as increase in mineralization by measuring calcium deposition at 5 uM by Alizarin Red staining assay relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1303221Retention time of compound by HPLC method2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1172640Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay2014Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
Bioactive triterpenoid saponins and phenolic compounds against glioma cells.
AID379313Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity2000Journal of natural products, Mar, Volume: 63, Issue:3
Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships.
AID466872Inhibition of electric eel AChE at 350 mM by microplate assay2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Acetylcholinesterase inhibitory pyridine alkaloids of the leaves of Senna multijuga.
AID1176036Induction of apoptosis in human K562 cells assessed as apoptotic cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1303232Metal chelating activity assessed as Cu2+ reducing activity at 120 degC after 4 hrs in presence of lysine2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1176001Antifungal activity against Trichophyton tonsurans Malmsten CBS 483.76 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1424235Antioxidant activity assessed as alkoxyl radical scavenging activity by measuring rate constant by ESR spin trapping method2017European journal of medicinal chemistry, Jun-16, Volume: 133Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases.
AID379568Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio relative to TPA2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID1257224Inhibition of Trichomonas vaginalis adenosine-guanosine preferring ribohydrolase after 40 mins2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
AID339142Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 100 ug/mL after 15 mins1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1303223Antioxidant activity assessed as DPPH scavenging activity at 20 to 100 ug/ml after 4 hrs in presence of lysine by spectrophotometric method2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1082340Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1126473Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1071677Inhibition of TRAP activity in Balb/c mouse RAW264.7 cells at 10 uM after 1 hr by ELISA relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1255828Neuroprotective activity against rotenone-induced cell damage in rat PC12 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay (Rvb = 53.9 +/- 7.1%)2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Forsythoneosides A-D, Neuroprotective Phenethanoid and Flavone Glycoside Heterodimers from the Fruits of Forsythia suspensa.
AID287077Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1243248Anti-inflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 20 uM by Griess reaction based ELISA method2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Chemical constituents of Miliusa balansae leaves and inhibition of nitric oxide production in lipopolysaccharide-induced RAW 264.7 cells.
AID1176030Induction of apoptosis in human K562 cells assessed as dead cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID379312Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity relative to Trolox2000Journal of natural products, Mar, Volume: 63, Issue:3
Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships.
AID1235284Antimicrobial activity against methicillin-resistant Staphylococcus aureus 344/2-32 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID643972Osteogenic activity in rat primary calvarial osteoblasts assessed as induction of ALP activity at 1 pM to 1 uM after 10 days by colorimetry2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1168621Antiglycation activity using bovine serum albumin incubated at 37 degC for 7 days by spectrofluorimetry2014European journal of medicinal chemistry, Nov-24, Volume: 87Implications of N-capped urea/thiourea and C-capped 3-(1-piperazinyl)-1,2-benzisothiazole with bridging Gly-Val/Phe-Gly-Val-Pro as therapeutic targets.
AID1256762Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate at 10 uM by spectrophotometric analysis relative to control2015European journal of medicinal chemistry, Nov-13, Volume: 105Inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis: in silico screening and in vitro validation.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1176016Antifungal activity against Nannizzia gypsea (Bodin) Guiart et Grigoraki CBS 286.63 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID294155Inhibition of diphenolase activity of mushroom tyrosinase at 0.055 mM2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.
AID379572Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID335838Inhibition of aldose reductase in rat lens homogenates by fluorophotometer2002Journal of natural products, Aug, Volume: 65, Issue:8
New flavonol oligoglycosides and polyacylated sucroses with inhibitory effects on aldose reductase and platelet aggregation from the flowers of Prunus mume.
AID1616814Cytoprotective activity against CdCl2-induced cell death in human HEK293T cells at 25 to 100 uM preincubated for 2 hrs followed by CdCl2 treatment and measured after 12 hrs by MTT assay2019Journal of natural products, 10-25, Volume: 82, Issue:10
Constituents from the Leaves of
AID1417124Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C2C4 trypomastigotes infected in rat skeletal myoblasts L-6 cells after 96 hrs by CPRG/Nonidet reagent based spectrophotometric method2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID1176031Induction of apoptosis in human K562 cells assessed as dead cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1064280Antioxidant activity assessed as DPPH radical scavenging activity2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Natural occurrence of organofluorine and other constituents from Streptomyces sp. TC1.
AID1176020Induction of apoptosis in human K562 cells assessed as live cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID402484Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment1997Journal of natural products, Aug, Volume: 60, Issue:8
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
AID1446621Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitrite production after 24 hrs by Griess assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID338023Inhibition of beef heart mitochondrial NADH oxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control
AID332645Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation up to 100 uM after 30 mins by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID1446628Cytotoxicity against human BT549 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1176010Antifungal activity against Trichophyton tonsurans Malmsten CBS 483.76 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1871974Antifungal activity against Candida albicans 475/15 assessed as fungal growth inhibition measured after 24 hrs by microdilution assay2022European journal of medicinal chemistry, Feb-05, Volume: 229Quercetin derivatives: Drug design, development, and biological activities, a review.
AID1424232Antioxidant activity assessed as superoxide anion free radical scavenging activity by measuring rate constant using UV irradiation by ESR spin trapping method2017European journal of medicinal chemistry, Jun-16, Volume: 133Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases.
AID666854Cytotoxicity against multidrug resistant human LCC-6 cells after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID1316658Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 1 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1510605Inhibition of alpha-chymotrypsin in bovine pancreas using SPpNA as substrate pretreated with enzyme for 30 mins followed by substrate addition and measured for 12 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1417122Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID1186764Inhibition of influenza A virus (A/Perth/16/2009(H3N2)) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID1515260Inhibition of LSD1 (unknown origin) by fluorescence assay2019Bioorganic & medicinal chemistry, 01-15, Volume: 27, Issue:2
Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro.
AID1071683Antiosteoporotic activity in C57BL/6 mouse MC3T3-E1 cells assessed as increase in collagen synthesis at 5 uM by Sirius Red-based colorimetric assay relative to control2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Identification and biological evaluation of flavonoids from the fruits of Prunus mume.
AID1446624Cytotoxicity against rat C6 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1064279Antioxidant activity assessed as hydroxyl radical scavenging activity after 15 mins by spectrophotometric analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Natural occurrence of organofluorine and other constituents from Streptomyces sp. TC1.
AID1082348Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID515378Antioxidant activity assessed as nitric oxide scavenging activity by spectrophotometry2010Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18
2,3-diarylxanthones as strong scavengers of reactive oxygen and nitrogen species: a structure-activity relationship study.
AID642414Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID462336Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID736009Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader2013Journal of natural products, Feb-22, Volume: 76, Issue:2
Flavone tetraglycosides and benzyl alcohol glycosides from the Mongolian medicinal plant Dracocephalum ruyschiana.
AID666853Cytotoxicity against human LCC-6 cells after 5 days by MTS assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells.
AID441660Inhibition of human recombinant AChE by Ellman's method2010European journal of medicinal chemistry, Jan, Volume: 45, Issue:1
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
AID1446625Cytotoxicity against human A549 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID253005Tested for vasorelaxant activity in rat thoracic aorta rings against PE-induced contractions2004Bioorganic & medicinal chemistry letters, Aug-02, Volume: 14, Issue:15
Synthesis and biological evaluation of flavonoids as vasorelaxant agents.
AID379096Stimulation of BALB/c mouse cloned 3T3/A31 cells proliferation at 0.01 to 10 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379096Stimulation of BALB/c mouse cloned 3T3/A31 cells proliferation at 0.01 to 10 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID462333Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells.
AID339127Inhibition of ADP-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method1993Journal of natural products, Jun, Volume: 56, Issue:6
Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants.
AID1235283Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1176034Induction of apoptosis in human K562 cells assessed as apoptotic cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID406717Photostability of compound assessed as protection factor-UVA after 120 mins2008Journal of natural products, Jun, Volume: 71, Issue:6
Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method.
AID517389Inhibition of AMPK-mediated adipocyte differentiation in mouse 3T3L1 cells2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID1126477Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA2014Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8
Anti-inflammatory components of Euphorbia humifusa Willd.
AID1243246Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability at 10 to 40 uM by MTT assay2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Chemical constituents of Miliusa balansae leaves and inhibition of nitric oxide production in lipopolysaccharide-induced RAW 264.7 cells.
AID1176005Antifungal activity against Nannizzia cajetani Ajello CBS 495.70 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1082338Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1176012Antifungal activity against Trichophyton mentagrophytes (Robin) Blanchard CBS 160.66 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1082326Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID402361Activity at human estrogen receptor expressed in transgenic Arabidopsis plant at 400 uM by pER8-GFP reporter assay2005Journal of natural products, Jul, Volume: 68, Issue:7
The transgenic Arabidopsis plant system, pER8-GFP, as a powerful tool in searching for natural product estrogen-agonists/antagonists.
AID366286Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID1176040Antioxidant activity assessed as inhibition of AAPH-induced peroxyl radical generation by oxygen radical absorbance capacity assay relative to trolox2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID1303231Antioxidant activity assessed as DPPH scavenging activity at 60 to 100 ug/ml and 120 degC after 4 hrs in presence of lysine by spectrophotometric method2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
Increase of rutin antioxidant activity by generating Maillard reaction products with lysine.
AID1266872Hepatoprotective activity against tert-butyl hydroperoxide-induced oxidative stress in Wistar rat hepatocytes assessed as cell viability at 60 ug/ml by tryphan blue exclusion method (Rvb = 74%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavoalkaloids and Flavonoids from Astragalus monspessulanus.
AID1082360Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1176037Induction of apoptosis in human K562 cells assessed as apoptotic cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%)2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Design, synthesis and biological activity of a novel Rutin analogue with improved lipid soluble properties.
AID366284Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
AID332646Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting up to 100 uM by agarose gel electrophoresis1995Journal of natural products, Feb, Volume: 58, Issue:2
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
AID466871Inhibition of electric eel AChE assessed as purple zones of inhibition after 20 mins by TLC bioautography2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Acetylcholinesterase inhibitory pyridine alkaloids of the leaves of Senna multijuga.
AID379565Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio relative to TPA2006Journal of natural products, Dec, Volume: 69, Issue:12
Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers.
AID1083149Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions2012Journal of agricultural and food chemistry, Nov-28, Volume: 60, Issue:47
Nematotoxic phenolic compounds from Melia azedarach against Meloidogyne incognita.
AID1417130Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 trypomastigotes after 72 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID287076Inhibition of TPA-induced inflammation in mouse assessed per ear by edema assay2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID453282Antioxidant activity assessed as nitric oxide scavenging activity by fluorescent triazofluorescein formation assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Synthesis and antioxidant properties of new chromone derivatives.
AID1082336Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1446626Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay2017Journal of natural products, 02-24, Volume: 80, Issue:2
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
AID1082337Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1434704Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Natural potential neuroinflammatory inhibitors from Alhagi sparsifolia Shap.
AID1266873Antioxidant activity assessed as reactive oxygen species scavenging activity2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavoalkaloids and Flavonoids from Astragalus monspessulanus.
AID642415Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of estrogen receptor α modulators from natural compounds in Si-Wu-Tang series decoctions using estrogen-responsive MCF-7 breast cancer cells.
AID1256761Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate up to 50 nM by spectrophotometric analysis2015European journal of medicinal chemistry, Nov-13, Volume: 105Inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis: in silico screening and in vitro validation.
AID517390Inhibition of PPAR-gamma-mediated adipocyte differentiation in mouse 3T3L1 cells2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells.
AID721628Inhibition of glycation of bovine serum albumin assessed as advanced glycated end product measured after 7 days by spectrofluorimeter in presence of glucose anhydrous2013European journal of medicinal chemistry, Feb, Volume: 60Inhibition of protein glycation by urea and thiourea derivatives of glycine/proline conjugated benzisoxazole analogue - synthesis and structure-activity studies.
AID1186763Inhibition of influenza A virus (A/California/07/2009(H1N1)) pdm09 neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID312021DPPH radical scavenging activity assessed as absorption change at 60 ppm by spectrophotometry2007Journal of natural products, Dec, Volume: 70, Issue:12
Lipoperoxidation and cyclooxygenase enzyme inhibitory piperidine alkaloids from Cassia spectabilis green fruits.
AID1257226Inhibition of Trichomonas vaginalis uridine ribohydrolase after 40 mins2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
AID380506Inhibition of CYP3A42006Journal of natural products, Mar, Volume: 69, Issue:3
Alkaloids from Eschscholzia californica and their capacity to inhibit binding of [3H]8-Hydroxy-2-(di-N-propylamino)tetralin to 5-HT1A receptors in Vitro.
AID1082359Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1884962Prevention of Streptococcus suis ATCC 700794 adherence to sucrose-dependent membrane surface at 78.1 ug/ml relative to control2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Small Carbohydrate Derivatives as Potent Antibiofilm Agents.
AID404008Cytotoxicity against human KB cells
AID287080Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 10 mol ratio/32 pmol TPA relative to TPA2007Journal of natural products, May, Volume: 70, Issue:5
Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
AID1071844Antioxidant activity assessed as riboflavin/EDTA-induced superoxide anion radical scavenging activity by ESR spin trapping method2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1799639Kinase Assay from Article 10.1002/cbic.201000487: \\Biological evaluation and structural determinants of p38u00CEu00B1 mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.\\2010Chembiochem : a European journal of chemical biology, Dec-10, Volume: 11, Issue:18
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1803131Enzyme Assay from Article 10.3109/14756366.2010.616860: \\Polyphenol fatty acid esters as serine protease inhibitors: a quantum-chemical QSAR analysis.\\2012Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 27, Issue:6
Polyphenol fatty acid esters as serine protease inhibitors: a quantum-chemical QSAR analysis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3,853)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901054 (27.36)18.7374
1990's228 (5.92)18.2507
2000's677 (17.57)29.6817
2010's1304 (33.84)24.3611
2020's590 (15.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.76 (24.57)
Research Supply Index8.38 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index153.01 (26.88)
Search Engine Supply Index3.85 (0.95)

This Compound (46.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials244 (5.94%)5.53%
Trials0 (0.00%)5.53%
Reviews134 (3.26%)6.00%
Reviews1 (4.55%)6.00%
Case Studies32 (0.78%)4.05%
Case Studies0 (0.00%)4.05%
Observational1 (0.02%)0.25%
Observational0 (0.00%)0.25%
Other3,694 (89.99%)84.16%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]